|
OMIM |
Link |
Information gain |
01 |
|
APOE
|
[NCBI]
|
0.00322973
|
|
|
VDR
|
[NCBI]
|
0.00290321
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00290309
|
|
|
MAFD6
|
[NCBI]
|
0.00255022
|
|
|
IGAN1
|
[NCBI]
|
0.0017245
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.00152019
|
|
|
EGF
|
[NCBI]
|
0.00148268
|
|
|
ACE
|
[NCBI]
|
0.00146005
|
|
|
COMT
|
[NCBI]
|
0.00144088
|
|
|
IDDM
|
[NCBI]
|
0.00144026
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.00128415
|
|
|
asparagus, specific smell hypersensitivity
|
[NCBI]
|
0.0012754
|
|
|
DYX8
|
[NCBI]
|
0.0012754
|
|
|
BMND3
|
[NCBI]
|
0.00102719
|
|
|
NGFB
|
[NCBI]
|
0.00096182
|
|
|
neuroticism
|
[NCBI]
|
0.00093611
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
0.00093611
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.00093611
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000917002
|
|
|
branchiootic syndrome 2
|
[NCBI]
|
0.000917002
|
|
|
ALS3
|
[NCBI]
|
0.000917002
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
0.000917002
|
|
|
GLC1M
|
[NCBI]
|
0.000917002
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
0.00083792
|
|
|
MAFD1
|
[NCBI]
|
0.000828073
|
|
|
VEGF
|
[NCBI]
|
0.000810163
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000758816
|
|
|
DFNB15
|
[NCBI]
|
0.000758816
|
|
|
ALS5
|
[NCBI]
|
0.000758816
|
|
|
SCZD5
|
[NCBI]
|
0.000758816
|
|
|
PRL
|
[NCBI]
|
0.000751575
|
|
|
AUTS6
|
[NCBI]
|
0.000736247
|
|
|
ESD
|
[NCBI]
|
0.000733371
|
|
|
PSORS2
|
[NCBI]
|
0.000685273
|
|
|
syndactyly, type i
|
[NCBI]
|
0.000652396
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000652396
|
|
|
IBD3
|
[NCBI]
|
0.000652396
|
|
|
PON1
|
[NCBI]
|
0.000649014
|
|
|
IDDM4
|
[NCBI]
|
0.000639641
|
|
|
melanoma, uveal, susceptibility to, 1
|
[NCBI]
|
0.000637356
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.000637356
|
|
|
knobloch syndrome, type ii
|
[NCBI]
|
0.000637356
|
|
|
tear protein, anodal
|
[NCBI]
|
0.000637356
|
|
|
Sf
|
[NCBI]
|
0.000637356
|
|
|
AGMX2
|
[NCBI]
|
0.000637356
|
|
|
EIG2
|
[NCBI]
|
0.000637356
|
|
|
BMND7
|
[NCBI]
|
0.000637356
|
|
|
theophylline biotransformation
|
[NCBI]
|
0.000637356
|
|
|
SPG27
|
[NCBI]
|
0.000637356
|
|
|
van der woude syndrome 2
|
[NCBI]
|
0.000637356
|
|
|
FGS3
|
[NCBI]
|
0.000637356
|
|
|
6-@phosphogluconolactonase deficiency
|
[NCBI]
|
0.000637356
|
|
|
GLC1B
|
[NCBI]
|
0.000637356
|
|
|
bone size quantitative trait locus 2
|
[NCBI]
|
0.000637356
|
|
|
EMWX
|
[NCBI]
|
0.000637356
|
|
|
FEB2
|
[NCBI]
|
0.000637356
|
|
|
DYT4
|
[NCBI]
|
0.000637356
|
|
|
PCNA
|
[NCBI]
|
0.000633879
|
|
|
behcet syndrome
|
[NCBI]
|
0.000631246
|
|
|
AVP
|
[NCBI]
|
0.000602995
|
|
|
MAOA
|
[NCBI]
|
0.000590881
|
|
|
GFAP
|
[NCBI]
|
0.000588471
|
|
|
ATOD6
|
[NCBI]
|
0.000572462
|
|
|
CNC2
|
[NCBI]
|
0.000572462
|
|
|
alopecia areata 1
|
[NCBI]
|
0.000560982
|
|
|
VIP
|
[NCBI]
|
0.000534726
|
|
|
DRD4
|
[NCBI]
|
0.000531213
|
|
|
MSSE
|
[NCBI]
|
0.000508834
|
|
|
CEACAM5
|
[NCBI]
|
0.000508767
|
|
|
TPMT
|
[NCBI]
|
0.000474325
|
|
|
HP
|
[NCBI]
|
0.000460282
|
|
|
malaria, susceptibility to
|
[NCBI]
|
0.000441768
|
|
|
GC
|
[NCBI]
|
0.000427636
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000422996
|
|
|
HGF
|
[NCBI]
|
0.000418556
|
|
|
NPY
|
[NCBI]
|
0.000412564
|
|
|
MBL2
|
[NCBI]
|
0.000409224
|
|
|
EPO
|
[NCBI]
|
0.000404568
|
|
|
MTR
|
[NCBI]
|
0.000397796
|
|
|
PTH
|
[NCBI]
|
0.000387424
|
|
|
CRH
|
[NCBI]
|
0.000382232
|
|
|
DFNA41
|
[NCBI]
|
0.00037909
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.00037909
|
|
|
HRPT3
|
[NCBI]
|
0.00037909
|
|
|
HCFP2
|
[NCBI]
|
0.00037909
|
|
|
melanoma, uveal, susceptibility to, 2
|
[NCBI]
|
0.00037909
|
|
|
hydrocephalus, autosomal dominant
|
[NCBI]
|
0.00037909
|
|
|
SPAX1
|
[NCBI]
|
0.00037909
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.00037909
|
|
|
BMND5
|
[NCBI]
|
0.00037909
|
|
|
MCOPCB2
|
[NCBI]
|
0.00037909
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.00037909
|
|
|
brachydactyly, type a1, b
|
[NCBI]
|
0.00037909
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.00037909
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.00037909
|
|
|
epidermolysis bullosa inversa dystrophica
|
[NCBI]
|
0.00037909
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.00037909
|
|
|
dermatoglyphics--fingerprint pattern
|
[NCBI]
|
0.00037909
|
|
|
alzheimer disease 7
|
[NCBI]
|
0.00037909
|
|
|
MTHFR
|
[NCBI]
|
0.000373542
|
|
|
AFP
|
[NCBI]
|
0.000369062
|
|
|
PCOS1
|
[NCBI]
|
0.000356185
|
|
|
ACHE
|
[NCBI]
|
0.000350439
|
|
|
KLK3
|
[NCBI]
|
0.00034959
|
|
|
PEE1
|
[NCBI]
|
0.000327427
|
|
|
MODY
|
[NCBI]
|
0.000321648
|
|
|
EIG
|
[NCBI]
|
0.000315672
|
|
|
CCK
|
[NCBI]
|
0.000309555
|
|
|
EGFR
|
[NCBI]
|
0.000301179
|
|
|
HBFQTL2
|
[NCBI]
|
0.00029417
|
|
|
FABP2
|
[NCBI]
|
0.000291741
|
|
|
FGS2
|
[NCBI]
|
0.000285937
|
|
|
wieacker syndrome
|
[NCBI]
|
0.000285937
|
|
|
MRX20
|
[NCBI]
|
0.000285937
|
|
|
prostate cancer, hereditary, 3
|
[NCBI]
|
0.000285937
|
|
|
IDDM18
|
[NCBI]
|
0.000285937
|
|
|
CFM1
|
[NCBI]
|
0.000285937
|
|
|
EJM2
|
[NCBI]
|
0.000285937
|
|
|
bone size quantitative trait locus 1
|
[NCBI]
|
0.000285937
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
0.000285937
|
|
|
hypoadrenocorticism, familial
|
[NCBI]
|
0.000285937
|
|
|
HHC2
|
[NCBI]
|
0.000285937
|
|
|
PDR
|
[NCBI]
|
0.000285937
|
|
|
AUTS10
|
[NCBI]
|
0.000285937
|
|
|
OFC2
|
[NCBI]
|
0.000285937
|
|
|
patent ductus arteriosus
|
[NCBI]
|
0.000285937
|
|
|
IBD9
|
[NCBI]
|
0.000285937
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
0.000275776
|
|
|
APOB
|
[NCBI]
|
0.000266971
|
|
|
SLC11A1
|
[NCBI]
|
0.000262995
|
|
|
RA
|
[NCBI]
|
0.000262296
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.000260112
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000256876
|
|
|
NPPA
|
[NCBI]
|
0.000255105
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
0.000247685
|
|
|
TF
|
[NCBI]
|
0.000239757
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.00023864
|
|
|
PAND1
|
[NCBI]
|
0.00023864
|
|
|
NAT1
|
[NCBI]
|
0.000236453
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
0.00023085
|
|
|
RP6
|
[NCBI]
|
0.000227882
|
|
|
ICCA
|
[NCBI]
|
0.000227882
|
|
|
antipyrine metabolism
|
[NCBI]
|
0.000227882
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
0.000227882
|
|
|
gout susceptibility 1
|
[NCBI]
|
0.000227882
|
|
|
pulmonary function
|
[NCBI]
|
0.000227882
|
|
|
LGMD1D
|
[NCBI]
|
0.000227882
|
|
|
eosinophilia, familial
|
[NCBI]
|
0.000227882
|
|
|
MRX23
|
[NCBI]
|
0.000227882
|
|
|
DYX5
|
[NCBI]
|
0.000227882
|
|
|
ALSFTD1
|
[NCBI]
|
0.000227882
|
|
|
RP24
|
[NCBI]
|
0.000227882
|
|
|
EVR3
|
[NCBI]
|
0.000227882
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000227882
|
|
|
HBFQTL4
|
[NCBI]
|
0.000227882
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000227882
|
|
|
LEPR
|
[NCBI]
|
0.000226606
|
|
|
CHAT
|
[NCBI]
|
0.000224456
|
|
|
alcohol dependence
|
[NCBI]
|
0.000224426
|
|
|
MS
|
[NCBI]
|
0.000223982
|
|
|
CJD
|
[NCBI]
|
0.000218568
|
|
|
CF
|
[NCBI]
|
0.000215422
|
|
|
IS1
|
[NCBI]
|
0.000212086
|
|
|
A2M
|
[NCBI]
|
0.000205145
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.00020048
|
|
|
CAT
|
[NCBI]
|
0.000199031
|
|
|
CYP2D6
|
[NCBI]
|
0.000198476
|
|
|
MBP
|
[NCBI]
|
0.000198092
|
|
|
TH
|
[NCBI]
|
0.000196633
|
|
|
abdominal body fat distribution
|
[NCBI]
|
0.00019403
|
|
|
AHSG
|
[NCBI]
|
0.000190066
|
|
|
GLC1C
|
[NCBI]
|
0.000186496
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000186496
|
|
|
OPA4
|
[NCBI]
|
0.000186496
|
|
|
ETM2
|
[NCBI]
|
0.000186496
|
|
|
AUTS5
|
[NCBI]
|
0.000186496
|
|
|
AD14
|
[NCBI]
|
0.000186496
|
|
|
WT3
|
[NCBI]
|
0.000186496
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000186496
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.000186496
|
|
|
AD13
|
[NCBI]
|
0.000186496
|
|
|
DRD2
|
[NCBI]
|
0.000186485
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.000185061
|
|
|
PSNP1
|
[NCBI]
|
0.000182608
|
|
|
hemophilia a
|
[NCBI]
|
0.000180279
|
|
|
CFH
|
[NCBI]
|
0.000178965
|
|
|
OFC1
|
[NCBI]
|
0.000178459
|
|
|
PRNP
|
[NCBI]
|
0.000174345
|
|
|
AR
|
[NCBI]
|
0.00017287
|
|
|
PGM1
|
[NCBI]
|
0.00017285
|
|
|
F3
|
[NCBI]
|
0.000172418
|
|
|
isoniazid inactivation
|
[NCBI]
|
0.000168051
|
|
|
MICA
|
[NCBI]
|
0.000167359
|
|
|
ADRB2
|
[NCBI]
|
0.000167359
|
|
|
SOD2
|
[NCBI]
|
0.000166943
|
|
|
C4A
|
[NCBI]
|
0.000165931
|
|
|
CFB
|
[NCBI]
|
0.000165815
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
0.000165375
|
|
|
PSORS1
|
[NCBI]
|
0.00016405
|
|
|
APOA1
|
[NCBI]
|
0.000163146
|
|
|
EPHX1
|
[NCBI]
|
0.000158325
|
|
|
parkinson disease, mitochondrial
|
[NCBI]
|
0.000156357
|
|
|
small cell cancer of the lung
|
[NCBI]
|
0.00015634
|
|
|
actinic prurigo
|
[NCBI]
|
0.000154928
|
|
|
RNANC
|
[NCBI]
|
0.000154928
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000154928
|
|
|
SCZD10
|
[NCBI]
|
0.000154928
|
|
|
aniridia, cerebellar ataxia, and mental deficiency
|
[NCBI]
|
0.000154928
|
|
|
lactase persistence
|
[NCBI]
|
0.000153986
|
|
|
LTA
|
[NCBI]
|
0.000152757
|
|
|
kuru, susceptibility to
|
[NCBI]
|
0.000150862
|
|
|
HPA1
|
[NCBI]
|
0.000149775
|
|
|
CCND1
|
[NCBI]
|
0.000149103
|
|
|
TNFSF6
|
[NCBI]
|
0.000149103
|
|
|
TYMS
|
[NCBI]
|
0.00014628
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000142797
|
|
|
IRDN
|
[NCBI]
|
0.000141742
|
|
|
complement component 6 deficiency
|
[NCBI]
|
0.0001374
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.00013626
|
|
|
CETP
|
[NCBI]
|
0.000134565
|
|
|
APS2
|
[NCBI]
|
0.000129848
|
|
|
BRCD1
|
[NCBI]
|
0.000129848
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000129848
|
|
|
MCOP1
|
[NCBI]
|
0.000129848
|
|
|
spiegler-brooke syndrome
|
[NCBI]
|
0.000129848
|
|
|
AUTS4
|
[NCBI]
|
0.000129848
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
0.000129848
|
|
|
cluster headache, familial
|
[NCBI]
|
0.000129848
|
|
|
MNG1
|
[NCBI]
|
0.000129848
|
|
|
SAL-I
|
[NCBI]
|
0.000129346
|
|
|
blepharospasm, benign essential
|
[NCBI]
|
0.000129346
|
|
|
fucosidase regulator
|
[NCBI]
|
0.000129346
|
|
|
orofacial cleft 6
|
[NCBI]
|
0.000129346
|
|
|
arteriovenous malformations of the brain
|
[NCBI]
|
0.000129346
|
|
|
novelty seeking personality trait
|
[NCBI]
|
0.000128231
|
|
|
respiratory distress syndrome in premature infants
|
[NCBI]
|
0.000128231
|
|
|
MFS
|
[NCBI]
|
0.000127962
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000126465
|
|
|
GAPDH
|
[NCBI]
|
0.000125593
|
|
|
FFI
|
[NCBI]
|
0.000125412
|
|
|
PRB1
|
[NCBI]
|
0.000123555
|
|
|
GDNF
|
[NCBI]
|
0.000123391
|
|
|
osteoarthritis
|
[NCBI]
|
0.000122906
|
|
|
ESR1
|
[NCBI]
|
0.000122515
|
|
|
G6PD
|
[NCBI]
|
0.000122225
|
|
|
PKD1
|
[NCBI]
|
0.000119593
|
|
|
HLA-A
|
[NCBI]
|
0.000119254
|
|
|
APOA4
|
[NCBI]
|
0.000117648
|
|
|
IL1A
|
[NCBI]
|
0.000117546
|
|
|
HTR2A
|
[NCBI]
|
0.000116478
|
|
|
ALD
|
[NCBI]
|
0.000116426
|
|
|
C4B
|
[NCBI]
|
0.000115466
|
|
|
PXE
|
[NCBI]
|
0.000115131
|
|
|
MAOB
|
[NCBI]
|
0.000115111
|
|
|
C3
|
[NCBI]
|
0.000113985
|
|
|
ALPP
|
[NCBI]
|
0.000113886
|
|
|
ADH2
|
[NCBI]
|
0.000113642
|
|
|
CRS2
|
[NCBI]
|
0.000113137
|
|
|
IL1RN
|
[NCBI]
|
0.000110592
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
0.000110521
|
|
|
alzheimer disease 3
|
[NCBI]
|
0.000110521
|
|
|
AUTS9
|
[NCBI]
|
0.00010938
|
|
|
gastroesophageal reflux
|
[NCBI]
|
0.00010938
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.00010938
|
|
|
C7
|
[NCBI]
|
0.000109063
|
|
|
HLA-DQA1
|
[NCBI]
|
0.000108372
|
|
|
RP3
|
[NCBI]
|
0.000106774
|
|
|
SLC6A4
|
[NCBI]
|
0.00010658
|
|
|
NOS3
|
[NCBI]
|
0.000106523
|
|
|
CYP2E
|
[NCBI]
|
0.000105396
|
|
|
thiopurine s-methyltransferase deficiency
|
[NCBI]
|
0.000105244
|
|
|
ALS2
|
[NCBI]
|
0.000105244
|
|
|
AGT
|
[NCBI]
|
0.00010503
|
|
|
APOH
|
[NCBI]
|
0.000103562
|
|
|
PTHLH
|
[NCBI]
|
0.000101925
|
|
|
FMO2
|
[NCBI]
|
0.000101496
|
|
|
BL
|
[NCBI]
|
9.99963e-05
|
|
|
ACP5
|
[NCBI]
|
9.85102e-05
|
|
|
CR1
|
[NCBI]
|
9.55596e-05
|
|
|
ADCYAP1
|
[NCBI]
|
9.53636e-05
|
|
|
CTLA4
|
[NCBI]
|
9.50949e-05
|
|
|
HLA-DRA
|
[NCBI]
|
9.50949e-05
|
|
|
LPA
|
[NCBI]
|
9.34293e-05
|
|
|
F13A1
|
[NCBI]
|
9.31669e-05
|
|
|
FSHMD1A
|
[NCBI]
|
9.31087e-05
|
|
|
AD
|
[NCBI]
|
9.30265e-05
|
|
|
HOKPP
|
[NCBI]
|
9.2731e-05
|
|
|
osteoporosis
|
[NCBI]
|
9.2731e-05
|
|
|
GCY
|
[NCBI]
|
9.23606e-05
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
9.23606e-05
|
|
|
SCZD6
|
[NCBI]
|
9.23606e-05
|
|
|
rheumatoid arthritis, systemic juvenile
|
[NCBI]
|
9.20448e-05
|
|
|
ACHM3
|
[NCBI]
|
9.20448e-05
|
|
|
CELIAC3
|
[NCBI]
|
9.18994e-05
|
|
|
blood group--froese
|
[NCBI]
|
9.18994e-05
|
|
|
PAI1
|
[NCBI]
|
9.12695e-05
|
|
|
phenylketonuria
|
[NCBI]
|
9.09708e-05
|
|
|
PYY
|
[NCBI]
|
9.05344e-05
|
|
|
MYOC
|
[NCBI]
|
9.00797e-05
|
|
|
FA
|
[NCBI]
|
8.93346e-05
|
|
|
OPA1
|
[NCBI]
|
8.74242e-05
|
|
|
HNMT
|
[NCBI]
|
8.60523e-05
|
|
|
ALAD
|
[NCBI]
|
8.57766e-05
|
|
|
TLR4
|
[NCBI]
|
8.48697e-05
|
|
|
ITGA2
|
[NCBI]
|
8.4822e-05
|
|
|
autism
|
[NCBI]
|
8.37299e-05
|
|
|
neural tube defects, folate-sensitive
|
[NCBI]
|
8.34193e-05
|
|
|
IL10
|
[NCBI]
|
8.2038e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
8.16165e-05
|
|
|
MMP3
|
[NCBI]
|
8.13157e-05
|
|
|
PRH1
|
[NCBI]
|
8.11009e-05
|
|
|
LPL
|
[NCBI]
|
7.99982e-05
|
|
|
XDH
|
[NCBI]
|
7.85958e-05
|
|
|
DRD3
|
[NCBI]
|
7.83541e-05
|
|
|
SHFLD1
|
[NCBI]
|
7.80177e-05
|
|
|
PARK3
|
[NCBI]
|
7.80177e-05
|
|
|
AMCN
|
[NCBI]
|
7.80177e-05
|
|
|
HPCX
|
[NCBI]
|
7.80177e-05
|
|
|
ME2
|
[NCBI]
|
7.77284e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.73132e-05
|
|
|
HK2
|
[NCBI]
|
7.6893e-05
|
|
|
FBN1
|
[NCBI]
|
7.61676e-05
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
7.59436e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
7.54185e-05
|
|
|
CCL
|
[NCBI]
|
7.54185e-05
|
|
|
buruli ulcer, susceptibility to
|
[NCBI]
|
7.54185e-05
|
|
|
raph blood group system
|
[NCBI]
|
7.54185e-05
|
|
|
SW
|
[NCBI]
|
7.54185e-05
|
|
|
REN
|
[NCBI]
|
7.42577e-05
|
|
|
SHH
|
[NCBI]
|
7.38377e-05
|
|
|
AACT
|
[NCBI]
|
7.36713e-05
|
|
|
WFS1
|
[NCBI]
|
7.36713e-05
|
|
|
CHM
|
[NCBI]
|
7.35869e-05
|
|
|
graves disease
|
[NCBI]
|
7.28429e-05
|
|
|
PON2
|
[NCBI]
|
7.27026e-05
|
|
|
CMPK1
|
[NCBI]
|
7.18099e-05
|
|
|
GJA4
|
[NCBI]
|
7.18099e-05
|
|
|
CASR
|
[NCBI]
|
7.14613e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
7.10012e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
6.9911e-05
|
|
|
HLA-B
|
[NCBI]
|
6.96559e-05
|
|
|
IL6R
|
[NCBI]
|
6.91845e-05
|
|
|
F13B
|
[NCBI]
|
6.90121e-05
|
|
|
KIR3DL1
|
[NCBI]
|
6.90121e-05
|
|
|
ABCC1
|
[NCBI]
|
6.81702e-05
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
6.76235e-05
|
|
|
PGP
|
[NCBI]
|
6.75528e-05
|
|
|
FMO3
|
[NCBI]
|
6.6526e-05
|
|
|
PLG
|
[NCBI]
|
6.64537e-05
|
|
|
CTGF
|
[NCBI]
|
6.64071e-05
|
|
|
CYLD
|
[NCBI]
|
6.6123e-05
|
|
|
ELN
|
[NCBI]
|
6.58164e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
6.58134e-05
|
|
|
alzheimer disease 6
|
[NCBI]
|
6.58134e-05
|
|
|
GSTM1
|
[NCBI]
|
6.57114e-05
|
|
|
DYT1
|
[NCBI]
|
6.5654e-05
|
|
|
TG
|
[NCBI]
|
6.55101e-05
|
|
|
DNASE1
|
[NCBI]
|
6.48347e-05
|
|
|
MODY7
|
[NCBI]
|
6.46699e-05
|
|
|
THB
|
[NCBI]
|
6.46699e-05
|
|
|
adrenal hypoplasia, congenital, with absent pituitary luteinizing hormone
|
[NCBI]
|
6.46699e-05
|
|
|
SMDP3
|
[NCBI]
|
6.46699e-05
|
|
|
epilepsy, x-linked, with variable learning disabilities and behavior disorders
|
[NCBI]
|
6.46699e-05
|
|
|
acylase, cobalt-activated
|
[NCBI]
|
6.46699e-05
|
|
|
blood group--public systems
|
[NCBI]
|
6.46699e-05
|
|
|
phenformin 4-hydroxylation
|
[NCBI]
|
6.46699e-05
|
|
|
FSGS3
|
[NCBI]
|
6.46699e-05
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
6.46699e-05
|
|
|
CMH2
|
[NCBI]
|
6.46699e-05
|
|
|
SAPX
|
[NCBI]
|
6.46699e-05
|
|
|
kleine-levin hibernation syndrome
|
[NCBI]
|
6.46699e-05
|
|
|
dopamine beta-hydroxylase, plasma, thermolability of
|
[NCBI]
|
6.46699e-05
|
|
|
smell ketone compounds, ability to
|
[NCBI]
|
6.46699e-05
|
|
|
ROCA
|
[NCBI]
|
6.46699e-05
|
|
|
TAQ1
|
[NCBI]
|
6.46699e-05
|
|
|
streptococcus, group a, severity of infection by
|
[NCBI]
|
6.46699e-05
|
|
|
RHE
|
[NCBI]
|
6.46699e-05
|
|
|
LCP1
|
[NCBI]
|
6.44603e-05
|
|
|
fragile site 10q25
|
[NCBI]
|
6.43586e-05
|
|
|
IDDM12
|
[NCBI]
|
6.43586e-05
|
|
|
STL3
|
[NCBI]
|
6.43586e-05
|
|
|
EDM3
|
[NCBI]
|
6.43586e-05
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
6.43586e-05
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
6.43079e-05
|
|
|
GPX1
|
[NCBI]
|
6.39551e-05
|
|
|
temporal arteritis
|
[NCBI]
|
6.36641e-05
|
|
|
ACP1
|
[NCBI]
|
6.36169e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
6.34154e-05
|
|
|
RET
|
[NCBI]
|
6.2811e-05
|
|
|
FRDA
|
[NCBI]
|
6.22089e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
6.21759e-05
|
|
|
BMND1
|
[NCBI]
|
6.14306e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
6.11951e-05
|
|
|
CACNG1
|
[NCBI]
|
6.04784e-05
|
|
|
galactosemia
|
[NCBI]
|
5.97752e-05
|
|
|
RHCE
|
[NCBI]
|
5.96114e-05
|
|
|
DPYD
|
[NCBI]
|
5.9132e-05
|
|
|
LDLR
|
[NCBI]
|
5.85931e-05
|
|
|
RNASE3
|
[NCBI]
|
5.83061e-05
|
|
|
obesity
|
[NCBI]
|
5.79386e-05
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
5.78841e-05
|
|
|
WFS1
|
[NCBI]
|
5.78841e-05
|
|
|
CYP2C9
|
[NCBI]
|
5.75446e-05
|
|
|
CNTF
|
[NCBI]
|
5.74092e-05
|
|
|
MODY1
|
[NCBI]
|
5.72024e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
5.72024e-05
|
|
|
ACHM2
|
[NCBI]
|
5.72024e-05
|
|
|
GPI
|
[NCBI]
|
5.70609e-05
|
|
|
T
|
[NCBI]
|
5.69351e-05
|
|
|
LEP
|
[NCBI]
|
5.66312e-05
|
|
|
MTND3
|
[NCBI]
|
5.66086e-05
|
|
|
IRS1
|
[NCBI]
|
5.60934e-05
|
|
|
SPG13
|
[NCBI]
|
5.60723e-05
|
|
|
RP13
|
[NCBI]
|
5.60723e-05
|
|
|
thrombophilia
|
[NCBI]
|
5.60723e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
5.60549e-05
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
5.53572e-05
|
|
|
leber optic atrophy
|
[NCBI]
|
5.52504e-05
|
|
|
HLA-DRB1
|
[NCBI]
|
5.49032e-05
|
|
|
PPARG
|
[NCBI]
|
5.48917e-05
|
|
|
OSM
|
[NCBI]
|
5.41154e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
5.36841e-05
|
|
|
HYPP
|
[NCBI]
|
5.36841e-05
|
|
|
GCCR
|
[NCBI]
|
5.35302e-05
|
|
|
GPT
|
[NCBI]
|
5.35302e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
5.33658e-05
|
|
|
GLO1
|
[NCBI]
|
5.32823e-05
|
|
|
CPB2
|
[NCBI]
|
5.30353e-05
|
|
|
ABCB1
|
[NCBI]
|
5.30106e-05
|
|
|
PPP1R3A
|
[NCBI]
|
5.28118e-05
|
|
|
GCK
|
[NCBI]
|
5.2567e-05
|
|
|
HPS
|
[NCBI]
|
5.18067e-05
|
|
|
RETN
|
[NCBI]
|
5.11365e-05
|
|
|
MUT
|
[NCBI]
|
5.02656e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.9864e-05
|
|
|
PARK6
|
[NCBI]
|
4.9864e-05
|
|
|
IVA
|
[NCBI]
|
4.9864e-05
|
|
|
TFPI
|
[NCBI]
|
4.98162e-05
|
|
|
IL6
|
[NCBI]
|
4.96492e-05
|
|
|
TSC2
|
[NCBI]
|
4.95791e-05
|
|
|
RP9
|
[NCBI]
|
4.94935e-05
|
|
|
KNO
|
[NCBI]
|
4.94935e-05
|
|
|
ALS4
|
[NCBI]
|
4.94935e-05
|
|
|
AN1
|
[NCBI]
|
4.94935e-05
|
|
|
CPVT
|
[NCBI]
|
4.94935e-05
|
|
|
GBS
|
[NCBI]
|
4.94935e-05
|
|
|
WT5
|
[NCBI]
|
4.94935e-05
|
|
|
ABO
|
[NCBI]
|
4.87395e-05
|
|
|
CCHCR1
|
[NCBI]
|
4.84658e-05
|
|
|
CALCR
|
[NCBI]
|
4.83531e-05
|
|
|
neural tube defects
|
[NCBI]
|
4.80854e-05
|
|
|
RP2
|
[NCBI]
|
4.76966e-05
|
|
|
CMM
|
[NCBI]
|
4.76497e-05
|
|
|
ITGB3
|
[NCBI]
|
4.76207e-05
|
|
|
CTSD
|
[NCBI]
|
4.7537e-05
|
|
|
ORM1
|
[NCBI]
|
4.7537e-05
|
|
|
PRB4
|
[NCBI]
|
4.73004e-05
|
|
|
COL1A1
|
[NCBI]
|
4.72751e-05
|
|
|
TYR
|
[NCBI]
|
4.69813e-05
|
|
|
longevity
|
[NCBI]
|
4.6652e-05
|
|
|
TMAU
|
[NCBI]
|
4.6652e-05
|
|
|
STAR
|
[NCBI]
|
4.66158e-05
|
|
|
FY
|
[NCBI]
|
4.65644e-05
|
|
|
MG
|
[NCBI]
|
4.64284e-05
|
|
|
IBGC1
|
[NCBI]
|
4.63568e-05
|
|
|
MCKD1
|
[NCBI]
|
4.63568e-05
|
|
|
FEB1
|
[NCBI]
|
4.63568e-05
|
|
|
CBBM
|
[NCBI]
|
4.63568e-05
|
|
|
megacystis-microcolon-intestinal hypoperistalsis syndrome
|
[NCBI]
|
4.63568e-05
|
|
|
GHRH
|
[NCBI]
|
4.6089e-05
|
|
|
APOC3
|
[NCBI]
|
4.604e-05
|
|
|
CD14
|
[NCBI]
|
4.604e-05
|
|
|
P2RX7
|
[NCBI]
|
4.604e-05
|
|
|
CRYGD
|
[NCBI]
|
4.604e-05
|
|
|
STGD1
|
[NCBI]
|
4.58648e-05
|
|
|
RP1
|
[NCBI]
|
4.58648e-05
|
|
|
COL1A2
|
[NCBI]
|
4.57178e-05
|
|
|
HEMB
|
[NCBI]
|
4.54095e-05
|
|
|
LRP1
|
[NCBI]
|
4.51342e-05
|
|
|
GALT
|
[NCBI]
|
4.50206e-05
|
|
|
CAPN10
|
[NCBI]
|
4.43456e-05
|
|
|
CA1
|
[NCBI]
|
4.43456e-05
|
|
|
MAG
|
[NCBI]
|
4.41741e-05
|
|
|
PG
|
[NCBI]
|
4.4167e-05
|
|
|
psoriatic arthritis, susceptibility to
|
[NCBI]
|
4.40768e-05
|
|
|
IDD
|
[NCBI]
|
4.40768e-05
|
|
|
VMCM
|
[NCBI]
|
4.40768e-05
|
|
|
RP10
|
[NCBI]
|
4.40768e-05
|
|
|
DRD5
|
[NCBI]
|
4.3926e-05
|
|
|
ENPP1
|
[NCBI]
|
4.37903e-05
|
|
|
homocysteinemia
|
[NCBI]
|
4.37549e-05
|
|
|
SLOS
|
[NCBI]
|
4.3744e-05
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
4.3693e-05
|
|
|
HFE
|
[NCBI]
|
4.34441e-05
|
|
|
BBS
|
[NCBI]
|
4.3375e-05
|
|
|
SAA1
|
[NCBI]
|
4.26452e-05
|
|
|
GIP
|
[NCBI]
|
4.20963e-05
|
|
|
SCARB1
|
[NCBI]
|
4.19814e-05
|
|
|
TPH1
|
[NCBI]
|
4.19814e-05
|
|
|
ADRB1
|
[NCBI]
|
4.19814e-05
|
|
|
CD99
|
[NCBI]
|
4.19814e-05
|
|
|
COL5A1
|
[NCBI]
|
4.19814e-05
|
|
|
CPS1
|
[NCBI]
|
4.19814e-05
|
|
|
GSTT1
|
[NCBI]
|
4.18246e-05
|
|
|
EPHX2
|
[NCBI]
|
4.18246e-05
|
|
|
ASPN
|
[NCBI]
|
4.18246e-05
|
|
|
SRS
|
[NCBI]
|
4.17516e-05
|
|
|
CLN2
|
[NCBI]
|
4.0957e-05
|
|
|
A1BG
|
[NCBI]
|
4.08669e-05
|
|
|
ABCC11
|
[NCBI]
|
4.08669e-05
|
|
|
saitohin
|
[NCBI]
|
4.08669e-05
|
|
|
MTCO2
|
[NCBI]
|
4.048e-05
|
|
|
CYP2A6
|
[NCBI]
|
4.048e-05
|
|
|
MC4R
|
[NCBI]
|
4.03282e-05
|
|
|
DOM3Z
|
[NCBI]
|
4.03182e-05
|
|
|
IFNG
|
[NCBI]
|
3.99211e-05
|
|
|
FCHL
|
[NCBI]
|
3.98365e-05
|
|
|
NIDDM
|
[NCBI]
|
3.97552e-05
|
|
|
LCT
|
[NCBI]
|
3.96596e-05
|
|
|
SPP1
|
[NCBI]
|
3.96339e-05
|
|
|
BRCA1
|
[NCBI]
|
3.95701e-05
|
|
|
PLSJ
|
[NCBI]
|
3.9504e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
3.9504e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
3.9504e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
3.9504e-05
|
|
|
emanuel syndrome
|
[NCBI]
|
3.9504e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.92033e-05
|
|
|
WAS
|
[NCBI]
|
3.89664e-05
|
|
|
OPA1
|
[NCBI]
|
3.89026e-05
|
|
|
PF4
|
[NCBI]
|
3.87907e-05
|
|
|
PKD2
|
[NCBI]
|
3.8762e-05
|
|
|
porphyria variegata
|
[NCBI]
|
3.8508e-05
|
|
|
HSCR1
|
[NCBI]
|
3.84974e-05
|
|
|
RASA1
|
[NCBI]
|
3.84907e-05
|
|
|
ALDH2
|
[NCBI]
|
3.84651e-05
|
|
|
mucopolysaccharidosis type iiib
|
[NCBI]
|
3.84191e-05
|
|
|
LGMD2A
|
[NCBI]
|
3.80147e-05
|
|
|
atrial standstill
|
[NCBI]
|
3.77062e-05
|
|
|
immunoglobulin switch sequences
|
[NCBI]
|
3.77062e-05
|
|
|
SHEP9
|
[NCBI]
|
3.77062e-05
|
|
|
favism, susceptibility to
|
[NCBI]
|
3.77062e-05
|
|
|
pseudoacromegaly with severe insulin resistance
|
[NCBI]
|
3.77062e-05
|
|
|
cataract, nonnuclear polymorphic congenital, autosomal dominant
|
[NCBI]
|
3.77062e-05
|
|
|
albinism, ocular, with sensorineural deafness
|
[NCBI]
|
3.77062e-05
|
|
|
lymphedema and ptosis
|
[NCBI]
|
3.77062e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
3.77062e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
3.77062e-05
|
|
|
KN
|
[NCBI]
|
3.77062e-05
|
|
|
autism, x-linked, susceptibility to, 3
|
[NCBI]
|
3.77062e-05
|
|
|
DMAT
|
[NCBI]
|
3.77062e-05
|
|
|
LFS2
|
[NCBI]
|
3.77062e-05
|
|
|
HS3
|
[NCBI]
|
3.77062e-05
|
|
|
MODY6
|
[NCBI]
|
3.77062e-05
|
|
|
MRX93
|
[NCBI]
|
3.77062e-05
|
|
|
bor-duane hydrocephalus contiguous gene syndrome
|
[NCBI]
|
3.77062e-05
|
|
|
CPI
|
[NCBI]
|
3.76636e-05
|
|
|
ADM
|
[NCBI]
|
3.70058e-05
|
|
|
ADRB3
|
[NCBI]
|
3.69532e-05
|
|
|
MC1R
|
[NCBI]
|
3.69151e-05
|
|
|
GOT2
|
[NCBI]
|
3.68308e-05
|
|
|
ADH3
|
[NCBI]
|
3.68308e-05
|
|
|
ORM2
|
[NCBI]
|
3.68308e-05
|
|
|
MS4A2
|
[NCBI]
|
3.68308e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
3.68148e-05
|
|
|
PKLR
|
[NCBI]
|
3.6584e-05
|
|
|
CHS
|
[NCBI]
|
3.65435e-05
|
|
|
HDC
|
[NCBI]
|
3.64572e-05
|
|
|
IMPA2
|
[NCBI]
|
3.63484e-05
|
|
|
SPG4
|
[NCBI]
|
3.62767e-05
|
|
|
SLC6A3
|
[NCBI]
|
3.61968e-05
|
|
|
ND
|
[NCBI]
|
3.61163e-05
|
|
|
SCN5A
|
[NCBI]
|
3.59155e-05
|
|
|
MB
|
[NCBI]
|
3.57371e-05
|
|
|
schwannomatosis
|
[NCBI]
|
3.55725e-05
|
|
|
ADA
|
[NCBI]
|
3.55504e-05
|
|
|
down syndrome
|
[NCBI]
|
3.55157e-05
|
|
|
CYP2C19
|
[NCBI]
|
3.54937e-05
|
|
|
GSTP1
|
[NCBI]
|
3.54523e-05
|
|
|
wilson disease
|
[NCBI]
|
3.53051e-05
|
|
|
CDK5
|
[NCBI]
|
3.4998e-05
|
|
|
IL1B
|
[NCBI]
|
3.43993e-05
|
|
|
CSTB
|
[NCBI]
|
3.43993e-05
|
|
|
CST3
|
[NCBI]
|
3.43993e-05
|
|
|
UCP1
|
[NCBI]
|
3.43848e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
3.38567e-05
|
|
|
OTC
|
[NCBI]
|
3.37492e-05
|
|
|
AK1
|
[NCBI]
|
3.33891e-05
|
|
|
GLI3
|
[NCBI]
|
3.33891e-05
|
|
|
CCR5
|
[NCBI]
|
3.29242e-05
|
|
|
CLN2
|
[NCBI]
|
3.28553e-05
|
|
|
CHRNB1
|
[NCBI]
|
3.28553e-05
|
|
|
PRB2
|
[NCBI]
|
3.28553e-05
|
|
|
HLA-F
|
[NCBI]
|
3.28553e-05
|
|
|
chromosome 17q21.31 microdeletion syndrome
|
[NCBI]
|
3.28553e-05
|
|
|
ADH1
|
[NCBI]
|
3.2851e-05
|
|
|
BLMH
|
[NCBI]
|
3.2851e-05
|
|
|
ASIP
|
[NCBI]
|
3.28316e-05
|
|
|
HLA-DQB1
|
[NCBI]
|
3.28316e-05
|
|
|
SCZD
|
[NCBI]
|
3.25999e-05
|
|
|
IL12B
|
[NCBI]
|
3.24191e-05
|
|
|
RP11
|
[NCBI]
|
3.2145e-05
|
|
|
HNPCC2
|
[NCBI]
|
3.2145e-05
|
|
|
LGMD1A
|
[NCBI]
|
3.2145e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
3.2145e-05
|
|
|
CDL1
|
[NCBI]
|
3.2145e-05
|
|
|
SCA14
|
[NCBI]
|
3.2145e-05
|
|
|
HTX1
|
[NCBI]
|
3.2145e-05
|
|
|
scheie syndrome
|
[NCBI]
|
3.2145e-05
|
|
|
DURS1
|
[NCBI]
|
3.18736e-05
|
|
|
glycogen storage disease iii
|
[NCBI]
|
3.17991e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
3.17991e-05
|
|
|
BRCA2
|
[NCBI]
|
3.17316e-05
|
|
|
hypertension, essential
|
[NCBI]
|
3.17137e-05
|
|
|
LTC4S
|
[NCBI]
|
3.16123e-05
|
|
|
MUC1
|
[NCBI]
|
3.15986e-05
|
|
|
PFKL
|
[NCBI]
|
3.11339e-05
|
|
|
AGXT
|
[NCBI]
|
3.11339e-05
|
|
|
PLA2G7
|
[NCBI]
|
3.11339e-05
|
|
|
SMAX1
|
[NCBI]
|
3.06892e-05
|
|
|
SPG4
|
[NCBI]
|
3.05892e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
3.05892e-05
|
|
|
PMM2
|
[NCBI]
|
3.04583e-05
|
|
|
TCF7L2
|
[NCBI]
|
3.01451e-05
|
|
|
TSC1
|
[NCBI]
|
3.01451e-05
|
|
|
HRAS
|
[NCBI]
|
2.98613e-05
|
|
|
ICAM1
|
[NCBI]
|
2.97249e-05
|
|
|
APOA2
|
[NCBI]
|
2.95615e-05
|
|
|
NAGLU
|
[NCBI]
|
2.95615e-05
|
|
|
SGSH
|
[NCBI]
|
2.95615e-05
|
|
|
SRD5A2
|
[NCBI]
|
2.93638e-05
|
|
|
VWS
|
[NCBI]
|
2.93243e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
2.91619e-05
|
|
|
HLA-DNA
|
[NCBI]
|
2.91619e-05
|
|
|
KIR2DS4
|
[NCBI]
|
2.91619e-05
|
|
|
NMOR2
|
[NCBI]
|
2.91619e-05
|
|
|
CLN5
|
[NCBI]
|
2.91244e-05
|
|
|
sarcoidosis
|
[NCBI]
|
2.91244e-05
|
|
|
SLS
|
[NCBI]
|
2.8206e-05
|
|
|
CYP1A2
|
[NCBI]
|
2.81133e-05
|
|
|
ELAC2
|
[NCBI]
|
2.81133e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
2.81133e-05
|
|
|
CYBA
|
[NCBI]
|
2.81133e-05
|
|
|
FCGR3A
|
[NCBI]
|
2.81133e-05
|
|
|
UGT1A1
|
[NCBI]
|
2.81099e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
2.80937e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
2.80648e-05
|
|
|
spastic ataxia
|
[NCBI]
|
2.80333e-05
|
|
|
IAHSP
|
[NCBI]
|
2.80333e-05
|
|
|
CIDX
|
[NCBI]
|
2.80333e-05
|
|
|
pulmonary hypertension, familial persistent, of the newborn
|
[NCBI]
|
2.80333e-05
|
|
|
CSNBAD2
|
[NCBI]
|
2.80333e-05
|
|
|
PPROM
|
[NCBI]
|
2.80333e-05
|
|
|
DFNB31
|
[NCBI]
|
2.80333e-05
|
|
|
LBSL
|
[NCBI]
|
2.80333e-05
|
|
|
ADCAD1
|
[NCBI]
|
2.80333e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
2.80333e-05
|
|
|
aromatic alpha-keto acid reductase
|
[NCBI]
|
2.80333e-05
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
2.80333e-05
|
|
|
DTGA1
|
[NCBI]
|
2.80333e-05
|
|
|
moved to 310600
|
[NCBI]
|
2.80333e-05
|
|
|
FEB8
|
[NCBI]
|
2.80333e-05
|
|
|
carcinoid tumors, intestinal
|
[NCBI]
|
2.80333e-05
|
|
|
adenosine triphosphate, elevated, of erythrocytes
|
[NCBI]
|
2.80333e-05
|
|
|
stroke, susceptibility to, 1
|
[NCBI]
|
2.80333e-05
|
|
|
microduplication 22q11.2
|
[NCBI]
|
2.80333e-05
|
|
|
sertoli cell-only syndrome
|
[NCBI]
|
2.80333e-05
|
|
|
mass syndrome
|
[NCBI]
|
2.80333e-05
|
|
|
ovarian teratoma
|
[NCBI]
|
2.80333e-05
|
|
|
brunner syndrome
|
[NCBI]
|
2.80333e-05
|
|
|
CMD3A
|
[NCBI]
|
2.80333e-05
|
|
|
MRGH
|
[NCBI]
|
2.80333e-05
|
|
|
mental retardation, x-linked, snyder-robinson type
|
[NCBI]
|
2.80333e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
2.80333e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
2.80333e-05
|
|
|
SLEB2
|
[NCBI]
|
2.80333e-05
|
|
|
BOS3
|
[NCBI]
|
2.80333e-05
|
|
|
lynch syndrome i
|
[NCBI]
|
2.77684e-05
|
|
|
CYP3A7
|
[NCBI]
|
2.76222e-05
|
|
|
NOTCH4
|
[NCBI]
|
2.76222e-05
|
|
|
SCGB3A2
|
[NCBI]
|
2.76222e-05
|
|
|
MTRR
|
[NCBI]
|
2.76222e-05
|
|
|
ACTN3
|
[NCBI]
|
2.76222e-05
|
|
|
CASQ2
|
[NCBI]
|
2.76222e-05
|
|
|
JAK2
|
[NCBI]
|
2.76139e-05
|
|
|
OPRM1
|
[NCBI]
|
2.74464e-05
|
|
|
OPTN
|
[NCBI]
|
2.7312e-05
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
2.68473e-05
|
|
|
IGHG1
|
[NCBI]
|
2.68165e-05
|
|
|
NSD1
|
[NCBI]
|
2.67731e-05
|
|
|
PDYN
|
[NCBI]
|
2.65623e-05
|
|
|
AGTR1
|
[NCBI]
|
2.65623e-05
|
|
|
EDM1
|
[NCBI]
|
2.64391e-05
|
|
|
FTNS
|
[NCBI]
|
2.64391e-05
|
|
|
PSEN1
|
[NCBI]
|
2.64015e-05
|
|
|
lung cancer
|
[NCBI]
|
2.63667e-05
|
|
|
BMD
|
[NCBI]
|
2.60745e-05
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
2.60745e-05
|
|
|
fucosidosis
|
[NCBI]
|
2.58374e-05
|
|
|
PWS
|
[NCBI]
|
2.57261e-05
|
|
|
IAPP
|
[NCBI]
|
2.56853e-05
|
|
|
RP1
|
[NCBI]
|
2.55656e-05
|
|
|
MT2A
|
[NCBI]
|
2.55656e-05
|
|
|
CD151
|
[NCBI]
|
2.55656e-05
|
|
|
CNGB3
|
[NCBI]
|
2.55656e-05
|
|
|
ITIH1
|
[NCBI]
|
2.55656e-05
|
|
|
SPG7
|
[NCBI]
|
2.55275e-05
|
|
|
TCRB
|
[NCBI]
|
2.54898e-05
|
|
|
FAAH
|
[NCBI]
|
2.5488e-05
|
|
|
MDD
|
[NCBI]
|
2.51411e-05
|
|
|
protoporphyria, erythropoietic
|
[NCBI]
|
2.51361e-05
|
|
|
HSAN3
|
[NCBI]
|
2.48536e-05
|
|
|
mucopolysaccharidosis type vii
|
[NCBI]
|
2.47693e-05
|
|
|
GP1BA
|
[NCBI]
|
2.46287e-05
|
|
|
AT
|
[NCBI]
|
2.46211e-05
|
|
|
INS
|
[NCBI]
|
2.43838e-05
|
|
|
PGM3
|
[NCBI]
|
2.43656e-05
|
|
|
HMOX1
|
[NCBI]
|
2.43656e-05
|
|
|
POMC
|
[NCBI]
|
2.42606e-05
|
|
|
ACTG2
|
[NCBI]
|
2.42316e-05
|
|
|
MAGEA2
|
[NCBI]
|
2.42316e-05
|
|
|
ACTN2
|
[NCBI]
|
2.42316e-05
|
|
|
FGFR3
|
[NCBI]
|
2.40824e-05
|
|
|
SPD1
|
[NCBI]
|
2.40351e-05
|
|
|
H6PD
|
[NCBI]
|
2.39603e-05
|
|
|
SCN4A
|
[NCBI]
|
2.37998e-05
|
|
|
NEUROD1
|
[NCBI]
|
2.37659e-05
|
|
|
CYLD1
|
[NCBI]
|
2.37659e-05
|
|
|
SORD
|
[NCBI]
|
2.37659e-05
|
|
|
NID
|
[NCBI]
|
2.37659e-05
|
|
|
PRND
|
[NCBI]
|
2.37659e-05
|
|
|
MXI1
|
[NCBI]
|
2.37659e-05
|
|
|
APH
|
[NCBI]
|
2.37659e-05
|
|
|
VMD
|
[NCBI]
|
2.3683e-05
|
|
|
GTS
|
[NCBI]
|
2.36573e-05
|
|
|
FSHR
|
[NCBI]
|
2.34886e-05
|
|
|
GALK1
|
[NCBI]
|
2.32781e-05
|
|
|
AMY1A
|
[NCBI]
|
2.32781e-05
|
|
|
BOR1
|
[NCBI]
|
2.32647e-05
|
|
|
prostate cancer
|
[NCBI]
|
2.31353e-05
|
|
|
SLC4A1
|
[NCBI]
|
2.30265e-05
|
|
|
ALDH3A2
|
[NCBI]
|
2.30149e-05
|
|
|
HBB
|
[NCBI]
|
2.2638e-05
|
|
|
TCRA
|
[NCBI]
|
2.2545e-05
|
|
|
CHRNA1
|
[NCBI]
|
2.22574e-05
|
|
|
SLC2A1
|
[NCBI]
|
2.22574e-05
|
|
|
ASPM
|
[NCBI]
|
2.21703e-05
|
|
|
IVL
|
[NCBI]
|
2.21703e-05
|
|
|
AMBP
|
[NCBI]
|
2.21703e-05
|
|
|
ITPA
|
[NCBI]
|
2.21703e-05
|
|
|
MATN1
|
[NCBI]
|
2.21703e-05
|
|
|
KIR2DL1
|
[NCBI]
|
2.21703e-05
|
|
|
LAM
|
[NCBI]
|
2.21629e-05
|
|
|
carbimazole sensitivity
|
[NCBI]
|
2.20358e-05
|
|
|
cortisone reductase deficiency
|
[NCBI]
|
2.20358e-05
|
|
|
carboxypeptidase n deficiency
|
[NCBI]
|
2.20358e-05
|
|
|
melanoma-astrocytoma syndrome
|
[NCBI]
|
2.20358e-05
|
|
|
dna, satellite, alpha type
|
[NCBI]
|
2.20358e-05
|
|
|
homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cble complementation type
|
[NCBI]
|
2.20358e-05
|
|
|
CFEOM2
|
[NCBI]
|
2.20358e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
2.20358e-05
|
|
|
FANCI
|
[NCBI]
|
2.20358e-05
|
|
|
myxoma, intracardiac
|
[NCBI]
|
2.20358e-05
|
|
|
marshall-smith syndrome
|
[NCBI]
|
2.20358e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
2.20358e-05
|
|
|
fanconi anemia, complementation group j
|
[NCBI]
|
2.20358e-05
|
|
|
heterotaxy, visceral, 2, autosomal
|
[NCBI]
|
2.20358e-05
|
|
|
acth deficiency
|
[NCBI]
|
2.20358e-05
|
|
|
SCA27
|
[NCBI]
|
2.20358e-05
|
|
|
yellow nail syndrome
|
[NCBI]
|
2.20358e-05
|
|
|
SPG7
|
[NCBI]
|
2.20358e-05
|
|
|
lig4 syndrome
|
[NCBI]
|
2.20358e-05
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
2.20358e-05
|
|
|
HPE5
|
[NCBI]
|
2.20358e-05
|
|
|
FIDD
|
[NCBI]
|
2.20358e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, infantile
|
[NCBI]
|
2.20358e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
2.20358e-05
|
|
|
tongue curling, folding, or rolling
|
[NCBI]
|
2.20358e-05
|
|
|
hyperoxaluria, primary, type ii
|
[NCBI]
|
2.20358e-05
|
|
|
ASAT
|
[NCBI]
|
2.20358e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 5
|
[NCBI]
|
2.20358e-05
|
|
|
simpson-golabi-behmel syndrome, type 2
|
[NCBI]
|
2.20358e-05
|
|
|
LGMD2K
|
[NCBI]
|
2.20358e-05
|
|
|
CSB
|
[NCBI]
|
2.20358e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
2.20358e-05
|
|
|
CTHM
|
[NCBI]
|
2.18702e-05
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
2.18702e-05
|
|
|
HBG1
|
[NCBI]
|
2.16943e-05
|
|
|
CLCN1
|
[NCBI]
|
2.153e-05
|
|
|
sotos syndrome
|
[NCBI]
|
2.14829e-05
|
|
|
DBH
|
[NCBI]
|
2.12969e-05
|
|
|
AMPD1
|
[NCBI]
|
2.12969e-05
|
|
|
cayler cardiofacial syndrome
|
[NCBI]
|
2.10734e-05
|
|
|
GPS
|
[NCBI]
|
2.10734e-05
|
|
|
WRN
|
[NCBI]
|
2.10513e-05
|
|
|
TFCP2
|
[NCBI]
|
2.09111e-05
|
|
|
NFKBIL1
|
[NCBI]
|
2.09111e-05
|
|
|
MX1
|
[NCBI]
|
2.09111e-05
|
|
|
KIR3DL2
|
[NCBI]
|
2.09111e-05
|
|
|
AHRR
|
[NCBI]
|
2.09111e-05
|
|
|
GABRA5
|
[NCBI]
|
2.09111e-05
|
|
|
GRM7
|
[NCBI]
|
2.09111e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
2.09111e-05
|
|
|
TSHR
|
[NCBI]
|
2.0849e-05
|
|
|
SPTA1
|
[NCBI]
|
2.08452e-05
|
|
|
PPOX
|
[NCBI]
|
2.08311e-05
|
|
|
APOC1
|
[NCBI]
|
2.07407e-05
|
|
|
CRYGC
|
[NCBI]
|
2.07407e-05
|
|
|
KLK1
|
[NCBI]
|
2.07407e-05
|
|
|
FCGR2B
|
[NCBI]
|
2.07407e-05
|
|
|
DHFR
|
[NCBI]
|
2.06437e-05
|
|
|
MEN2A
|
[NCBI]
|
2.04669e-05
|
|
|
LS
|
[NCBI]
|
2.0454e-05
|
|
|
CTSB
|
[NCBI]
|
2.03909e-05
|
|
|
RHD
|
[NCBI]
|
2.03909e-05
|
|
|
COL3A1
|
[NCBI]
|
2.02516e-05
|
|
|
RNPEPL1
|
[NCBI]
|
2.01588e-05
|
|
|
DYNLT3
|
[NCBI]
|
2.01588e-05
|
|
|
KRT78
|
[NCBI]
|
2.01588e-05
|
|
|
GSTA5
|
[NCBI]
|
2.01588e-05
|
|
|
KLC3
|
[NCBI]
|
2.01588e-05
|
|
|
RFPL3
|
[NCBI]
|
2.01588e-05
|
|
|
RFPL1S
|
[NCBI]
|
2.01588e-05
|
|
|
otospiralin
|
[NCBI]
|
2.01588e-05
|
|
|
serum protein polymorphism m-158
|
[NCBI]
|
2.01588e-05
|
|
|
TMEM183B
|
[NCBI]
|
2.01588e-05
|
|
|
lymphocyte cytosol polypeptide, 40-kd
|
[NCBI]
|
2.01588e-05
|
|
|
TSGA10
|
[NCBI]
|
2.01588e-05
|
|
|
CYP2A7
|
[NCBI]
|
2.01588e-05
|
|
|
SLC9A5
|
[NCBI]
|
2.01588e-05
|
|
|
ZNF193
|
[NCBI]
|
2.01588e-05
|
|
|
GALNT8
|
[NCBI]
|
2.01588e-05
|
|
|
lymphocyte cytosol polypeptide, 49-kd
|
[NCBI]
|
2.01588e-05
|
|
|
lymphocyte cytosol polypeptide, 100-kd
|
[NCBI]
|
2.01588e-05
|
|
|
RFPL3S
|
[NCBI]
|
2.01588e-05
|
|
|
ESB3
|
[NCBI]
|
2.01588e-05
|
|
|
ZNF192
|
[NCBI]
|
2.01588e-05
|
|
|
NFYB
|
[NCBI]
|
2.01588e-05
|
|
|
WDR4
|
[NCBI]
|
2.01588e-05
|
|
|
NVL
|
[NCBI]
|
2.01588e-05
|
|
|
KRT6L
|
[NCBI]
|
2.01588e-05
|
|
|
RPL23L
|
[NCBI]
|
2.01588e-05
|
|
|
rgd-, leucine-rich repeat-, tropomodulin domain-, and proline-rich domain-containing protein
|
[NCBI]
|
2.01588e-05
|
|
|
x123 gene
|
[NCBI]
|
2.01588e-05
|
|
|
TMEM2
|
[NCBI]
|
2.01588e-05
|
|
|
RFPL2
|
[NCBI]
|
2.01588e-05
|
|
|
r binder protein
|
[NCBI]
|
2.01588e-05
|
|
|
minor histocompatibility antigen hb-1
|
[NCBI]
|
2.01588e-05
|
|
|
KRT80
|
[NCBI]
|
2.01588e-05
|
|
|
GOLGA6
|
[NCBI]
|
2.01588e-05
|
|
|
VSNL1
|
[NCBI]
|
2.01588e-05
|
|
|
ZNF121
|
[NCBI]
|
2.01588e-05
|
|
|
ribonuclease 1, serum
|
[NCBI]
|
2.01588e-05
|
|
|
CR1L
|
[NCBI]
|
2.01588e-05
|
|
|
TCTE1
|
[NCBI]
|
2.01588e-05
|
|
|
CVID
|
[NCBI]
|
2.00379e-05
|
|
|
DNMT1
|
[NCBI]
|
1.992e-05
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
1.99114e-05
|
|
|
PFIC1
|
[NCBI]
|
1.99114e-05
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
1.99114e-05
|
|
|
hurler-scheie syndrome
|
[NCBI]
|
1.99114e-05
|
|
|
NP
|
[NCBI]
|
1.97189e-05
|
|
|
TBG
|
[NCBI]
|
1.97189e-05
|
|
|
CDSN
|
[NCBI]
|
1.95345e-05
|
|
|
MSX1
|
[NCBI]
|
1.95345e-05
|
|
|
DRPLA
|
[NCBI]
|
1.95345e-05
|
|
|
CRYAA
|
[NCBI]
|
1.95345e-05
|
|
|
CYP11B1
|
[NCBI]
|
1.95345e-05
|
|
|
ABCC6
|
[NCBI]
|
1.95116e-05
|
|
|
NPS
|
[NCBI]
|
1.94569e-05
|
|
|
TPH2
|
[NCBI]
|
1.94489e-05
|
|
|
MTP
|
[NCBI]
|
1.94489e-05
|
|
|
HLA-C
|
[NCBI]
|
1.94489e-05
|
|
|
XG
|
[NCBI]
|
1.94489e-05
|
|
|
ODC1
|
[NCBI]
|
1.94489e-05
|
|
|
SFTPA1
|
[NCBI]
|
1.94489e-05
|
|
|
alsin
|
[NCBI]
|
1.94489e-05
|
|
|
CYP3A5
|
[NCBI]
|
1.94489e-05
|
|
|
NQO1
|
[NCBI]
|
1.94489e-05
|
|
|
HGD
|
[NCBI]
|
1.94489e-05
|
|
|
STAT6
|
[NCBI]
|
1.92534e-05
|
|
|
FPLD2
|
[NCBI]
|
1.92425e-05
|
|
|
ESR2
|
[NCBI]
|
1.88882e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
1.88587e-05
|
|
|
ALDH9A1
|
[NCBI]
|
1.84142e-05
|
|
|
CLTA
|
[NCBI]
|
1.84142e-05
|
|
|
PON3
|
[NCBI]
|
1.84142e-05
|
|
|
ADRA2C
|
[NCBI]
|
1.84142e-05
|
|
|
PTMA
|
[NCBI]
|
1.84142e-05
|
|
|
ALPPL2
|
[NCBI]
|
1.84142e-05
|
|
|
MGP
|
[NCBI]
|
1.84142e-05
|
|
|
MLH3
|
[NCBI]
|
1.84142e-05
|
|
|
PRB3
|
[NCBI]
|
1.84142e-05
|
|
|
ABCG1
|
[NCBI]
|
1.84142e-05
|
|
|
CASQ1
|
[NCBI]
|
1.84142e-05
|
|
|
BTNL2
|
[NCBI]
|
1.84142e-05
|
|
|
FUCA2
|
[NCBI]
|
1.84142e-05
|
|
|
CALU
|
[NCBI]
|
1.84142e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
1.84142e-05
|
|
|
KIR2DL2
|
[NCBI]
|
1.84142e-05
|
|
|
HK3
|
[NCBI]
|
1.84142e-05
|
|
|
VBP1
|
[NCBI]
|
1.84142e-05
|
|
|
PDE6B
|
[NCBI]
|
1.82872e-05
|
|
|
AHCY
|
[NCBI]
|
1.82734e-05
|
|
|
HABP2
|
[NCBI]
|
1.82734e-05
|
|
|
ACO1
|
[NCBI]
|
1.82734e-05
|
|
|
KRT10
|
[NCBI]
|
1.82734e-05
|
|
|
alkaptonuria
|
[NCBI]
|
1.81319e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
1.81319e-05
|
|
|
acromegaly
|
[NCBI]
|
1.81319e-05
|
|
|
mucopolysaccharidosis type iiia
|
[NCBI]
|
1.81319e-05
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
1.81319e-05
|
|
|
NPHS1
|
[NCBI]
|
1.81319e-05
|
|
|
SCCMS
|
[NCBI]
|
1.81319e-05
|
|
|
ABP1
|
[NCBI]
|
1.8047e-05
|
|
|
NRAS
|
[NCBI]
|
1.79542e-05
|
|
|
HPX
|
[NCBI]
|
1.79542e-05
|
|
|
CDKN1C
|
[NCBI]
|
1.79542e-05
|
|
|
hyperprolinemia, type ii
|
[NCBI]
|
1.77839e-05
|
|
|
FCDT
|
[NCBI]
|
1.77839e-05
|
|
|
EDM2
|
[NCBI]
|
1.77839e-05
|
|
|
NEM1
|
[NCBI]
|
1.77839e-05
|
|
|
anderson disease
|
[NCBI]
|
1.77839e-05
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
1.77839e-05
|
|
|
RTADR
|
[NCBI]
|
1.77839e-05
|
|
|
witkop syndrome
|
[NCBI]
|
1.77839e-05
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
1.77839e-05
|
|
|
pyogenic sterile arthritis, pyoderma gangrenosum, and acne
|
[NCBI]
|
1.77839e-05
|
|
|
watson syndrome
|
[NCBI]
|
1.77839e-05
|
|
|
beta thalassemia, dominant inclusion body type
|
[NCBI]
|
1.77839e-05
|
|
|
enterokinase deficiency
|
[NCBI]
|
1.77839e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
1.77839e-05
|
|
|
IN
|
[NCBI]
|
1.77839e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
1.77839e-05
|
|
|
macrocephaly/autism syndrome
|
[NCBI]
|
1.77839e-05
|
|
|
JAE
|
[NCBI]
|
1.77839e-05
|
|
|
n-acetylglutamate synthase deficiency
|
[NCBI]
|
1.77839e-05
|
|
|
macrocephaly, benign familial
|
[NCBI]
|
1.77839e-05
|
|
|
NAIC
|
[NCBI]
|
1.77839e-05
|
|
|
MRX54
|
[NCBI]
|
1.77839e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
1.77839e-05
|
|
|
POF2A
|
[NCBI]
|
1.77839e-05
|
|
|
PC2
|
[NCBI]
|
1.77839e-05
|
|
|
shprintzen-goldberg craniosynostosis syndrome
|
[NCBI]
|
1.77839e-05
|
|
|
AVSD2
|
[NCBI]
|
1.77839e-05
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
1.77839e-05
|
|
|
3-@methylglutaconic aciduria, type iii
|
[NCBI]
|
1.77839e-05
|
|
|
MYH7
|
[NCBI]
|
1.72678e-05
|
|
|
PDCD1
|
[NCBI]
|
1.71974e-05
|
|
|
GGCX
|
[NCBI]
|
1.71974e-05
|
|
|
BMPR2
|
[NCBI]
|
1.71974e-05
|
|
|
AGL
|
[NCBI]
|
1.71974e-05
|
|
|
SLC26A3
|
[NCBI]
|
1.71974e-05
|
|
|
LDHC
|
[NCBI]
|
1.71974e-05
|
|
|
C4BPA
|
[NCBI]
|
1.71974e-05
|
|
|
ATP7B
|
[NCBI]
|
1.71479e-05
|
|
|
ACH
|
[NCBI]
|
1.70582e-05
|
|
|
TERT
|
[NCBI]
|
1.68681e-05
|
|
|
CD
|
[NCBI]
|
1.67935e-05
|
|
|
ATHS
|
[NCBI]
|
1.67788e-05
|
|
|
SHFM3
|
[NCBI]
|
1.67788e-05
|
|
|
BTK
|
[NCBI]
|
1.6735e-05
|
|
|
CCM
|
[NCBI]
|
1.67113e-05
|
|
|
FBS
|
[NCBI]
|
1.65098e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
1.65098e-05
|
|
|
SHEP2
|
[NCBI]
|
1.65098e-05
|
|
|
APC
|
[NCBI]
|
1.64916e-05
|
|
|
SP110
|
[NCBI]
|
1.64243e-05
|
|
|
MUC3A
|
[NCBI]
|
1.64243e-05
|
|
|
KLF11
|
[NCBI]
|
1.64243e-05
|
|
|
TLR10
|
[NCBI]
|
1.64243e-05
|
|
|
HLA-DPB1
|
[NCBI]
|
1.64243e-05
|
|
|
PCK1
|
[NCBI]
|
1.64243e-05
|
|
|
KIR2DL4
|
[NCBI]
|
1.64243e-05
|
|
|
P2RY12
|
[NCBI]
|
1.64243e-05
|
|
|
VPS13A
|
[NCBI]
|
1.64243e-05
|
|
|
CALB1
|
[NCBI]
|
1.64243e-05
|
|
|
GCLC
|
[NCBI]
|
1.64243e-05
|
|
|
SUMO4
|
[NCBI]
|
1.64243e-05
|
|
|
KCNA5
|
[NCBI]
|
1.64243e-05
|
|
|
TAP2
|
[NCBI]
|
1.64243e-05
|
|
|
PSEN2
|
[NCBI]
|
1.63768e-05
|
|
|
SELE
|
[NCBI]
|
1.62073e-05
|
|
|
ALOX5
|
[NCBI]
|
1.62073e-05
|
|
|
COL18A1
|
[NCBI]
|
1.62073e-05
|
|
|
IRF6
|
[NCBI]
|
1.62073e-05
|
|
|
THBD
|
[NCBI]
|
1.62073e-05
|
|
|
ATXN3
|
[NCBI]
|
1.62073e-05
|
|
|
SLC19A1
|
[NCBI]
|
1.62073e-05
|
|
|
AGER
|
[NCBI]
|
1.61916e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.60853e-05
|
|
|
FGF2
|
[NCBI]
|
1.60329e-05
|
|
|
RPGR
|
[NCBI]
|
1.59486e-05
|
|
|
ARSA
|
[NCBI]
|
1.5866e-05
|
|
|
C1NH
|
[NCBI]
|
1.58649e-05
|
|
|
COL17A1
|
[NCBI]
|
1.58649e-05
|
|
|
HNF1A
|
[NCBI]
|
1.57511e-05
|
|
|
HMBS
|
[NCBI]
|
1.57e-05
|
|
|
MTCYB
|
[NCBI]
|
1.55804e-05
|
|
|
MLH1
|
[NCBI]
|
1.55071e-05
|
|
|
SLC45A2
|
[NCBI]
|
1.52925e-05
|
|
|
GNB3
|
[NCBI]
|
1.52925e-05
|
|
|
DCK
|
[NCBI]
|
1.51727e-05
|
|
|
CDH1
|
[NCBI]
|
1.5125e-05
|
|
|
HRPT1
|
[NCBI]
|
1.50272e-05
|
|
|
IBM2
|
[NCBI]
|
1.50272e-05
|
|
|
CBAVD
|
[NCBI]
|
1.50272e-05
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
1.50272e-05
|
|
|
STAT1
|
[NCBI]
|
1.48739e-05
|
|
|
XLP1
|
[NCBI]
|
1.48342e-05
|
|
|
OCA2
|
[NCBI]
|
1.48342e-05
|
|
|
MM
|
[NCBI]
|
1.48342e-05
|
|
|
PCTT
|
[NCBI]
|
1.48342e-05
|
|
|
ABCG5
|
[NCBI]
|
1.47796e-05
|
|
|
VTN
|
[NCBI]
|
1.47796e-05
|
|
|
COL9A3
|
[NCBI]
|
1.47796e-05
|
|
|
APBB1
|
[NCBI]
|
1.47796e-05
|
|
|
USP9Y
|
[NCBI]
|
1.47796e-05
|
|
|
TST
|
[NCBI]
|
1.47796e-05
|
|
|
TARDBP
|
[NCBI]
|
1.47796e-05
|
|
|
GPR154
|
[NCBI]
|
1.47796e-05
|
|
|
IL11
|
[NCBI]
|
1.47796e-05
|
|
|
tl antigen
|
[NCBI]
|
1.47796e-05
|
|
|
ME1
|
[NCBI]
|
1.47796e-05
|
|
|
CNGA3
|
[NCBI]
|
1.47796e-05
|
|
|
MTND4
|
[NCBI]
|
1.47288e-05
|
|
|
NPC1
|
[NCBI]
|
1.4629e-05
|
|
|
CYP11B2
|
[NCBI]
|
1.4629e-05
|
|
|
IRS2
|
[NCBI]
|
1.4629e-05
|
|
|
DFNA5
|
[NCBI]
|
1.45601e-05
|
|
|
nonarteritic anterior ischemic optic neuropathy, susceptibility to
|
[NCBI]
|
1.45601e-05
|
|
|
DFNB7
|
[NCBI]
|
1.45601e-05
|
|
|
sarcosinemia
|
[NCBI]
|
1.45601e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
1.45601e-05
|
|
|
DFNB10
|
[NCBI]
|
1.45601e-05
|
|
|
OCA4
|
[NCBI]
|
1.45601e-05
|
|
|
PRTH
|
[NCBI]
|
1.45601e-05
|
|
|
HOA
|
[NCBI]
|
1.45601e-05
|
|
|
DFNB8
|
[NCBI]
|
1.45601e-05
|
|
|
uniparental disomy, paternal, chromosome 14
|
[NCBI]
|
1.45601e-05
|
|
|
ATCAY
|
[NCBI]
|
1.45601e-05
|
|
|
CGL1
|
[NCBI]
|
1.45601e-05
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
1.45601e-05
|
|
|
CMD1E
|
[NCBI]
|
1.45601e-05
|
|
|
glaucoma, normal tension, susceptibility to
|
[NCBI]
|
1.45601e-05
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
1.45601e-05
|
|
|
oguchi disease
|
[NCBI]
|
1.45601e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
1.45601e-05
|
|
|
corticosterone methyloxidase type i deficiency
|
[NCBI]
|
1.45601e-05
|
|
|
PVOD
|
[NCBI]
|
1.45601e-05
|
|
|
CMRD
|
[NCBI]
|
1.45601e-05
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
1.45601e-05
|
|
|
UCHL1
|
[NCBI]
|
1.44438e-05
|
|
|
HBZ
|
[NCBI]
|
1.44438e-05
|
|
|
SURF1
|
[NCBI]
|
1.44438e-05
|
|
|
NF2
|
[NCBI]
|
1.43425e-05
|
|
|
EPOR
|
[NCBI]
|
1.42975e-05
|
|
|
MJD
|
[NCBI]
|
1.42964e-05
|
|
|
MTM1
|
[NCBI]
|
1.42801e-05
|
|
|
IDUA
|
[NCBI]
|
1.41445e-05
|
|
|
LCAT
|
[NCBI]
|
1.41059e-05
|
|
|
IGF1R
|
[NCBI]
|
1.40518e-05
|
|
|
CAPN3
|
[NCBI]
|
1.40518e-05
|
|
|
glycogen storage disease ii
|
[NCBI]
|
1.40452e-05
|
|
|
menkes disease
|
[NCBI]
|
1.40452e-05
|
|
|
PEDF
|
[NCBI]
|
1.40082e-05
|
|
|
CYP19A1
|
[NCBI]
|
1.39659e-05
|
|
|
SDC2
|
[NCBI]
|
1.3885e-05
|
|
|
CTSC
|
[NCBI]
|
1.3719e-05
|
|
|
stroke, ischemic
|
[NCBI]
|
1.36688e-05
|
|
|
AAA
|
[NCBI]
|
1.36688e-05
|
|
|
MEN2B
|
[NCBI]
|
1.36688e-05
|
|
|
ACTC1
|
[NCBI]
|
1.3654e-05
|
|
|
NR4A2
|
[NCBI]
|
1.3654e-05
|
|
|
PRKCG
|
[NCBI]
|
1.3654e-05
|
|
|
PCCB
|
[NCBI]
|
1.3654e-05
|
|
|
AIRE
|
[NCBI]
|
1.36515e-05
|
|
|
PNMT
|
[NCBI]
|
1.33985e-05
|
|
|
AZGP1
|
[NCBI]
|
1.33855e-05
|
|
|
ST7
|
[NCBI]
|
1.33855e-05
|
|
|
GCLM
|
[NCBI]
|
1.33855e-05
|
|
|
SACS
|
[NCBI]
|
1.33855e-05
|
|
|
CFHR1
|
[NCBI]
|
1.33855e-05
|
|
|
SIPA1
|
[NCBI]
|
1.33855e-05
|
|
|
CHRND
|
[NCBI]
|
1.33855e-05
|
|
|
PRH2
|
[NCBI]
|
1.33855e-05
|
|
|
SIRT3
|
[NCBI]
|
1.33855e-05
|
|
|
IRF2
|
[NCBI]
|
1.33855e-05
|
|
|
COL9A2
|
[NCBI]
|
1.33855e-05
|
|
|
GRIK1
|
[NCBI]
|
1.33855e-05
|
|
|
HTR2C
|
[NCBI]
|
1.33855e-05
|
|
|
complement component c1r deficiency
|
[NCBI]
|
1.33855e-05
|
|
|
OXT
|
[NCBI]
|
1.32901e-05
|
|
|
breast cancer
|
[NCBI]
|
1.32342e-05
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
1.31114e-05
|
|
|
OMP
|
[NCBI]
|
1.30796e-05
|
|
|
metachromatic leukodystrophy
|
[NCBI]
|
1.30351e-05
|
|
|
OCA1A
|
[NCBI]
|
1.29668e-05
|
|
|
C9
|
[NCBI]
|
1.29167e-05
|
|
|
DMBT1
|
[NCBI]
|
1.29167e-05
|
|
|
IGHV
|
[NCBI]
|
1.29167e-05
|
|
|
SFTPB
|
[NCBI]
|
1.29167e-05
|
|
|
NCSTN
|
[NCBI]
|
1.29167e-05
|
|
|
CD
|
[NCBI]
|
1.2817e-05
|
|
|
CACNA1A
|
[NCBI]
|
1.24703e-05
|
|
|
CBD
|
[NCBI]
|
1.24636e-05
|
|
|
histidinemia
|
[NCBI]
|
1.24218e-05
|
|
|
EBR1
|
[NCBI]
|
1.24218e-05
|
|
|
APL
|
[NCBI]
|
1.24218e-05
|
|
|
PMD
|
[NCBI]
|
1.23611e-05
|
|
|
GNAS
|
[NCBI]
|
1.2303e-05
|
|
|
PYGM
|
[NCBI]
|
1.22267e-05
|
|
|
MYH6
|
[NCBI]
|
1.22267e-05
|
|
|
CPT2
|
[NCBI]
|
1.22267e-05
|
|
|
HLA-G
|
[NCBI]
|
1.22267e-05
|
|
|
GHR
|
[NCBI]
|
1.2223e-05
|
|
|
MORF4
|
[NCBI]
|
1.21817e-05
|
|
|
CCL11
|
[NCBI]
|
1.21817e-05
|
|
|
PRKG1
|
[NCBI]
|
1.21817e-05
|
|
|
IGKV
|
[NCBI]
|
1.21817e-05
|
|
|
HAVCR1
|
[NCBI]
|
1.21817e-05
|
|
|
APOA5
|
[NCBI]
|
1.21817e-05
|
|
|
HAL
|
[NCBI]
|
1.21817e-05
|
|
|
HBA2
|
[NCBI]
|
1.21164e-05
|
|
|
DARS2
|
[NCBI]
|
1.21155e-05
|
|
|
CYP2A13
|
[NCBI]
|
1.21155e-05
|
|
|
LRE2
|
[NCBI]
|
1.21155e-05
|
|
|
PKNOX1
|
[NCBI]
|
1.21155e-05
|
|
|
MEPCE
|
[NCBI]
|
1.21155e-05
|
|
|
KRTAP1-5
|
[NCBI]
|
1.21155e-05
|
|
|
FCGR3B
|
[NCBI]
|
1.21155e-05
|
|
|
CHRFAM7A
|
[NCBI]
|
1.21155e-05
|
|
|
NDUFV3
|
[NCBI]
|
1.21155e-05
|
|
|
myeloid leukemia-related gene
|
[NCBI]
|
1.21155e-05
|
|
|
minisatellite 33.6
|
[NCBI]
|
1.21155e-05
|
|
|
TM7SF2
|
[NCBI]
|
1.21155e-05
|
|
|
TP53I3
|
[NCBI]
|
1.21155e-05
|
|
|
minisatellite 33.15
|
[NCBI]
|
1.21155e-05
|
|
|
FAM50A
|
[NCBI]
|
1.21155e-05
|
|
|
SLC26A1
|
[NCBI]
|
1.21155e-05
|
|
|
EZH1
|
[NCBI]
|
1.21155e-05
|
|
|
CHRM4
|
[NCBI]
|
1.21155e-05
|
|
|
brain-specific protein pc-1
|
[NCBI]
|
1.21155e-05
|
|
|
KRT77
|
[NCBI]
|
1.21155e-05
|
|
|
STK10
|
[NCBI]
|
1.21155e-05
|
|
|
KRTAP1-1
|
[NCBI]
|
1.21155e-05
|
|
|
MAGEB5
|
[NCBI]
|
1.21155e-05
|
|
|
SEC14L1
|
[NCBI]
|
1.21155e-05
|
|
|
yeast factor
|
[NCBI]
|
1.21155e-05
|
|
|
MUC20
|
[NCBI]
|
1.21155e-05
|
|
|
COX7B2
|
[NCBI]
|
1.21155e-05
|
|
|
MTNR1B
|
[NCBI]
|
1.21155e-05
|
|
|
OVOL1
|
[NCBI]
|
1.21155e-05
|
|
|
KRTAP1-3
|
[NCBI]
|
1.21155e-05
|
|
|
RIMBP2
|
[NCBI]
|
1.21155e-05
|
|
|
HMX1
|
[NCBI]
|
1.21155e-05
|
|
|
KRTHB3
|
[NCBI]
|
1.21155e-05
|
|
|
dynein, axonemal, intermediate chain 2
|
[NCBI]
|
1.21155e-05
|
|
|
PRCD
|
[NCBI]
|
1.21155e-05
|
|
|
THBS4
|
[NCBI]
|
1.21155e-05
|
|
|
NFYA
|
[NCBI]
|
1.21155e-05
|
|
|
RFPL1
|
[NCBI]
|
1.21155e-05
|
|
|
IGF2AS
|
[NCBI]
|
1.21155e-05
|
|
|
BZRAP1
|
[NCBI]
|
1.21155e-05
|
|
|
TPM4
|
[NCBI]
|
1.21155e-05
|
|
|
MTATP8
|
[NCBI]
|
1.21155e-05
|
|
|
GPR75
|
[NCBI]
|
1.21155e-05
|
|
|
DUSP8
|
[NCBI]
|
1.21155e-05
|
|
|
TBL1Y
|
[NCBI]
|
1.21155e-05
|
|
|
KIR2DS5
|
[NCBI]
|
1.21155e-05
|
|
|
KIAA0020
|
[NCBI]
|
1.21155e-05
|
|
|
KRTAP1-4
|
[NCBI]
|
1.21155e-05
|
|
|
IFI44
|
[NCBI]
|
1.21155e-05
|
|
|
selenoprotein, 15-kd
|
[NCBI]
|
1.21155e-05
|
|
|
MAGEB6
|
[NCBI]
|
1.21155e-05
|
|
|
GCET2
|
[NCBI]
|
1.21155e-05
|
|
|
ZNF165
|
[NCBI]
|
1.21155e-05
|
|
|
PAPOLA
|
[NCBI]
|
1.21155e-05
|
|
|
DIRC1
|
[NCBI]
|
1.21155e-05
|
|
|
CTTNBP2
|
[NCBI]
|
1.21155e-05
|
|
|
KIR2DS1
|
[NCBI]
|
1.21155e-05
|
|
|
HLA8
|
[NCBI]
|
1.21155e-05
|
|
|
phosphoglycerate mutase family 3
|
[NCBI]
|
1.21155e-05
|
|
|
MAGEC3
|
[NCBI]
|
1.21155e-05
|
|
|
XYLT2
|
[NCBI]
|
1.21155e-05
|
|
|
GPR35
|
[NCBI]
|
1.21155e-05
|
|
|
SMA1
|
[NCBI]
|
1.20506e-05
|
|
|
AHO
|
[NCBI]
|
1.20506e-05
|
|
|
CLN6
|
[NCBI]
|
1.20156e-05
|
|
|
STHAG3
|
[NCBI]
|
1.20156e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
1.20156e-05
|
|
|
EJM1
|
[NCBI]
|
1.20156e-05
|
|
|
F5F8D
|
[NCBI]
|
1.20156e-05
|
|
|
MCOPS9
|
[NCBI]
|
1.20156e-05
|
|
|
MPD1
|
[NCBI]
|
1.20156e-05
|
|
|
body mass index
|
[NCBI]
|
1.20156e-05
|
|
|
CO
|
[NCBI]
|
1.20156e-05
|
|
|
short stature, idiopathic, autosomal
|
[NCBI]
|
1.20156e-05
|
|
|
methylcobalamin deficiency, cblg type
|
[NCBI]
|
1.20156e-05
|
|
|
pierson syndrome
|
[NCBI]
|
1.20156e-05
|
|
|
FHL2
|
[NCBI]
|
1.20156e-05
|
|
|
LGMD1C
|
[NCBI]
|
1.20156e-05
|
|
|
IDDM5
|
[NCBI]
|
1.20156e-05
|
|
|
SQT1
|
[NCBI]
|
1.20156e-05
|
|
|
endometrial cancer
|
[NCBI]
|
1.20156e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
1.20156e-05
|
|
|
aplastic anemia
|
[NCBI]
|
1.20156e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.2012e-05
|
|
|
TYRP1
|
[NCBI]
|
1.19773e-05
|
|
|
TPO
|
[NCBI]
|
1.19657e-05
|
|
|
ADHD
|
[NCBI]
|
1.19534e-05
|
|
|
SHBG
|
[NCBI]
|
1.18097e-05
|
|
|
IGFALS
|
[NCBI]
|
1.1798e-05
|
|
|
DKC1
|
[NCBI]
|
1.15795e-05
|
|
|
SELP
|
[NCBI]
|
1.15795e-05
|
|
|
F12
|
[NCBI]
|
1.15795e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
1.15565e-05
|
|
|
von willebrand disease
|
[NCBI]
|
1.15332e-05
|
|
|
MYO7A
|
[NCBI]
|
1.15105e-05
|
|
|
APP
|
[NCBI]
|
1.13236e-05
|
|
|
HHF1
|
[NCBI]
|
1.12909e-05
|
|
|
melanoma, uveal
|
[NCBI]
|
1.12909e-05
|
|
|
CHAC
|
[NCBI]
|
1.12754e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
1.12754e-05
|
|
|
HD
|
[NCBI]
|
1.12345e-05
|
|
|
PTN
|
[NCBI]
|
1.11654e-05
|
|
|
DBA
|
[NCBI]
|
1.11576e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.11576e-05
|
|
|
SLC1A5
|
[NCBI]
|
1.11277e-05
|
|
|
SLC17A5
|
[NCBI]
|
1.11277e-05
|
|
|
PEPC
|
[NCBI]
|
1.11277e-05
|
|
|
INPPL1
|
[NCBI]
|
1.11277e-05
|
|
|
SGCG
|
[NCBI]
|
1.11277e-05
|
|
|
SGCB
|
[NCBI]
|
1.11277e-05
|
|
|
MUC2
|
[NCBI]
|
1.11277e-05
|
|
|
ACO2
|
[NCBI]
|
1.11277e-05
|
|
|
LAMC1
|
[NCBI]
|
1.11277e-05
|
|
|
LAMB1
|
[NCBI]
|
1.11277e-05
|
|
|
APOC2
|
[NCBI]
|
1.10621e-05
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
1.10621e-05
|
|
|
CYP3A4
|
[NCBI]
|
1.10621e-05
|
|
|
SDHD
|
[NCBI]
|
1.09711e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.09711e-05
|
|
|
KCNH2
|
[NCBI]
|
1.09377e-05
|
|
|
TPI1
|
[NCBI]
|
1.06311e-05
|
|
|
PTPRC
|
[NCBI]
|
1.06311e-05
|
|
|
MSH2
|
[NCBI]
|
1.0627e-05
|
|
|
NPM1
|
[NCBI]
|
1.05388e-05
|
|
|
LPO
|
[NCBI]
|
1.05388e-05
|
|
|
IRF1
|
[NCBI]
|
1.03982e-05
|
|
|
EMD
|
[NCBI]
|
1.03982e-05
|
|
|
UCN
|
[NCBI]
|
1.03832e-05
|
|
|
PLP1
|
[NCBI]
|
1.029e-05
|
|
|
TLR9
|
[NCBI]
|
1.02279e-05
|
|
|
MLC
|
[NCBI]
|
1.02202e-05
|
|
|
CLN1
|
[NCBI]
|
1.02202e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
1.02202e-05
|
|
|
USH2A
|
[NCBI]
|
1.02202e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
1.02167e-05
|
|
|
MLC1
|
[NCBI]
|
1.01945e-05
|
|
|
MYH1
|
[NCBI]
|
1.01945e-05
|
|
|
LTK
|
[NCBI]
|
1.01945e-05
|
|
|
SAG
|
[NCBI]
|
1.01945e-05
|
|
|
MCPH1
|
[NCBI]
|
1.01945e-05
|
|
|
SOST
|
[NCBI]
|
1.01945e-05
|
|
|
CX3CR1
|
[NCBI]
|
1.01945e-05
|
|
|
CYP7A1
|
[NCBI]
|
1.01945e-05
|
|
|
UBQLN1
|
[NCBI]
|
1.01945e-05
|
|
|
RYR3
|
[NCBI]
|
1.01945e-05
|
|
|
KCNQ4
|
[NCBI]
|
1.01945e-05
|
|
|
CHRNA3
|
[NCBI]
|
1.01945e-05
|
|
|
TIMELESS
|
[NCBI]
|
1.01945e-05
|
|
|
MEN1
|
[NCBI]
|
1.01657e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.01657e-05
|
|
|
TCOF
|
[NCBI]
|
1.01258e-05
|
|
|
VUR1
|
[NCBI]
|
1.00051e-05
|
|
|
PIL
|
[NCBI]
|
9.954e-06
|
|
|
CHED2
|
[NCBI]
|
9.954e-06
|
|
|
takayasu arteritis
|
[NCBI]
|
9.954e-06
|
|
|
opitz syndrome
|
[NCBI]
|
9.954e-06
|
|
|
SANDO
|
[NCBI]
|
9.954e-06
|
|
|
monosomy 1p36 syndrome
|
[NCBI]
|
9.954e-06
|
|
|
SC
|
[NCBI]
|
9.954e-06
|
|
|
IBMPFD
|
[NCBI]
|
9.954e-06
|
|
|
JBTS3
|
[NCBI]
|
9.954e-06
|
|
|
char syndrome
|
[NCBI]
|
9.954e-06
|
|
|
AITD3
|
[NCBI]
|
9.954e-06
|
|
|
EVR2
|
[NCBI]
|
9.954e-06
|
|
|
OPLL
|
[NCBI]
|
9.954e-06
|
|
|
MFS2
|
[NCBI]
|
9.954e-06
|
|
|
myopathy, myosin storage
|
[NCBI]
|
9.954e-06
|
|
|
EBS-MP
|
[NCBI]
|
9.954e-06
|
|
|
AIH2
|
[NCBI]
|
9.954e-06
|
|
|
ear wax, wet/dry
|
[NCBI]
|
9.954e-06
|
|
|
ODG2
|
[NCBI]
|
9.954e-06
|
|
|
MDC1C
|
[NCBI]
|
9.954e-06
|
|
|
cryptorchidism, unilateral or bilateral
|
[NCBI]
|
9.954e-06
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
9.954e-06
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
9.954e-06
|
|
|
hyperbilirubinemia, transient familial neonatal
|
[NCBI]
|
9.954e-06
|
|
|
homocystinuria
|
[NCBI]
|
9.92192e-06
|
|
|
CRP
|
[NCBI]
|
9.85773e-06
|
|
|
SMN2
|
[NCBI]
|
9.81795e-06
|
|
|
IGER
|
[NCBI]
|
9.78646e-06
|
|
|
NF1
|
[NCBI]
|
9.71003e-06
|
|
|
HOS
|
[NCBI]
|
9.66037e-06
|
|
|
SLC2A2
|
[NCBI]
|
9.64477e-06
|
|
|
RYR1
|
[NCBI]
|
9.5532e-06
|
|
|
RBP1
|
[NCBI]
|
9.45786e-06
|
|
|
MATN3
|
[NCBI]
|
9.36084e-06
|
|
|
ADD1
|
[NCBI]
|
9.36084e-06
|
|
|
CD209
|
[NCBI]
|
9.36084e-06
|
|
|
SULT1A1
|
[NCBI]
|
9.36084e-06
|
|
|
PAPSS2
|
[NCBI]
|
9.36084e-06
|
|
|
diphosphoglycerate mutase deficiency of erythrocyte
|
[NCBI]
|
9.36084e-06
|
|
|
EMX2
|
[NCBI]
|
9.36084e-06
|
|
|
ZFY
|
[NCBI]
|
9.36084e-06
|
|
|
SOX3
|
[NCBI]
|
9.36084e-06
|
|
|
ART4
|
[NCBI]
|
9.36084e-06
|
|
|
MTM1
|
[NCBI]
|
9.34715e-06
|
|
|
pta deficiency
|
[NCBI]
|
9.34715e-06
|
|
|
MTND2
|
[NCBI]
|
9.34715e-06
|
|
|
GALC
|
[NCBI]
|
9.34715e-06
|
|
|
RBP3
|
[NCBI]
|
9.34715e-06
|
|
|
CMM2
|
[NCBI]
|
9.2481e-06
|
|
|
biotinidase deficiency
|
[NCBI]
|
9.2481e-06
|
|
|
WT1
|
[NCBI]
|
9.24588e-06
|
|
|
PADI3
|
[NCBI]
|
9.20679e-06
|
|
|
HS1BP3
|
[NCBI]
|
9.20679e-06
|
|
|
ST3GAL6
|
[NCBI]
|
9.20679e-06
|
|
|
HRASLS
|
[NCBI]
|
9.20679e-06
|
|
|
MLN
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA12
|
[NCBI]
|
9.20679e-06
|
|
|
DMGDH
|
[NCBI]
|
9.20679e-06
|
|
|
PPP1R10
|
[NCBI]
|
9.20679e-06
|
|
|
nebulette
|
[NCBI]
|
9.20679e-06
|
|
|
USP17
|
[NCBI]
|
9.20679e-06
|
|
|
BUB3
|
[NCBI]
|
9.20679e-06
|
|
|
ARL11
|
[NCBI]
|
9.20679e-06
|
|
|
TLL1
|
[NCBI]
|
9.20679e-06
|
|
|
NEUROD4
|
[NCBI]
|
9.20679e-06
|
|
|
GSTA3
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA3
|
[NCBI]
|
9.20679e-06
|
|
|
C11ORF5
|
[NCBI]
|
9.20679e-06
|
|
|
RIMS2
|
[NCBI]
|
9.20679e-06
|
|
|
ACCN4
|
[NCBI]
|
9.20679e-06
|
|
|
AS3MT
|
[NCBI]
|
9.20679e-06
|
|
|
MFAP2
|
[NCBI]
|
9.20679e-06
|
|
|
PLEK
|
[NCBI]
|
9.20679e-06
|
|
|
MCM3
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA10
|
[NCBI]
|
9.20679e-06
|
|
|
KCNJ12
|
[NCBI]
|
9.20679e-06
|
|
|
ZNF239
|
[NCBI]
|
9.20679e-06
|
|
|
deleted in endometrial carcinoma
|
[NCBI]
|
9.20679e-06
|
|
|
ANGPT4
|
[NCBI]
|
9.20679e-06
|
|
|
TLL2
|
[NCBI]
|
9.20679e-06
|
|
|
PWP2H
|
[NCBI]
|
9.20679e-06
|
|
|
WFDC12
|
[NCBI]
|
9.20679e-06
|
|
|
ATP6V0A4
|
[NCBI]
|
9.20679e-06
|
|
|
PLS3
|
[NCBI]
|
9.20679e-06
|
|
|
HLA-MT
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA6
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA9
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA4
|
[NCBI]
|
9.20679e-06
|
|
|
TAAR6
|
[NCBI]
|
9.20679e-06
|
|
|
PTGES2
|
[NCBI]
|
9.20679e-06
|
|
|
P2RX5
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEA11
|
[NCBI]
|
9.20679e-06
|
|
|
C20ORF41
|
[NCBI]
|
9.20679e-06
|
|
|
IGLP1
|
[NCBI]
|
9.20679e-06
|
|
|
ETFDH
|
[NCBI]
|
9.20679e-06
|
|
|
PADI1
|
[NCBI]
|
9.20679e-06
|
|
|
TMEM1
|
[NCBI]
|
9.20679e-06
|
|
|
IHG
|
[NCBI]
|
9.20679e-06
|
|
|
SACP
|
[NCBI]
|
9.20679e-06
|
|
|
PDE4C
|
[NCBI]
|
9.20679e-06
|
|
|
ANP32C
|
[NCBI]
|
9.20679e-06
|
|
|
HNRPA0
|
[NCBI]
|
9.20679e-06
|
|
|
GSTA1
|
[NCBI]
|
9.20679e-06
|
|
|
IGHG4
|
[NCBI]
|
9.20679e-06
|
|
|
KIAA0513
|
[NCBI]
|
9.20679e-06
|
|
|
BARX2
|
[NCBI]
|
9.20679e-06
|
|
|
EDG6
|
[NCBI]
|
9.20679e-06
|
|
|
USP26
|
[NCBI]
|
9.20679e-06
|
|
|
PKDREJ
|
[NCBI]
|
9.20679e-06
|
|
|
MUC3B
|
[NCBI]
|
9.20679e-06
|
|
|
DGCR6
|
[NCBI]
|
9.20679e-06
|
|
|
EMILIN2
|
[NCBI]
|
9.20679e-06
|
|
|
SEZ6L
|
[NCBI]
|
9.20679e-06
|
|
|
LY75
|
[NCBI]
|
9.20679e-06
|
|
|
MAN2C1
|
[NCBI]
|
9.20679e-06
|
|
|
ABCG4
|
[NCBI]
|
9.20679e-06
|
|
|
IGJ
|
[NCBI]
|
9.20679e-06
|
|
|
ANXA3
|
[NCBI]
|
9.20679e-06
|
|
|
TXNRD3
|
[NCBI]
|
9.20679e-06
|
|
|
MAD2L2
|
[NCBI]
|
9.20679e-06
|
|
|
MAGEC1
|
[NCBI]
|
9.20679e-06
|
|
|
FBN3
|
[NCBI]
|
9.20679e-06
|
|
|
ABCC12
|
[NCBI]
|
9.20679e-06
|
|
|
ABR
|
[NCBI]
|
9.20679e-06
|
|
|
PPP3CC
|
[NCBI]
|
9.20679e-06
|
|
|
KCNJ13
|
[NCBI]
|
9.20679e-06
|
|
|
RIMS3
|
[NCBI]
|
9.20679e-06
|
|
|
CYP2G1
|
[NCBI]
|
9.20679e-06
|
|
|
MKS1
|
[NCBI]
|
9.20101e-06
|
|
|
ARMD1
|
[NCBI]
|
9.20101e-06
|
|
|
NR1I2
|
[NCBI]
|
9.17391e-06
|
|
|
IFNA1
|
[NCBI]
|
9.15292e-06
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
9.09318e-06
|
|
|
MMP9
|
[NCBI]
|
9.03563e-06
|
|
|
HDAC1
|
[NCBI]
|
9.00114e-06
|
|
|
PCD
|
[NCBI]
|
8.9208e-06
|
|
|
IL4R
|
[NCBI]
|
8.86414e-06
|
|
|
ALDH1A1
|
[NCBI]
|
8.86414e-06
|
|
|
GJA5
|
[NCBI]
|
8.86414e-06
|
|
|
CD4
|
[NCBI]
|
8.86414e-06
|
|
|
SLC2A4
|
[NCBI]
|
8.77427e-06
|
|
|
DAZL
|
[NCBI]
|
8.6107e-06
|
|
|
SFTPC
|
[NCBI]
|
8.6107e-06
|
|
|
CRYGA
|
[NCBI]
|
8.6107e-06
|
|
|
HCRTR2
|
[NCBI]
|
8.6107e-06
|
|
|
IKBKAP
|
[NCBI]
|
8.6107e-06
|
|
|
ABCB4
|
[NCBI]
|
8.6107e-06
|
|
|
MED12
|
[NCBI]
|
8.6107e-06
|
|
|
EIF2B5
|
[NCBI]
|
8.6107e-06
|
|
|
RAI1
|
[NCBI]
|
8.6107e-06
|
|
|
OLR1
|
[NCBI]
|
8.6107e-06
|
|
|
EN2
|
[NCBI]
|
8.6107e-06
|
|
|
COL9A1
|
[NCBI]
|
8.6107e-06
|
|
|
KRT9
|
[NCBI]
|
8.6107e-06
|
|
|
ZP3
|
[NCBI]
|
8.6107e-06
|
|
|
PDE4D
|
[NCBI]
|
8.6107e-06
|
|
|
IL4
|
[NCBI]
|
8.55615e-06
|
|
|
BCNS
|
[NCBI]
|
8.55181e-06
|
|
|
SI
|
[NCBI]
|
8.54867e-06
|
|
|
PIGR
|
[NCBI]
|
8.54867e-06
|
|
|
AHR
|
[NCBI]
|
8.47654e-06
|
|
|
IVD
|
[NCBI]
|
8.40664e-06
|
|
|
GAS
|
[NCBI]
|
8.40664e-06
|
|
|
PTCH1
|
[NCBI]
|
8.40664e-06
|
|
|
CYP17A1
|
[NCBI]
|
8.36524e-06
|
|
|
citrullinemia, classic
|
[NCBI]
|
8.35193e-06
|
|
|
PDB
|
[NCBI]
|
8.35193e-06
|
|
|
MHA
|
[NCBI]
|
8.35193e-06
|
|
|
PNKD1
|
[NCBI]
|
8.35193e-06
|
|
|
NEM3
|
[NCBI]
|
8.35193e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
8.35193e-06
|
|
|
CPX
|
[NCBI]
|
8.35193e-06
|
|
|
TP53
|
[NCBI]
|
8.30565e-06
|
|
|
bare lymphocyte syndrome, type ii
|
[NCBI]
|
8.30138e-06
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
8.25341e-06
|
|
|
CMH4
|
[NCBI]
|
8.25341e-06
|
|
|
OCA3
|
[NCBI]
|
8.25341e-06
|
|
|
SBS
|
[NCBI]
|
8.25341e-06
|
|
|
EDM4
|
[NCBI]
|
8.25341e-06
|
|
|
NIDDM1
|
[NCBI]
|
8.25341e-06
|
|
|
IHCM
|
[NCBI]
|
8.25341e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
8.25341e-06
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
8.25341e-06
|
|
|
RP12
|
[NCBI]
|
8.25341e-06
|
|
|
macular dystrophy, vitelliform, adult-onset
|
[NCBI]
|
8.25341e-06
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
8.25341e-06
|
|
|
MODY2
|
[NCBI]
|
8.25341e-06
|
|
|
LRS1
|
[NCBI]
|
8.25341e-06
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
8.25341e-06
|
|
|
RHN
|
[NCBI]
|
8.25341e-06
|
|
|
HHF6
|
[NCBI]
|
8.25341e-06
|
|
|
CMT2D
|
[NCBI]
|
8.25341e-06
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
8.25341e-06
|
|
|
XPB
|
[NCBI]
|
8.25341e-06
|
|
|
ZS
|
[NCBI]
|
8.15631e-06
|
|
|
DAZ
|
[NCBI]
|
8.03437e-06
|
|
|
THRA
|
[NCBI]
|
7.97283e-06
|
|
|
CALCA
|
[NCBI]
|
7.97283e-06
|
|
|
IGF2R
|
[NCBI]
|
7.97283e-06
|
|
|
SLC22A1
|
[NCBI]
|
7.9316e-06
|
|
|
LU
|
[NCBI]
|
7.9316e-06
|
|
|
RNR1
|
[NCBI]
|
7.9316e-06
|
|
|
OGG1
|
[NCBI]
|
7.9316e-06
|
|
|
HSPD1
|
[NCBI]
|
7.9316e-06
|
|
|
NEFH
|
[NCBI]
|
7.9316e-06
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
7.81501e-06
|
|
|
VLDLR
|
[NCBI]
|
7.71529e-06
|
|
|
BIRC1
|
[NCBI]
|
7.65549e-06
|
|
|
RB1
|
[NCBI]
|
7.61613e-06
|
|
|
CHGA
|
[NCBI]
|
7.56107e-06
|
|
|
RYR2
|
[NCBI]
|
7.56107e-06
|
|
|
NOS2A
|
[NCBI]
|
7.56107e-06
|
|
|
velocardiofacial syndrome
|
[NCBI]
|
7.53173e-06
|
|
|
DYX1
|
[NCBI]
|
7.52552e-06
|
|
|
SMA2
|
[NCBI]
|
7.52552e-06
|
|
|
AMH
|
[NCBI]
|
7.48536e-06
|
|
|
RCC1
|
[NCBI]
|
7.4288e-06
|
|
|
L1CAM
|
[NCBI]
|
7.40747e-06
|
|
|
factor x deficiency
|
[NCBI]
|
7.40747e-06
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
7.40389e-06
|
|
|
TGFB1
|
[NCBI]
|
7.40189e-06
|
|
|
TLE3
|
[NCBI]
|
7.38952e-06
|
|
|
fe65-like 2
|
[NCBI]
|
7.38952e-06
|
|
|
KLRG1
|
[NCBI]
|
7.38952e-06
|
|
|
CYP4F12
|
[NCBI]
|
7.38952e-06
|
|
|
PF4V1
|
[NCBI]
|
7.38952e-06
|
|
|
PHLDA1
|
[NCBI]
|
7.38952e-06
|
|
|
GUCY2F
|
[NCBI]
|
7.38952e-06
|
|
|
UGT1A9
|
[NCBI]
|
7.38952e-06
|
|
|
GNG2
|
[NCBI]
|
7.38952e-06
|
|
|
EFHC1
|
[NCBI]
|
7.38952e-06
|
|
|
MAGEA8
|
[NCBI]
|
7.38952e-06
|
|
|
NBR1
|
[NCBI]
|
7.38952e-06
|
|
|
DYNLT1
|
[NCBI]
|
7.38952e-06
|
|
|
NELF
|
[NCBI]
|
7.38952e-06
|
|
|
PPT2
|
[NCBI]
|
7.38952e-06
|
|
|
IFNA17
|
[NCBI]
|
7.38952e-06
|
|
|
CYP46A1
|
[NCBI]
|
7.38952e-06
|
|
|
MUC7
|
[NCBI]
|
7.38952e-06
|
|
|
breast cancer-associated df3 antigen
|
[NCBI]
|
7.38952e-06
|
|
|
solute carrier family 26 (anion transporter), member 6: slc26a6
|
[NCBI]
|
7.38952e-06
|
|
|
UBC
|
[NCBI]
|
7.38952e-06
|
|
|
PSMB8
|
[NCBI]
|
7.38952e-06
|
|
|
L3MBTL
|
[NCBI]
|
7.38952e-06
|
|
|
RRAD
|
[NCBI]
|
7.38952e-06
|
|
|
PHF11
|
[NCBI]
|
7.38952e-06
|
|
|
antigen defined by monoclonal antibody f10.44.2
|
[NCBI]
|
7.38952e-06
|
|
|
PHKG1
|
[NCBI]
|
7.38952e-06
|
|
|
BST1
|
[NCBI]
|
7.38952e-06
|
|
|
CACNB1
|
[NCBI]
|
7.38952e-06
|
|
|
NEDD4L
|
[NCBI]
|
7.38952e-06
|
|
|
JRK
|
[NCBI]
|
7.38952e-06
|
|
|
FIGN
|
[NCBI]
|
7.38952e-06
|
|
|
CENPI
|
[NCBI]
|
7.38952e-06
|
|
|
ITPKC
|
[NCBI]
|
7.38952e-06
|
|
|
EXTL1
|
[NCBI]
|
7.38952e-06
|
|
|
HOXD8
|
[NCBI]
|
7.38952e-06
|
|
|
ARHGAP8
|
[NCBI]
|
7.38952e-06
|
|
|
PIK3CB
|
[NCBI]
|
7.38952e-06
|
|
|
PDE7A
|
[NCBI]
|
7.38952e-06
|
|
|
EBF2
|
[NCBI]
|
7.38952e-06
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
7.38952e-06
|
|
|
XYLT1
|
[NCBI]
|
7.38952e-06
|
|
|
GPD1L
|
[NCBI]
|
7.38952e-06
|
|
|
OAZ3
|
[NCBI]
|
7.38952e-06
|
|
|
RASSF5
|
[NCBI]
|
7.38952e-06
|
|
|
TNNC2
|
[NCBI]
|
7.38952e-06
|
|
|
CD72
|
[NCBI]
|
7.38952e-06
|
|
|
SMYD3
|
[NCBI]
|
7.38952e-06
|
|
|
RAB4
|
[NCBI]
|
7.38952e-06
|
|
|
GSTM3
|
[NCBI]
|
7.38952e-06
|
|
|
SLC12A6
|
[NCBI]
|
7.38952e-06
|
|
|
RP9
|
[NCBI]
|
7.38952e-06
|
|
|
STRA6
|
[NCBI]
|
7.38952e-06
|
|
|
GSTA4
|
[NCBI]
|
7.38952e-06
|
|
|
VAMP4
|
[NCBI]
|
7.38952e-06
|
|
|
PCM1
|
[NCBI]
|
7.38952e-06
|
|
|
ETFB
|
[NCBI]
|
7.38952e-06
|
|
|
UGT1A8
|
[NCBI]
|
7.38952e-06
|
|
|
OTOR
|
[NCBI]
|
7.38952e-06
|
|
|
UTY
|
[NCBI]
|
7.38952e-06
|
|
|
MYOM1
|
[NCBI]
|
7.38952e-06
|
|
|
IGKV1OR2108
|
[NCBI]
|
7.38952e-06
|
|
|
MAGEA5
|
[NCBI]
|
7.38952e-06
|
|
|
PTPRJ
|
[NCBI]
|
7.38952e-06
|
|
|
DUSP3
|
[NCBI]
|
7.38952e-06
|
|
|
ATP1B2
|
[NCBI]
|
7.38952e-06
|
|
|
MAB21L1
|
[NCBI]
|
7.38952e-06
|
|
|
GABRB1
|
[NCBI]
|
7.38952e-06
|
|
|
PDC
|
[NCBI]
|
7.31368e-06
|
|
|
PFC
|
[NCBI]
|
7.31368e-06
|
|
|
PKHD1
|
[NCBI]
|
7.31368e-06
|
|
|
PLAU
|
[NCBI]
|
7.31368e-06
|
|
|
SSTR5
|
[NCBI]
|
7.31368e-06
|
|
|
LIG4
|
[NCBI]
|
7.31368e-06
|
|
|
MTND4L
|
[NCBI]
|
7.31368e-06
|
|
|
apc gene
|
[NCBI]
|
7.26439e-06
|
|
|
GCDH
|
[NCBI]
|
7.16989e-06
|
|
|
PPR
|
[NCBI]
|
6.97976e-06
|
|
|
NETH
|
[NCBI]
|
6.83305e-06
|
|
|
GBD1
|
[NCBI]
|
6.83305e-06
|
|
|
EBS2
|
[NCBI]
|
6.83305e-06
|
|
|
hyperornithinemia-hyperammonemia-homocitrullinuria syndrome
|
[NCBI]
|
6.83305e-06
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
6.83305e-06
|
|
|
BRIC1
|
[NCBI]
|
6.83305e-06
|
|
|
pulmonary edema of mountaineers
|
[NCBI]
|
6.83305e-06
|
|
|
glycogen storage disease ic
|
[NCBI]
|
6.83305e-06
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
6.83305e-06
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
6.83305e-06
|
|
|
PKD3
|
[NCBI]
|
6.83305e-06
|
|
|
MCPH5
|
[NCBI]
|
6.83305e-06
|
|
|
LGMD2E
|
[NCBI]
|
6.83305e-06
|
|
|
gm1-gangliosidosis, type ii
|
[NCBI]
|
6.83305e-06
|
|
|
SXI1
|
[NCBI]
|
6.83305e-06
|
|
|
PBT
|
[NCBI]
|
6.83305e-06
|
|
|
NYS1
|
[NCBI]
|
6.83305e-06
|
|
|
FMD
|
[NCBI]
|
6.83305e-06
|
|
|
NTRK1
|
[NCBI]
|
6.82378e-06
|
|
|
MSTN
|
[NCBI]
|
6.82378e-06
|
|
|
BDNF
|
[NCBI]
|
6.79798e-06
|
|
|
COL6A1
|
[NCBI]
|
6.79794e-06
|
|
|
ALPL
|
[NCBI]
|
6.79794e-06
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
6.79794e-06
|
|
|
FHM1
|
[NCBI]
|
6.76339e-06
|
|
|
AMY2A
|
[NCBI]
|
6.749e-06
|
|
|
ANGPT1
|
[NCBI]
|
6.749e-06
|
|
|
FGF1
|
[NCBI]
|
6.64311e-06
|
|
|
CDK4
|
[NCBI]
|
6.61895e-06
|
|
|
CLS
|
[NCBI]
|
6.58536e-06
|
|
|
SCA7
|
[NCBI]
|
6.58536e-06
|
|
|
ALB
|
[NCBI]
|
6.5833e-06
|
|
|
GBA
|
[NCBI]
|
6.56971e-06
|
|
|
FMF
|
[NCBI]
|
6.55621e-06
|
|
|
MTND6
|
[NCBI]
|
6.44404e-06
|
|
|
oca2 gene
|
[NCBI]
|
6.44404e-06
|
|
|
COL10A1
|
[NCBI]
|
6.44404e-06
|
|
|
TNF
|
[NCBI]
|
6.33824e-06
|
|
|
KEL
|
[NCBI]
|
6.23107e-06
|
|
|
CAST
|
[NCBI]
|
6.23107e-06
|
|
|
DLL3
|
[NCBI]
|
6.23107e-06
|
|
|
SLC22A8
|
[NCBI]
|
6.23107e-06
|
|
|
CBR1
|
[NCBI]
|
6.23107e-06
|
|
|
CBFA2T1
|
[NCBI]
|
6.23107e-06
|
|
|
USH2A
|
[NCBI]
|
6.23107e-06
|
|
|
THY1
|
[NCBI]
|
6.23107e-06
|
|
|
SCNN1A
|
[NCBI]
|
6.23107e-06
|
|
|
CYP11A1
|
[NCBI]
|
6.23107e-06
|
|
|
FGB
|
[NCBI]
|
6.23107e-06
|
|
|
SMN1
|
[NCBI]
|
6.1847e-06
|
|
|
AMC
|
[NCBI]
|
6.17529e-06
|
|
|
OCP
|
[NCBI]
|
6.17529e-06
|
|
|
CFI
|
[NCBI]
|
6.10708e-06
|
|
|
GRPR
|
[NCBI]
|
6.10708e-06
|
|
|
CORT
|
[NCBI]
|
6.09061e-06
|
|
|
TREH
|
[NCBI]
|
6.09061e-06
|
|
|
PRSS7
|
[NCBI]
|
6.09061e-06
|
|
|
SLC14A2
|
[NCBI]
|
6.09061e-06
|
|
|
INTS6
|
[NCBI]
|
6.09061e-06
|
|
|
CPT1B
|
[NCBI]
|
6.09061e-06
|
|
|
MAGEE1
|
[NCBI]
|
6.09061e-06
|
|
|
SKIV2L
|
[NCBI]
|
6.09061e-06
|
|
|
AARS
|
[NCBI]
|
6.09061e-06
|
|
|
GLMN
|
[NCBI]
|
6.09061e-06
|
|
|
CDK5RAP2
|
[NCBI]
|
6.09061e-06
|
|
|
SFRS2
|
[NCBI]
|
6.09061e-06
|
|
|
BRSK2
|
[NCBI]
|
6.09061e-06
|
|
|
ETFA
|
[NCBI]
|
6.09061e-06
|
|
|
B4GALNT2
|
[NCBI]
|
6.09061e-06
|
|
|
NTSR1
|
[NCBI]
|
6.09061e-06
|
|
|
REV3L
|
[NCBI]
|
6.09061e-06
|
|
|
TAAR5
|
[NCBI]
|
6.09061e-06
|
|
|
KIR2DS2
|
[NCBI]
|
6.09061e-06
|
|
|
DOK1
|
[NCBI]
|
6.09061e-06
|
|
|
SNCAIP
|
[NCBI]
|
6.09061e-06
|
|
|
GANC
|
[NCBI]
|
6.09061e-06
|
|
|
NAPA
|
[NCBI]
|
6.09061e-06
|
|
|
ABAT
|
[NCBI]
|
6.09061e-06
|
|
|
HLA-E
|
[NCBI]
|
6.09061e-06
|
|
|
rad54, s. cerevisiae, homolog of, b
|
[NCBI]
|
6.09061e-06
|
|
|
EPIM
|
[NCBI]
|
6.09061e-06
|
|
|
RDBP
|
[NCBI]
|
6.09061e-06
|
|
|
CSNK1E
|
[NCBI]
|
6.09061e-06
|
|
|
ADAM33
|
[NCBI]
|
6.09061e-06
|
|
|
ELA1
|
[NCBI]
|
6.09061e-06
|
|
|
GLRB
|
[NCBI]
|
6.09061e-06
|
|
|
TUBA4A
|
[NCBI]
|
6.09061e-06
|
|
|
GPR14
|
[NCBI]
|
6.09061e-06
|
|
|
TJP2
|
[NCBI]
|
6.09061e-06
|
|
|
CHML
|
[NCBI]
|
6.09061e-06
|
|
|
ATXN10
|
[NCBI]
|
6.09061e-06
|
|
|
CD79B
|
[NCBI]
|
6.09061e-06
|
|
|
CCL24
|
[NCBI]
|
6.09061e-06
|
|
|
MOX2
|
[NCBI]
|
6.09061e-06
|
|
|
PLA1A
|
[NCBI]
|
6.09061e-06
|
|
|
SSTR3
|
[NCBI]
|
6.09061e-06
|
|
|
ADRA2B
|
[NCBI]
|
6.09061e-06
|
|
|
HRC
|
[NCBI]
|
6.09061e-06
|
|
|
GDF9
|
[NCBI]
|
6.09061e-06
|
|
|
SARDH
|
[NCBI]
|
6.09061e-06
|
|
|
PPP1R13L
|
[NCBI]
|
6.09061e-06
|
|
|
FXYD2
|
[NCBI]
|
6.09061e-06
|
|
|
GABRA6
|
[NCBI]
|
6.09061e-06
|
|
|
CSTA
|
[NCBI]
|
6.09061e-06
|
|
|
PRSS2
|
[NCBI]
|
6.09061e-06
|
|
|
AK2
|
[NCBI]
|
6.09061e-06
|
|
|
RAD54L
|
[NCBI]
|
6.09061e-06
|
|
|
neuroblastoma stage 4s gene
|
[NCBI]
|
6.09061e-06
|
|
|
POSTN
|
[NCBI]
|
6.09061e-06
|
|
|
SLC25A12
|
[NCBI]
|
6.09061e-06
|
|
|
SSPN
|
[NCBI]
|
6.09061e-06
|
|
|
CYSLTR2
|
[NCBI]
|
6.09061e-06
|
|
|
ZAN
|
[NCBI]
|
6.09061e-06
|
|
|
CLN6
|
[NCBI]
|
6.09061e-06
|
|
|
CALM2
|
[NCBI]
|
6.09061e-06
|
|
|
GIF
|
[NCBI]
|
6.09061e-06
|
|
|
NPR1
|
[NCBI]
|
6.09061e-06
|
|
|
REEP5
|
[NCBI]
|
6.09061e-06
|
|
|
ASGR1
|
[NCBI]
|
6.09061e-06
|
|
|
NINJ1
|
[NCBI]
|
6.09061e-06
|
|
|
FBP1
|
[NCBI]
|
6.09061e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
6.07733e-06
|
|
|
PHS
|
[NCBI]
|
6.06067e-06
|
|
|
DAR
|
[NCBI]
|
6.06067e-06
|
|
|
HSAS
|
[NCBI]
|
6.06067e-06
|
|
|
MTND1
|
[NCBI]
|
6.0218e-06
|
|
|
THRB
|
[NCBI]
|
5.81019e-06
|
|
|
RARA
|
[NCBI]
|
5.78607e-06
|
|
|
NF2
|
[NCBI]
|
5.77342e-06
|
|
|
FXN
|
[NCBI]
|
5.77258e-06
|
|
|
AVSD
|
[NCBI]
|
5.76017e-06
|
|
|
TPM3
|
[NCBI]
|
5.75453e-06
|
|
|
TGFBR1
|
[NCBI]
|
5.75453e-06
|
|
|
JK
|
[NCBI]
|
5.75453e-06
|
|
|
C5
|
[NCBI]
|
5.75453e-06
|
|
|
GLUD1
|
[NCBI]
|
5.75453e-06
|
|
|
GLRA1
|
[NCBI]
|
5.75453e-06
|
|
|
Ge
|
[NCBI]
|
5.75453e-06
|
|
|
MODY3
|
[NCBI]
|
5.63656e-06
|
|
|
platelet glycoprotein iv deficiency
|
[NCBI]
|
5.63656e-06
|
|
|
kawasaki disease
|
[NCBI]
|
5.63656e-06
|
|
|
PHA1
|
[NCBI]
|
5.63656e-06
|
|
|
SPG6
|
[NCBI]
|
5.63656e-06
|
|
|
GVM
|
[NCBI]
|
5.63656e-06
|
|
|
IFD
|
[NCBI]
|
5.63656e-06
|
|
|
OSMED
|
[NCBI]
|
5.63656e-06
|
|
|
GINGF
|
[NCBI]
|
5.63656e-06
|
|
|
DMD
|
[NCBI]
|
5.63124e-06
|
|
|
LRRK2
|
[NCBI]
|
5.60683e-06
|
|
|
NMB
|
[NCBI]
|
5.5227e-06
|
|
|
IL13
|
[NCBI]
|
5.48008e-06
|
|
|
GHRL
|
[NCBI]
|
5.48008e-06
|
|
|
OA1
|
[NCBI]
|
5.48008e-06
|
|
|
PLN
|
[NCBI]
|
5.3859e-06
|
|
|
glioma of brain, familial
|
[NCBI]
|
5.38008e-06
|
|
|
hypertrophic neuropathy of dejerine-sottas
|
[NCBI]
|
5.38008e-06
|
|
|
BRRS
|
[NCBI]
|
5.38008e-06
|
|
|
CSF1R
|
[NCBI]
|
5.31489e-06
|
|
|
SGCE
|
[NCBI]
|
5.31489e-06
|
|
|
FRAXE
|
[NCBI]
|
5.31489e-06
|
|
|
LMX1B
|
[NCBI]
|
5.31489e-06
|
|
|
PTPN22
|
[NCBI]
|
5.31489e-06
|
|
|
COL11A2
|
[NCBI]
|
5.31489e-06
|
|
|
KRIT1
|
[NCBI]
|
5.31489e-06
|
|
|
TNFRSF13B
|
[NCBI]
|
5.31489e-06
|
|
|
MMP12
|
[NCBI]
|
5.31489e-06
|
|
|
KCNE1
|
[NCBI]
|
5.31489e-06
|
|
|
ST3
|
[NCBI]
|
5.25968e-06
|
|
|
CLU
|
[NCBI]
|
5.24988e-06
|
|
|
PRPH2
|
[NCBI]
|
5.18829e-06
|
|
|
NDP
|
[NCBI]
|
5.18829e-06
|
|
|
coproporphyria
|
[NCBI]
|
5.18829e-06
|
|
|
PTHR1
|
[NCBI]
|
5.18829e-06
|
|
|
COMP
|
[NCBI]
|
5.17969e-06
|
|
|
HHT
|
[NCBI]
|
5.17822e-06
|
|
|
MYC
|
[NCBI]
|
5.11466e-06
|
|
|
SLC2A10
|
[NCBI]
|
5.09701e-06
|
|
|
FGR
|
[NCBI]
|
5.09701e-06
|
|
|
KIR2DL3
|
[NCBI]
|
5.09701e-06
|
|
|
SLC29A2
|
[NCBI]
|
5.09701e-06
|
|
|
GDA
|
[NCBI]
|
5.09701e-06
|
|
|
VSX1
|
[NCBI]
|
5.09701e-06
|
|
|
PCDH8
|
[NCBI]
|
5.09701e-06
|
|
|
ribonucleic acid, ribosomal, 5s
|
[NCBI]
|
5.09701e-06
|
|
|
DIA3
|
[NCBI]
|
5.09701e-06
|
|
|
TUBAL1
|
[NCBI]
|
5.09701e-06
|
|
|
PADI4
|
[NCBI]
|
5.09701e-06
|
|
|
ARMET
|
[NCBI]
|
5.09701e-06
|
|
|
SYT3
|
[NCBI]
|
5.09701e-06
|
|
|
IGHA2
|
[NCBI]
|
5.09701e-06
|
|
|
TAS1R1
|
[NCBI]
|
5.09701e-06
|
|
|
CES2
|
[NCBI]
|
5.09701e-06
|
|
|
ARNT2
|
[NCBI]
|
5.09701e-06
|
|
|
SMS
|
[NCBI]
|
5.09701e-06
|
|
|
CMA1
|
[NCBI]
|
5.09701e-06
|
|
|
E2F2
|
[NCBI]
|
5.09701e-06
|
|
|
DEFB103A
|
[NCBI]
|
5.09701e-06
|
|
|
WFDC1
|
[NCBI]
|
5.09701e-06
|
|
|
ATP1A3
|
[NCBI]
|
5.09701e-06
|
|
|
MMP10
|
[NCBI]
|
5.09701e-06
|
|
|
GRIK2
|
[NCBI]
|
5.09701e-06
|
|
|
LW
|
[NCBI]
|
5.09701e-06
|
|
|
GPRK2L
|
[NCBI]
|
5.09701e-06
|
|
|
TYRO3
|
[NCBI]
|
5.09701e-06
|
|
|
PREP
|
[NCBI]
|
5.09701e-06
|
|
|
MFRP
|
[NCBI]
|
5.09701e-06
|
|
|
HSD17B3
|
[NCBI]
|
5.09701e-06
|
|
|
IGHD
|
[NCBI]
|
5.09701e-06
|
|
|
MCCC1
|
[NCBI]
|
5.09701e-06
|
|
|
SULT2A1
|
[NCBI]
|
5.09701e-06
|
|
|
MYCL1
|
[NCBI]
|
5.09701e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
5.09701e-06
|
|
|
IL22
|
[NCBI]
|
5.09701e-06
|
|
|
UBE2B
|
[NCBI]
|
5.09701e-06
|
|
|
CFC1
|
[NCBI]
|
5.09701e-06
|
|
|
MAGEA1
|
[NCBI]
|
5.09701e-06
|
|
|
PTGIS
|
[NCBI]
|
5.09701e-06
|
|
|
CACNB3
|
[NCBI]
|
5.09701e-06
|
|
|
lipase, congenital absence of pancreatic
|
[NCBI]
|
5.09701e-06
|
|
|
UGT2B17
|
[NCBI]
|
5.09701e-06
|
|
|
C8G
|
[NCBI]
|
5.09701e-06
|
|
|
SCAMP1
|
[NCBI]
|
5.09701e-06
|
|
|
HMCN1
|
[NCBI]
|
5.09701e-06
|
|
|
CDY1
|
[NCBI]
|
5.09701e-06
|
|
|
NOVA2
|
[NCBI]
|
5.09701e-06
|
|
|
PKD2L1
|
[NCBI]
|
5.09701e-06
|
|
|
HSPA1L
|
[NCBI]
|
5.09701e-06
|
|
|
PVRL2
|
[NCBI]
|
5.09701e-06
|
|
|
CASP12
|
[NCBI]
|
5.09701e-06
|
|
|
NOD1
|
[NCBI]
|
5.09701e-06
|
|
|
ALOX15
|
[NCBI]
|
5.09701e-06
|
|
|
TBXAS1
|
[NCBI]
|
5.09701e-06
|
|
|
MIC2Y
|
[NCBI]
|
5.09701e-06
|
|
|
bkm dna
|
[NCBI]
|
5.09701e-06
|
|
|
calcineurin-binding protein 1
|
[NCBI]
|
5.09701e-06
|
|
|
FDXR
|
[NCBI]
|
5.09701e-06
|
|
|
PRKAR2B
|
[NCBI]
|
5.09701e-06
|
|
|
ANKK1
|
[NCBI]
|
5.09701e-06
|
|
|
AGPAT2
|
[NCBI]
|
5.09701e-06
|
|
|
PHF9
|
[NCBI]
|
5.09701e-06
|
|
|
NFKB1
|
[NCBI]
|
5.07461e-06
|
|
|
MITF
|
[NCBI]
|
4.99952e-06
|
|
|
CMT1B
|
[NCBI]
|
4.99563e-06
|
|
|
neuroblastoma
|
[NCBI]
|
4.99563e-06
|
|
|
CSA
|
[NCBI]
|
4.99563e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
4.99563e-06
|
|
|
CFTR
|
[NCBI]
|
4.98829e-06
|
|
|
IBD1
|
[NCBI]
|
4.98734e-06
|
|
|
PSACH
|
[NCBI]
|
4.98734e-06
|
|
|
SMS
|
[NCBI]
|
4.9659e-06
|
|
|
ACADS
|
[NCBI]
|
4.90992e-06
|
|
|
MTCO1
|
[NCBI]
|
4.90992e-06
|
|
|
PHOX2B
|
[NCBI]
|
4.90835e-06
|
|
|
CACNA1S
|
[NCBI]
|
4.90835e-06
|
|
|
NNMT
|
[NCBI]
|
4.90835e-06
|
|
|
NEU1
|
[NCBI]
|
4.90835e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
4.90835e-06
|
|
|
PGD
|
[NCBI]
|
4.90835e-06
|
|
|
CGD
|
[NCBI]
|
4.88122e-06
|
|
|
BCR
|
[NCBI]
|
4.87767e-06
|
|
|
F2
|
[NCBI]
|
4.85753e-06
|
|
|
BSG
|
[NCBI]
|
4.84667e-06
|
|
|
STC1
|
[NCBI]
|
4.84667e-06
|
|
|
NRCLP1
|
[NCBI]
|
4.81663e-06
|
|
|
MCOPS7
|
[NCBI]
|
4.81663e-06
|
|
|
MHS1
|
[NCBI]
|
4.7358e-06
|
|
|
AN2
|
[NCBI]
|
4.7358e-06
|
|
|
TRPV1
|
[NCBI]
|
4.71395e-06
|
|
|
SPINK1
|
[NCBI]
|
4.66626e-06
|
|
|
PRLR
|
[NCBI]
|
4.65563e-06
|
|
|
JAG1
|
[NCBI]
|
4.64428e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
4.62723e-06
|
|
|
SFD
|
[NCBI]
|
4.62304e-06
|
|
|
carbamoyl phosphate synthetase i deficiency, hyperammonemia due to
|
[NCBI]
|
4.62304e-06
|
|
|
CMT4A
|
[NCBI]
|
4.62304e-06
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
4.62304e-06
|
|
|
MTC
|
[NCBI]
|
4.62304e-06
|
|
|
PMDS
|
[NCBI]
|
4.62304e-06
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
4.62304e-06
|
|
|
apolipoprotein c-ii deficiency
|
[NCBI]
|
4.62304e-06
|
|
|
medulloblastoma
|
[NCBI]
|
4.62304e-06
|
|
|
DFNA6
|
[NCBI]
|
4.62304e-06
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
4.62304e-06
|
|
|
SACS
|
[NCBI]
|
4.62304e-06
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
4.62304e-06
|
|
|
ALUNC
|
[NCBI]
|
4.62304e-06
|
|
|
SEDT
|
[NCBI]
|
4.62304e-06
|
|
|
IHPS1
|
[NCBI]
|
4.62304e-06
|
|
|
acheiropody
|
[NCBI]
|
4.62304e-06
|
|
|
PPD2
|
[NCBI]
|
4.62304e-06
|
|
|
carnitine palmitoyltransferase ii deficiency, late-onset
|
[NCBI]
|
4.62304e-06
|
|
|
CMT2B
|
[NCBI]
|
4.62304e-06
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
4.62304e-06
|
|
|
pycnodysostosis
|
[NCBI]
|
4.62304e-06
|
|
|
FGFR2
|
[NCBI]
|
4.56655e-06
|
|
|
NME1
|
[NCBI]
|
4.53167e-06
|
|
|
ACADM
|
[NCBI]
|
4.47031e-06
|
|
|
PLTP
|
[NCBI]
|
4.47031e-06
|
|
|
MAPT
|
[NCBI]
|
4.45681e-06
|
|
|
NOD2
|
[NCBI]
|
4.39069e-06
|
|
|
SRY
|
[NCBI]
|
4.35712e-06
|
|
|
HRG
|
[NCBI]
|
4.32981e-06
|
|
|
BMP2
|
[NCBI]
|
4.32112e-06
|
|
|
ADD2
|
[NCBI]
|
4.30513e-06
|
|
|
LIPG
|
[NCBI]
|
4.30513e-06
|
|
|
OMG
|
[NCBI]
|
4.30513e-06
|
|
|
PDE4B
|
[NCBI]
|
4.30513e-06
|
|
|
XRCC3
|
[NCBI]
|
4.30513e-06
|
|
|
TPM2
|
[NCBI]
|
4.30513e-06
|
|
|
MIRN15A
|
[NCBI]
|
4.30513e-06
|
|
|
PTBP1
|
[NCBI]
|
4.30513e-06
|
|
|
FBXW4
|
[NCBI]
|
4.30513e-06
|
|
|
ARAF1
|
[NCBI]
|
4.30513e-06
|
|
|
RPS25
|
[NCBI]
|
4.30513e-06
|
|
|
DLX2
|
[NCBI]
|
4.30513e-06
|
|
|
PHKB
|
[NCBI]
|
4.30513e-06
|
|
|
TAS2R10
|
[NCBI]
|
4.30513e-06
|
|
|
ABCA3
|
[NCBI]
|
4.30513e-06
|
|
|
TRPV6
|
[NCBI]
|
4.30513e-06
|
|
|
NEGF2
|
[NCBI]
|
4.30513e-06
|
|
|
AKR1C3
|
[NCBI]
|
4.30513e-06
|
|
|
CACNA2D1
|
[NCBI]
|
4.30513e-06
|
|
|
AKAP13
|
[NCBI]
|
4.30513e-06
|
|
|
HRPT2
|
[NCBI]
|
4.30513e-06
|
|
|
PTPRN
|
[NCBI]
|
4.30513e-06
|
|
|
DBY
|
[NCBI]
|
4.30513e-06
|
|
|
DYX1C1
|
[NCBI]
|
4.30513e-06
|
|
|
PRPS2
|
[NCBI]
|
4.30513e-06
|
|
|
EPS8
|
[NCBI]
|
4.30513e-06
|
|
|
ARIX
|
[NCBI]
|
4.30513e-06
|
|
|
PTPN13
|
[NCBI]
|
4.30513e-06
|
|
|
UGT2B4
|
[NCBI]
|
4.30513e-06
|
|
|
ALDH4A1
|
[NCBI]
|
4.30513e-06
|
|
|
CPN1
|
[NCBI]
|
4.30513e-06
|
|
|
RNU1
|
[NCBI]
|
4.30513e-06
|
|
|
MDH2
|
[NCBI]
|
4.30513e-06
|
|
|
ESPN
|
[NCBI]
|
4.30513e-06
|
|
|
BUB1
|
[NCBI]
|
4.30513e-06
|
|
|
IL21
|
[NCBI]
|
4.30513e-06
|
|
|
TSN
|
[NCBI]
|
4.30513e-06
|
|
|
MPP1
|
[NCBI]
|
4.30513e-06
|
|
|
PCMT1
|
[NCBI]
|
4.30513e-06
|
|
|
PPARGC1B
|
[NCBI]
|
4.30513e-06
|
|
|
CDC20
|
[NCBI]
|
4.30513e-06
|
|
|
FABP4
|
[NCBI]
|
4.30513e-06
|
|
|
NCOA4
|
[NCBI]
|
4.30513e-06
|
|
|
WHRN
|
[NCBI]
|
4.30513e-06
|
|
|
MYH2
|
[NCBI]
|
4.30513e-06
|
|
|
SEMA4A
|
[NCBI]
|
4.30513e-06
|
|
|
SRP19
|
[NCBI]
|
4.30513e-06
|
|
|
GLP1R
|
[NCBI]
|
4.30513e-06
|
|
|
ADH4
|
[NCBI]
|
4.30513e-06
|
|
|
PTPNS1
|
[NCBI]
|
4.30513e-06
|
|
|
GAB1
|
[NCBI]
|
4.30513e-06
|
|
|
HAGH
|
[NCBI]
|
4.30513e-06
|
|
|
locus control region, beta
|
[NCBI]
|
4.30513e-06
|
|
|
RENBP
|
[NCBI]
|
4.30513e-06
|
|
|
IL23R
|
[NCBI]
|
4.30513e-06
|
|
|
CKB
|
[NCBI]
|
4.30513e-06
|
|
|
NPEPPS
|
[NCBI]
|
4.30513e-06
|
|
|
NS1
|
[NCBI]
|
4.30047e-06
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
4.26797e-06
|
|
|
ALGS1
|
[NCBI]
|
4.25498e-06
|
|
|
SCS
|
[NCBI]
|
4.25498e-06
|
|
|
IGF1
|
[NCBI]
|
4.24932e-06
|
|
|
KCNQ1
|
[NCBI]
|
4.24932e-06
|
|
|
BCHE
|
[NCBI]
|
4.20366e-06
|
|
|
MCP
|
[NCBI]
|
4.18556e-06
|
|
|
FOXC2
|
[NCBI]
|
4.18206e-06
|
|
|
OR1D2
|
[NCBI]
|
4.18206e-06
|
|
|
SLE
|
[NCBI]
|
4.15098e-06
|
|
|
BWS
|
[NCBI]
|
4.14905e-06
|
|
|
CDKN2A
|
[NCBI]
|
4.06986e-06
|
|
|
XIST
|
[NCBI]
|
4.06391e-06
|
|
|
BMP4
|
[NCBI]
|
4.02035e-06
|
|
|
PAX6
|
[NCBI]
|
3.93678e-06
|
|
|
ARPKD
|
[NCBI]
|
3.9267e-06
|
|
|
GAA
|
[NCBI]
|
3.91735e-06
|
|
|
RNASE2
|
[NCBI]
|
3.91551e-06
|
|
|
LAD
|
[NCBI]
|
3.89964e-06
|
|
|
PLAT
|
[NCBI]
|
3.85711e-06
|
|
|
TCOF1
|
[NCBI]
|
3.85711e-06
|
|
|
IL3
|
[NCBI]
|
3.81067e-06
|
|
|
cystinuria
|
[NCBI]
|
3.76391e-06
|
|
|
DJS
|
[NCBI]
|
3.76391e-06
|
|
|
alzheimer disease 2
|
[NCBI]
|
3.7619e-06
|
|
|
ARH
|
[NCBI]
|
3.7619e-06
|
|
|
CDGG1
|
[NCBI]
|
3.7619e-06
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
3.7619e-06
|
|
|
ACCPN
|
[NCBI]
|
3.7619e-06
|
|
|
monilethrix
|
[NCBI]
|
3.7619e-06
|
|
|
mulibrey nanism
|
[NCBI]
|
3.7619e-06
|
|
|
XPD
|
[NCBI]
|
3.7619e-06
|
|
|
ED2
|
[NCBI]
|
3.7619e-06
|
|
|
NM
|
[NCBI]
|
3.7619e-06
|
|
|
OPD1
|
[NCBI]
|
3.7619e-06
|
|
|
KFSD
|
[NCBI]
|
3.7619e-06
|
|
|
USH3
|
[NCBI]
|
3.7619e-06
|
|
|
MCDS
|
[NCBI]
|
3.7619e-06
|
|
|
denys-drash syndrome
|
[NCBI]
|
3.7619e-06
|
|
|
DSMA1
|
[NCBI]
|
3.7619e-06
|
|
|
SHEP1
|
[NCBI]
|
3.7619e-06
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
3.7619e-06
|
|
|
LDS
|
[NCBI]
|
3.7619e-06
|
|
|
crouzon syndrome
|
[NCBI]
|
3.7619e-06
|
|
|
epidermolysis bullosa simplex and limb-girdle muscular dystrophy
|
[NCBI]
|
3.7619e-06
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
3.7619e-06
|
|
|
WS2A
|
[NCBI]
|
3.7619e-06
|
|
|
septooptic dysplasia
|
[NCBI]
|
3.7619e-06
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
3.7619e-06
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
3.7619e-06
|
|
|
TCRG
|
[NCBI]
|
3.69651e-06
|
|
|
ABCA4
|
[NCBI]
|
3.69651e-06
|
|
|
FOLH1
|
[NCBI]
|
3.69651e-06
|
|
|
NIPBL
|
[NCBI]
|
3.65664e-06
|
|
|
LECT2
|
[NCBI]
|
3.65664e-06
|
|
|
RNU2
|
[NCBI]
|
3.65664e-06
|
|
|
LAMB2
|
[NCBI]
|
3.65664e-06
|
|
|
LPIN2
|
[NCBI]
|
3.65664e-06
|
|
|
FKBP1B
|
[NCBI]
|
3.65664e-06
|
|
|
ADRA2A
|
[NCBI]
|
3.65664e-06
|
|
|
KCNJ3
|
[NCBI]
|
3.65664e-06
|
|
|
IL10RB
|
[NCBI]
|
3.65664e-06
|
|
|
HSD17B1
|
[NCBI]
|
3.65664e-06
|
|
|
DNASE2
|
[NCBI]
|
3.65664e-06
|
|
|
VKORC1
|
[NCBI]
|
3.65664e-06
|
|
|
TMPRSS3
|
[NCBI]
|
3.65664e-06
|
|
|
GLRA2
|
[NCBI]
|
3.65664e-06
|
|
|
TM4SF2
|
[NCBI]
|
3.65664e-06
|
|
|
IFNAR2
|
[NCBI]
|
3.65664e-06
|
|
|
ROBO1
|
[NCBI]
|
3.65664e-06
|
|
|
cocaine- and amphetamine-regulated transcript
|
[NCBI]
|
3.65664e-06
|
|
|
FSCN2
|
[NCBI]
|
3.65664e-06
|
|
|
ACP2
|
[NCBI]
|
3.65664e-06
|
|
|
EVPL
|
[NCBI]
|
3.65664e-06
|
|
|
PSTPIP1
|
[NCBI]
|
3.65664e-06
|
|
|
DTNA
|
[NCBI]
|
3.65664e-06
|
|
|
E2F4
|
[NCBI]
|
3.65664e-06
|
|
|
AVPR1A
|
[NCBI]
|
3.65664e-06
|
|
|
TTK
|
[NCBI]
|
3.65664e-06
|
|
|
GCGR
|
[NCBI]
|
3.65664e-06
|
|
|
EPB72
|
[NCBI]
|
3.65664e-06
|
|
|
PPP1R2
|
[NCBI]
|
3.65664e-06
|
|
|
MUSK
|
[NCBI]
|
3.65664e-06
|
|
|
ISL1
|
[NCBI]
|
3.65664e-06
|
|
|
CUL2
|
[NCBI]
|
3.65664e-06
|
|
|
BCYRN1
|
[NCBI]
|
3.65664e-06
|
|
|
CCL4L1
|
[NCBI]
|
3.65664e-06
|
|
|
CLCN2
|
[NCBI]
|
3.65664e-06
|
|
|
TMC1
|
[NCBI]
|
3.65664e-06
|
|
|
FUT6
|
[NCBI]
|
3.65664e-06
|
|
|
ROM1
|
[NCBI]
|
3.65664e-06
|
|
|
RPL7A
|
[NCBI]
|
3.65664e-06
|
|
|
CASP7
|
[NCBI]
|
3.65664e-06
|
|
|
PTPRG
|
[NCBI]
|
3.65664e-06
|
|
|
AGRP
|
[NCBI]
|
3.65664e-06
|
|
|
LGR8
|
[NCBI]
|
3.65664e-06
|
|
|
HAVCR2
|
[NCBI]
|
3.65664e-06
|
|
|
OGFR
|
[NCBI]
|
3.65664e-06
|
|
|
LOXL1
|
[NCBI]
|
3.65664e-06
|
|
|
SLC27A4
|
[NCBI]
|
3.65664e-06
|
|
|
GSTA2
|
[NCBI]
|
3.65664e-06
|
|
|
PLCG1
|
[NCBI]
|
3.65664e-06
|
|
|
ANPEP
|
[NCBI]
|
3.65664e-06
|
|
|
glycogen storage disease vi
|
[NCBI]
|
3.65664e-06
|
|
|
HES1
|
[NCBI]
|
3.65664e-06
|
|
|
KRT4
|
[NCBI]
|
3.65664e-06
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
3.65664e-06
|
|
|
SLC10A2
|
[NCBI]
|
3.65664e-06
|
|
|
ACVR2B
|
[NCBI]
|
3.65664e-06
|
|
|
WBS
|
[NCBI]
|
3.56434e-06
|
|
|
F2R
|
[NCBI]
|
3.56161e-06
|
|
|
VHL
|
[NCBI]
|
3.55825e-06
|
|
|
PINK1
|
[NCBI]
|
3.55472e-06
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
3.53096e-06
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
3.53096e-06
|
|
|
CMH
|
[NCBI]
|
3.52016e-06
|
|
|
GLA
|
[NCBI]
|
3.48557e-06
|
|
|
costello syndrome
|
[NCBI]
|
3.30162e-06
|
|
|
POLG
|
[NCBI]
|
3.28407e-06
|
|
|
ENG
|
[NCBI]
|
3.28407e-06
|
|
|
STAT5A
|
[NCBI]
|
3.28229e-06
|
|
|
MMP1
|
[NCBI]
|
3.27305e-06
|
|
|
FGFR4
|
[NCBI]
|
3.27305e-06
|
|
|
MYH9
|
[NCBI]
|
3.27305e-06
|
|
|
SLC3A1
|
[NCBI]
|
3.27305e-06
|
|
|
CLOCK
|
[NCBI]
|
3.27305e-06
|
|
|
MTCO3
|
[NCBI]
|
3.27305e-06
|
|
|
hurler syndrome
|
[NCBI]
|
3.21208e-06
|
|
|
SERPINA6
|
[NCBI]
|
3.17357e-06
|
|
|
INSR
|
[NCBI]
|
3.14979e-06
|
|
|
GCKR
|
[NCBI]
|
3.11535e-06
|
|
|
MAS1
|
[NCBI]
|
3.11535e-06
|
|
|
glutathionuria
|
[NCBI]
|
3.11535e-06
|
|
|
PTGES
|
[NCBI]
|
3.11535e-06
|
|
|
FGF14
|
[NCBI]
|
3.11535e-06
|
|
|
PEPB
|
[NCBI]
|
3.11535e-06
|
|
|
ACR
|
[NCBI]
|
3.11535e-06
|
|
|
BDKRB2
|
[NCBI]
|
3.11535e-06
|
|
|
ADORA2A
|
[NCBI]
|
3.11535e-06
|
|
|
RCV1
|
[NCBI]
|
3.11535e-06
|
|
|
NEUROG3
|
[NCBI]
|
3.11535e-06
|
|
|
PITPN
|
[NCBI]
|
3.11535e-06
|
|
|
EDNRA
|
[NCBI]
|
3.11535e-06
|
|
|
MIRN16-1
|
[NCBI]
|
3.11535e-06
|
|
|
PDE4A
|
[NCBI]
|
3.11535e-06
|
|
|
SSTR1
|
[NCBI]
|
3.11535e-06
|
|
|
NRG2
|
[NCBI]
|
3.11535e-06
|
|
|
CASP10
|
[NCBI]
|
3.11535e-06
|
|
|
ADRA1B
|
[NCBI]
|
3.11535e-06
|
|
|
PEX13
|
[NCBI]
|
3.11535e-06
|
|
|
DPEP1
|
[NCBI]
|
3.11535e-06
|
|
|
NTS
|
[NCBI]
|
3.11535e-06
|
|
|
SLC30A4
|
[NCBI]
|
3.11535e-06
|
|
|
IL21R
|
[NCBI]
|
3.11535e-06
|
|
|
CLCNKB
|
[NCBI]
|
3.11535e-06
|
|
|
GRHPR
|
[NCBI]
|
3.11535e-06
|
|
|
MYLK
|
[NCBI]
|
3.11535e-06
|
|
|
DFNA5
|
[NCBI]
|
3.11535e-06
|
|
|
HCF2
|
[NCBI]
|
3.11535e-06
|
|
|
BSCL2
|
[NCBI]
|
3.11535e-06
|
|
|
SEMA7A
|
[NCBI]
|
3.11535e-06
|
|
|
ABCG8
|
[NCBI]
|
3.11535e-06
|
|
|
CCKBR
|
[NCBI]
|
3.11535e-06
|
|
|
FGF20
|
[NCBI]
|
3.11535e-06
|
|
|
PEG10
|
[NCBI]
|
3.11535e-06
|
|
|
RABAC1
|
[NCBI]
|
3.11535e-06
|
|
|
KRT12
|
[NCBI]
|
3.11535e-06
|
|
|
MLLT4
|
[NCBI]
|
3.11535e-06
|
|
|
CYSLTR1
|
[NCBI]
|
3.11535e-06
|
|
|
PGAM1
|
[NCBI]
|
3.11535e-06
|
|
|
PRLHR
|
[NCBI]
|
3.11535e-06
|
|
|
GPD2
|
[NCBI]
|
3.11535e-06
|
|
|
AHI1
|
[NCBI]
|
3.11535e-06
|
|
|
SEMA5A
|
[NCBI]
|
3.11535e-06
|
|
|
MAPK10
|
[NCBI]
|
3.11535e-06
|
|
|
TEK
|
[NCBI]
|
3.11535e-06
|
|
|
hemojuvelin
|
[NCBI]
|
3.11535e-06
|
|
|
PECAM1
|
[NCBI]
|
3.11535e-06
|
|
|
FCAR
|
[NCBI]
|
3.11535e-06
|
|
|
TFAP2C
|
[NCBI]
|
3.11535e-06
|
|
|
ITGAL
|
[NCBI]
|
3.11535e-06
|
|
|
CALCRL
|
[NCBI]
|
3.10837e-06
|
|
|
GSR
|
[NCBI]
|
3.0916e-06
|
|
|
KAL1
|
[NCBI]
|
3.0916e-06
|
|
|
CTNNB1
|
[NCBI]
|
3.07697e-06
|
|
|
CORDX1
|
[NCBI]
|
3.02961e-06
|
|
|
diabetes mellitus, insulin-resistant, with acanthosis nigricans
|
[NCBI]
|
3.02961e-06
|
|
|
NFNS
|
[NCBI]
|
3.02961e-06
|
|
|
USH1C
|
[NCBI]
|
3.02961e-06
|
|
|
erythrocytosis, familial, 2
|
[NCBI]
|
3.02961e-06
|
|
|
niemann-pick disease, type b
|
[NCBI]
|
3.02961e-06
|
|
|
JME
|
[NCBI]
|
3.02961e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
3.02961e-06
|
|
|
mitochondrial dna depletion syndrome, hepatocerebral form
|
[NCBI]
|
3.02961e-06
|
|
|
BHD
|
[NCBI]
|
3.02961e-06
|
|
|
ARMD4
|
[NCBI]
|
3.02961e-06
|
|
|
sitosterolemia
|
[NCBI]
|
3.02961e-06
|
|
|
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1
|
[NCBI]
|
3.02961e-06
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
3.02961e-06
|
|
|
OPD2
|
[NCBI]
|
3.02961e-06
|
|
|
HMN5
|
[NCBI]
|
3.02961e-06
|
|
|
kaposi sarcoma
|
[NCBI]
|
3.02961e-06
|
|
|
alpers diffuse degeneration of cerebral gray matter with hepatic cirrhosis
|
[NCBI]
|
3.02961e-06
|
|
|
HSCR2
|
[NCBI]
|
3.02961e-06
|
|
|
EXT1
|
[NCBI]
|
3.01046e-06
|
|
|
IL2RG
|
[NCBI]
|
3.01046e-06
|
|
|
SCN1A
|
[NCBI]
|
3.01046e-06
|
|
|
FMR1
|
[NCBI]
|
2.96182e-06
|
|
|
CCL17
|
[NCBI]
|
2.9588e-06
|
|
|
kabuki syndrome
|
[NCBI]
|
2.92747e-06
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
2.92747e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
2.90776e-06
|
|
|
CDSP
|
[NCBI]
|
2.89928e-06
|
|
|
myoclonic dystonia
|
[NCBI]
|
2.87853e-06
|
|
|
COL2A1
|
[NCBI]
|
2.76604e-06
|
|
|
CHM
|
[NCBI]
|
2.76551e-06
|
|
|
PTPN1
|
[NCBI]
|
2.76551e-06
|
|
|
CTSK
|
[NCBI]
|
2.76551e-06
|
|
|
ATXN8OS
|
[NCBI]
|
2.76551e-06
|
|
|
MVK
|
[NCBI]
|
2.76551e-06
|
|
|
PI
|
[NCBI]
|
2.74378e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
2.73219e-06
|
|
|
DMPK
|
[NCBI]
|
2.73219e-06
|
|
|
JAK3
|
[NCBI]
|
2.72632e-06
|
|
|
FOXP3
|
[NCBI]
|
2.72632e-06
|
|
|
PRLH
|
[NCBI]
|
2.72632e-06
|
|
|
EIF4E
|
[NCBI]
|
2.72632e-06
|
|
|
SPARC
|
[NCBI]
|
2.72632e-06
|
|
|
KCNJ6
|
[NCBI]
|
2.65728e-06
|
|
|
AGC1
|
[NCBI]
|
2.65728e-06
|
|
|
KRTHB6
|
[NCBI]
|
2.65728e-06
|
|
|
FZD4
|
[NCBI]
|
2.65728e-06
|
|
|
LMBR1
|
[NCBI]
|
2.65728e-06
|
|
|
ELOVL4
|
[NCBI]
|
2.65728e-06
|
|
|
SYN1
|
[NCBI]
|
2.65728e-06
|
|
|
SCN1B
|
[NCBI]
|
2.65728e-06
|
|
|
PAPSS1
|
[NCBI]
|
2.65728e-06
|
|
|
PLCB3
|
[NCBI]
|
2.65728e-06
|
|
|
HTN3
|
[NCBI]
|
2.65728e-06
|
|
|
flaujeac factor deficiency
|
[NCBI]
|
2.65728e-06
|
|
|
DIO1
|
[NCBI]
|
2.65728e-06
|
|
|
HBE1
|
[NCBI]
|
2.65728e-06
|
|
|
BMP6
|
[NCBI]
|
2.65728e-06
|
|
|
AMT
|
[NCBI]
|
2.65728e-06
|
|
|
SNCG
|
[NCBI]
|
2.65728e-06
|
|
|
KRT2A
|
[NCBI]
|
2.65728e-06
|
|
|
farber lipogranulomatosis
|
[NCBI]
|
2.65728e-06
|
|
|
SYT2
|
[NCBI]
|
2.65728e-06
|
|
|
APBA1
|
[NCBI]
|
2.65728e-06
|
|
|
ANXA7
|
[NCBI]
|
2.65728e-06
|
|
|
GRHL3
|
[NCBI]
|
2.65728e-06
|
|
|
SLC22A18
|
[NCBI]
|
2.65728e-06
|
|
|
A4GALT
|
[NCBI]
|
2.65728e-06
|
|
|
FGF5
|
[NCBI]
|
2.65728e-06
|
|
|
TUB
|
[NCBI]
|
2.65728e-06
|
|
|
FCER1A
|
[NCBI]
|
2.65728e-06
|
|
|
CTSG
|
[NCBI]
|
2.65728e-06
|
|
|
ZIC2
|
[NCBI]
|
2.65728e-06
|
|
|
ACACB
|
[NCBI]
|
2.65728e-06
|
|
|
SREBF2
|
[NCBI]
|
2.65728e-06
|
|
|
MAP3K1
|
[NCBI]
|
2.65728e-06
|
|
|
ANKH
|
[NCBI]
|
2.65728e-06
|
|
|
PSMB9
|
[NCBI]
|
2.65728e-06
|
|
|
CXCL1
|
[NCBI]
|
2.65728e-06
|
|
|
NCAM1
|
[NCBI]
|
2.65728e-06
|
|
|
MIRN155
|
[NCBI]
|
2.65728e-06
|
|
|
LMAN1
|
[NCBI]
|
2.65728e-06
|
|
|
ABCC8
|
[NCBI]
|
2.62497e-06
|
|
|
VHL
|
[NCBI]
|
2.61508e-06
|
|
|
DNTT
|
[NCBI]
|
2.61208e-06
|
|
|
FOP
|
[NCBI]
|
2.58953e-06
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
2.58953e-06
|
|
|
VIM
|
[NCBI]
|
2.54321e-06
|
|
|
AICDA
|
[NCBI]
|
2.53691e-06
|
|
|
MYCN
|
[NCBI]
|
2.53691e-06
|
|
|
TNNT2
|
[NCBI]
|
2.53691e-06
|
|
|
PROP1
|
[NCBI]
|
2.53691e-06
|
|
|
MMP2
|
[NCBI]
|
2.49922e-06
|
|
|
CLL
|
[NCBI]
|
2.4923e-06
|
|
|
campomelic dysplasia
|
[NCBI]
|
2.4923e-06
|
|
|
meningioma, familial
|
[NCBI]
|
2.4923e-06
|
|
|
ALPS
|
[NCBI]
|
2.47225e-06
|
|
|
CP
|
[NCBI]
|
2.42977e-06
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
2.40772e-06
|
|
|
BHC
|
[NCBI]
|
2.40772e-06
|
|
|
gilbert syndrome
|
[NCBI]
|
2.40772e-06
|
|
|
dent disease 1
|
[NCBI]
|
2.40772e-06
|
|
|
MCPH1
|
[NCBI]
|
2.40772e-06
|
|
|
SCZD4
|
[NCBI]
|
2.40772e-06
|
|
|
GAN1
|
[NCBI]
|
2.40772e-06
|
|
|
propionic acidemia
|
[NCBI]
|
2.40772e-06
|
|
|
PALS
|
[NCBI]
|
2.40772e-06
|
|
|
glutaric acidemia i
|
[NCBI]
|
2.40772e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
2.40772e-06
|
|
|
CFTD
|
[NCBI]
|
2.40772e-06
|
|
|
holocarboxylase synthetase deficiency
|
[NCBI]
|
2.40772e-06
|
|
|
PPCD1
|
[NCBI]
|
2.40772e-06
|
|
|
SOST
|
[NCBI]
|
2.40772e-06
|
|
|
PRF1
|
[NCBI]
|
2.40449e-06
|
|
|
WAS
|
[NCBI]
|
2.40449e-06
|
|
|
FTD
|
[NCBI]
|
2.35688e-06
|
|
|
TIMP1
|
[NCBI]
|
2.32353e-06
|
|
|
SLC25A4
|
[NCBI]
|
2.32353e-06
|
|
|
APEX
|
[NCBI]
|
2.32353e-06
|
|
|
ARSB
|
[NCBI]
|
2.32353e-06
|
|
|
HMGA2
|
[NCBI]
|
2.32353e-06
|
|
|
TRPS2
|
[NCBI]
|
2.29264e-06
|
|
|
BTHS
|
[NCBI]
|
2.29264e-06
|
|
|
GSC
|
[NCBI]
|
2.27785e-06
|
|
|
HNF4A
|
[NCBI]
|
2.27785e-06
|
|
|
CSN2
|
[NCBI]
|
2.26568e-06
|
|
|
DEFB4
|
[NCBI]
|
2.26568e-06
|
|
|
GYS1
|
[NCBI]
|
2.26568e-06
|
|
|
INSIG2
|
[NCBI]
|
2.26568e-06
|
|
|
HOXA1
|
[NCBI]
|
2.26568e-06
|
|
|
NPPB
|
[NCBI]
|
2.26568e-06
|
|
|
CCL5
|
[NCBI]
|
2.26568e-06
|
|
|
DAP3
|
[NCBI]
|
2.26568e-06
|
|
|
HPR
|
[NCBI]
|
2.26568e-06
|
|
|
NAGS
|
[NCBI]
|
2.26568e-06
|
|
|
PEX1
|
[NCBI]
|
2.26568e-06
|
|
|
CD38
|
[NCBI]
|
2.26568e-06
|
|
|
ALPI
|
[NCBI]
|
2.26568e-06
|
|
|
IGHM
|
[NCBI]
|
2.26568e-06
|
|
|
RPA1
|
[NCBI]
|
2.26568e-06
|
|
|
CTSE
|
[NCBI]
|
2.26568e-06
|
|
|
PLA2G4A
|
[NCBI]
|
2.26568e-06
|
|
|
LAMA3
|
[NCBI]
|
2.26568e-06
|
|
|
TAS1R3
|
[NCBI]
|
2.26568e-06
|
|
|
CCL4
|
[NCBI]
|
2.26568e-06
|
|
|
AMN
|
[NCBI]
|
2.26568e-06
|
|
|
AAAS
|
[NCBI]
|
2.26568e-06
|
|
|
INSIG1
|
[NCBI]
|
2.26568e-06
|
|
|
MTNR1A
|
[NCBI]
|
2.26568e-06
|
|
|
PDCD2
|
[NCBI]
|
2.26568e-06
|
|
|
CFD
|
[NCBI]
|
2.26568e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
2.23343e-06
|
|
|
PGR
|
[NCBI]
|
2.15267e-06
|
|
|
FIH
|
[NCBI]
|
2.14079e-06
|
|
|
SMA3
|
[NCBI]
|
2.14079e-06
|
|
|
CLN3
|
[NCBI]
|
2.14079e-06
|
|
|
UCP2
|
[NCBI]
|
2.13979e-06
|
|
|
ABCB11
|
[NCBI]
|
2.10181e-06
|
|
|
SOD1
|
[NCBI]
|
2.04657e-06
|
|
|
aHUS
|
[NCBI]
|
2.00928e-06
|
|
|
FGA
|
[NCBI]
|
2.00216e-06
|
|
|
DRPLA
|
[NCBI]
|
1.9979e-06
|
|
|
PSAP
|
[NCBI]
|
1.96696e-06
|
|
|
CRC
|
[NCBI]
|
1.95006e-06
|
|
|
amyloidosis vi
|
[NCBI]
|
1.94074e-06
|
|
|
ADH5
|
[NCBI]
|
1.93835e-06
|
|
|
TGFBR2
|
[NCBI]
|
1.93835e-06
|
|
|
NCOA3
|
[NCBI]
|
1.93835e-06
|
|
|
STAT4
|
[NCBI]
|
1.93835e-06
|
|
|
IFNB1
|
[NCBI]
|
1.93835e-06
|
|
|
PRODH
|
[NCBI]
|
1.93835e-06
|
|
|
RBP4
|
[NCBI]
|
1.93835e-06
|
|
|
GPC3
|
[NCBI]
|
1.93835e-06
|
|
|
ATXN1
|
[NCBI]
|
1.93835e-06
|
|
|
CRHR2
|
[NCBI]
|
1.92842e-06
|
|
|
ERCC8
|
[NCBI]
|
1.92842e-06
|
|
|
KRT17
|
[NCBI]
|
1.92842e-06
|
|
|
CKM
|
[NCBI]
|
1.92842e-06
|
|
|
TFAP2B
|
[NCBI]
|
1.92842e-06
|
|
|
BCL2A1
|
[NCBI]
|
1.92842e-06
|
|
|
POLB
|
[NCBI]
|
1.92842e-06
|
|
|
IGHMBP2
|
[NCBI]
|
1.92842e-06
|
|
|
ZIC3
|
[NCBI]
|
1.92842e-06
|
|
|
GLUL
|
[NCBI]
|
1.92842e-06
|
|
|
CILP
|
[NCBI]
|
1.92842e-06
|
|
|
CX3CL1
|
[NCBI]
|
1.92842e-06
|
|
|
MCM6
|
[NCBI]
|
1.92842e-06
|
|
|
RARB
|
[NCBI]
|
1.92842e-06
|
|
|
SOAT1
|
[NCBI]
|
1.92842e-06
|
|
|
PAX9
|
[NCBI]
|
1.92842e-06
|
|
|
IL12RB1
|
[NCBI]
|
1.92842e-06
|
|
|
PTGDS
|
[NCBI]
|
1.92842e-06
|
|
|
MSH3
|
[NCBI]
|
1.92842e-06
|
|
|
EIF2AK3
|
[NCBI]
|
1.92842e-06
|
|
|
FMN
|
[NCBI]
|
1.92842e-06
|
|
|
SLC6A2
|
[NCBI]
|
1.92842e-06
|
|
|
JARID1C
|
[NCBI]
|
1.92842e-06
|
|
|
FUT3
|
[NCBI]
|
1.92842e-06
|
|
|
RAB7
|
[NCBI]
|
1.92842e-06
|
|
|
ECGF1
|
[NCBI]
|
1.92842e-06
|
|
|
MYF5
|
[NCBI]
|
1.92842e-06
|
|
|
FUR
|
[NCBI]
|
1.92842e-06
|
|
|
DGAT1
|
[NCBI]
|
1.92842e-06
|
|
|
TTPA
|
[NCBI]
|
1.92842e-06
|
|
|
ALDH3A1
|
[NCBI]
|
1.92842e-06
|
|
|
ZNF9
|
[NCBI]
|
1.92842e-06
|
|
|
phosphoglycerate mutase, muscle, deficiency of
|
[NCBI]
|
1.92842e-06
|
|
|
C10ORF2
|
[NCBI]
|
1.92842e-06
|
|
|
IRF5
|
[NCBI]
|
1.92842e-06
|
|
|
PARK2
|
[NCBI]
|
1.8912e-06
|
|
|
TTP
|
[NCBI]
|
1.88146e-06
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
1.88146e-06
|
|
|
coumarin resistance
|
[NCBI]
|
1.88146e-06
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
1.88146e-06
|
|
|
NBIA1
|
[NCBI]
|
1.88146e-06
|
|
|
CSID
|
[NCBI]
|
1.88146e-06
|
|
|
DFFB
|
[NCBI]
|
1.85382e-06
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.84635e-06
|
|
|
B2M
|
[NCBI]
|
1.83443e-06
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
1.82203e-06
|
|
|
TLR2
|
[NCBI]
|
1.81958e-06
|
|
|
GH1
|
[NCBI]
|
1.8134e-06
|
|
|
ABCC2
|
[NCBI]
|
1.77e-06
|
|
|
DCN
|
[NCBI]
|
1.76478e-06
|
|
|
LBR
|
[NCBI]
|
1.75202e-06
|
|
|
DGS
|
[NCBI]
|
1.75182e-06
|
|
|
krabbe disease
|
[NCBI]
|
1.74731e-06
|
|
|
SCA1
|
[NCBI]
|
1.74731e-06
|
|
|
LFS1
|
[NCBI]
|
1.74019e-06
|
|
|
COH1
|
[NCBI]
|
1.74019e-06
|
|
|
ATS
|
[NCBI]
|
1.74019e-06
|
|
|
CDG1A
|
[NCBI]
|
1.74019e-06
|
|
|
LMNA
|
[NCBI]
|
1.72313e-06
|
|
|
TTR
|
[NCBI]
|
1.6935e-06
|
|
|
AIS
|
[NCBI]
|
1.66368e-06
|
|
|
TFRC
|
[NCBI]
|
1.65202e-06
|
|
|
INSL3
|
[NCBI]
|
1.65202e-06
|
|
|
DMD
|
[NCBI]
|
1.63745e-06
|
|
|
ASCL1
|
[NCBI]
|
1.6364e-06
|
|
|
IDH1
|
[NCBI]
|
1.6364e-06
|
|
|
ANXA2
|
[NCBI]
|
1.6364e-06
|
|
|
NPC2
|
[NCBI]
|
1.6364e-06
|
|
|
COL6A2
|
[NCBI]
|
1.6364e-06
|
|
|
LTA4H
|
[NCBI]
|
1.6364e-06
|
|
|
RIMS1
|
[NCBI]
|
1.6364e-06
|
|
|
LCN1
|
[NCBI]
|
1.6364e-06
|
|
|
PITX1
|
[NCBI]
|
1.6364e-06
|
|
|
CNTFR
|
[NCBI]
|
1.6364e-06
|
|
|
ID3
|
[NCBI]
|
1.6364e-06
|
|
|
SEPT9
|
[NCBI]
|
1.6364e-06
|
|
|
KRT8
|
[NCBI]
|
1.6364e-06
|
|
|
OCRL
|
[NCBI]
|
1.6364e-06
|
|
|
DYRK1A
|
[NCBI]
|
1.6364e-06
|
|
|
SGCD
|
[NCBI]
|
1.6364e-06
|
|
|
COL6A3
|
[NCBI]
|
1.6364e-06
|
|
|
CHRNB2
|
[NCBI]
|
1.6364e-06
|
|
|
PDCD5
|
[NCBI]
|
1.6364e-06
|
|
|
PPY
|
[NCBI]
|
1.6364e-06
|
|
|
MEG3
|
[NCBI]
|
1.6364e-06
|
|
|
MAD2L1
|
[NCBI]
|
1.6364e-06
|
|
|
KRT5
|
[NCBI]
|
1.60286e-06
|
|
|
FASN
|
[NCBI]
|
1.60286e-06
|
|
|
IL8
|
[NCBI]
|
1.60286e-06
|
|
|
DYSF
|
[NCBI]
|
1.60286e-06
|
|
|
MTND5
|
[NCBI]
|
1.60286e-06
|
|
|
CXCL12
|
[NCBI]
|
1.60286e-06
|
|
|
MN
|
[NCBI]
|
1.60286e-06
|
|
|
SLC18A2
|
[NCBI]
|
1.58787e-06
|
|
|
ABL1
|
[NCBI]
|
1.55389e-06
|
|
|
LHCGR
|
[NCBI]
|
1.55389e-06
|
|
|
PROCR
|
[NCBI]
|
1.55389e-06
|
|
|
GLC1A
|
[NCBI]
|
1.53425e-06
|
|
|
GCPS
|
[NCBI]
|
1.48615e-06
|
|
|
MEB
|
[NCBI]
|
1.48615e-06
|
|
|
CMTX1
|
[NCBI]
|
1.48615e-06
|
|
|
kartagener syndrome
|
[NCBI]
|
1.48615e-06
|
|
|
MDLS
|
[NCBI]
|
1.48615e-06
|
|
|
FLNA
|
[NCBI]
|
1.45769e-06
|
|
|
RLBP1
|
[NCBI]
|
1.45769e-06
|
|
|
CDKN1A
|
[NCBI]
|
1.45187e-06
|
|
|
DYT3
|
[NCBI]
|
1.43888e-06
|
|
|
DHRD
|
[NCBI]
|
1.43888e-06
|
|
|
blood group, p system
|
[NCBI]
|
1.43888e-06
|
|
|
hydatidiform mole
|
[NCBI]
|
1.43888e-06
|
|
|
SPCH1
|
[NCBI]
|
1.43888e-06
|
|
|
SCZD1
|
[NCBI]
|
1.43888e-06
|
|
|
PHA
|
[NCBI]
|
1.43888e-06
|
|
|
DYX2
|
[NCBI]
|
1.43888e-06
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
1.43888e-06
|
|
|
CORD2
|
[NCBI]
|
1.43888e-06
|
|
|
EVR1
|
[NCBI]
|
1.43888e-06
|
|
|
HPC1
|
[NCBI]
|
1.43888e-06
|
|
|
AHDS
|
[NCBI]
|
1.43888e-06
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
1.43888e-06
|
|
|
SPG2
|
[NCBI]
|
1.43888e-06
|
|
|
ARNT
|
[NCBI]
|
1.3962e-06
|
|
|
HMGA1
|
[NCBI]
|
1.38265e-06
|
|
|
XRCC2
|
[NCBI]
|
1.38265e-06
|
|
|
GARS
|
[NCBI]
|
1.38265e-06
|
|
|
ACTG1
|
[NCBI]
|
1.38265e-06
|
|
|
MPI
|
[NCBI]
|
1.38265e-06
|
|
|
MCOLN1
|
[NCBI]
|
1.38265e-06
|
|
|
GDF15
|
[NCBI]
|
1.38265e-06
|
|
|
C5R1
|
[NCBI]
|
1.38265e-06
|
|
|
CSF2RB
|
[NCBI]
|
1.38265e-06
|
|
|
SKI
|
[NCBI]
|
1.38265e-06
|
|
|
MTHFD1
|
[NCBI]
|
1.38265e-06
|
|
|
ATP1A1
|
[NCBI]
|
1.38265e-06
|
|
|
TFF2
|
[NCBI]
|
1.38265e-06
|
|
|
TPM1
|
[NCBI]
|
1.38265e-06
|
|
|
FCGR2A
|
[NCBI]
|
1.38265e-06
|
|
|
CDX2
|
[NCBI]
|
1.38265e-06
|
|
|
CPT1A
|
[NCBI]
|
1.38265e-06
|
|
|
TRAPPC2
|
[NCBI]
|
1.38265e-06
|
|
|
ONECUT1
|
[NCBI]
|
1.38265e-06
|
|
|
MSX2
|
[NCBI]
|
1.38265e-06
|
|
|
GOT1
|
[NCBI]
|
1.38265e-06
|
|
|
GABRA1
|
[NCBI]
|
1.38265e-06
|
|
|
SRA2
|
[NCBI]
|
1.38265e-06
|
|
|
TCF4
|
[NCBI]
|
1.38265e-06
|
|
|
PEPA
|
[NCBI]
|
1.38265e-06
|
|
|
HLCS
|
[NCBI]
|
1.38265e-06
|
|
|
PLAG1
|
[NCBI]
|
1.38265e-06
|
|
|
NCL
|
[NCBI]
|
1.38265e-06
|
|
|
NPAS2
|
[NCBI]
|
1.38265e-06
|
|
|
DRD1
|
[NCBI]
|
1.38265e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
1.38265e-06
|
|
|
GNRHR
|
[NCBI]
|
1.36452e-06
|
|
|
GSN
|
[NCBI]
|
1.31119e-06
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
1.31119e-06
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.27577e-06
|
|
|
MAP1B
|
[NCBI]
|
1.27137e-06
|
|
|
HS
|
[NCBI]
|
1.27137e-06
|
|
|
IGF2
|
[NCBI]
|
1.26104e-06
|
|
|
HIGM1
|
[NCBI]
|
1.24804e-06
|
|
|
walker-warburg syndrome
|
[NCBI]
|
1.24804e-06
|
|
|
TBS
|
[NCBI]
|
1.24804e-06
|
|
|
CADASIL
|
[NCBI]
|
1.24804e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
1.21228e-06
|
|
|
SLAMF1
|
[NCBI]
|
1.18024e-06
|
|
|
STAT5B
|
[NCBI]
|
1.18024e-06
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
1.18024e-06
|
|
|
AOS
|
[NCBI]
|
1.18018e-06
|
|
|
migraine with or without aura, susceptibility to, 1
|
[NCBI]
|
1.18018e-06
|
|
|
HGPS
|
[NCBI]
|
1.16784e-06
|
|
|
SVAS
|
[NCBI]
|
1.16784e-06
|
|
|
HBD
|
[NCBI]
|
1.16279e-06
|
|
|
AURKA
|
[NCBI]
|
1.16167e-06
|
|
|
MAP1A
|
[NCBI]
|
1.16167e-06
|
|
|
PCSK9
|
[NCBI]
|
1.16167e-06
|
|
|
TBXA2R
|
[NCBI]
|
1.16167e-06
|
|
|
FSHB
|
[NCBI]
|
1.16167e-06
|
|
|
GGH
|
[NCBI]
|
1.16167e-06
|
|
|
GRB10
|
[NCBI]
|
1.16167e-06
|
|
|
SLCO2A1
|
[NCBI]
|
1.16167e-06
|
|
|
SALL1
|
[NCBI]
|
1.16167e-06
|
|
|
MT1A
|
[NCBI]
|
1.16167e-06
|
|
|
SLC27A1
|
[NCBI]
|
1.16167e-06
|
|
|
PCCA
|
[NCBI]
|
1.16167e-06
|
|
|
EPM2A
|
[NCBI]
|
1.16167e-06
|
|
|
TNNI3
|
[NCBI]
|
1.16167e-06
|
|
|
CLEC4M
|
[NCBI]
|
1.16167e-06
|
|
|
FOLR1
|
[NCBI]
|
1.16167e-06
|
|
|
SORBS1
|
[NCBI]
|
1.16167e-06
|
|
|
AGTR2
|
[NCBI]
|
1.16167e-06
|
|
|
CGA
|
[NCBI]
|
1.16167e-06
|
|
|
BTD
|
[NCBI]
|
1.16167e-06
|
|
|
ZFP36
|
[NCBI]
|
1.1019e-06
|
|
|
NRG1
|
[NCBI]
|
1.1005e-06
|
|
|
HCRT
|
[NCBI]
|
1.0937e-06
|
|
|
AANAT
|
[NCBI]
|
1.0937e-06
|
|
|
camurati-engelmann disease
|
[NCBI]
|
1.07009e-06
|
|
|
MNS
|
[NCBI]
|
1.07009e-06
|
|
|
EA2
|
[NCBI]
|
1.07009e-06
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
1.07009e-06
|
|
|
factor xii deficiency
|
[NCBI]
|
1.07009e-06
|
|
|
bladder cancer
|
[NCBI]
|
1.07009e-06
|
|
|
weaver syndrome
|
[NCBI]
|
1.07009e-06
|
|
|
PGK1
|
[NCBI]
|
1.06958e-06
|
|
|
PHEX
|
[NCBI]
|
1.05848e-06
|
|
|
POAG
|
[NCBI]
|
1.04509e-06
|
|
|
SMEI
|
[NCBI]
|
1.04509e-06
|
|
|
ASS
|
[NCBI]
|
1.03508e-06
|
|
|
AQP1
|
[NCBI]
|
1.03508e-06
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.02677e-06
|
|
|
HCH
|
[NCBI]
|
1.02677e-06
|
|
|
COL7A1
|
[NCBI]
|
1.00832e-06
|
|
|
WT1
|
[NCBI]
|
9.81258e-07
|
|
|
PCI
|
[NCBI]
|
9.70636e-07
|
|
|
IGFBP3
|
[NCBI]
|
9.69095e-07
|
|
|
MMP7
|
[NCBI]
|
9.69095e-07
|
|
|
HPSE
|
[NCBI]
|
9.69095e-07
|
|
|
DTNBP1
|
[NCBI]
|
9.69095e-07
|
|
|
KCNQ2
|
[NCBI]
|
9.69095e-07
|
|
|
ECE1
|
[NCBI]
|
9.69095e-07
|
|
|
TAP1
|
[NCBI]
|
9.69095e-07
|
|
|
SDHB
|
[NCBI]
|
9.69095e-07
|
|
|
JARID1D
|
[NCBI]
|
9.69095e-07
|
|
|
SIX5
|
[NCBI]
|
9.69095e-07
|
|
|
POMT1
|
[NCBI]
|
9.69095e-07
|
|
|
CNP
|
[NCBI]
|
9.69095e-07
|
|
|
TNFRSF11A
|
[NCBI]
|
9.69095e-07
|
|
|
MMP13
|
[NCBI]
|
9.69095e-07
|
|
|
IGLC1
|
[NCBI]
|
9.69095e-07
|
|
|
ENAM
|
[NCBI]
|
9.69095e-07
|
|
|
SPG3A
|
[NCBI]
|
9.69095e-07
|
|
|
CCKAR
|
[NCBI]
|
9.69095e-07
|
|
|
NTF3
|
[NCBI]
|
9.69095e-07
|
|
|
TNFRSF25
|
[NCBI]
|
9.69095e-07
|
|
|
MOS
|
[NCBI]
|
9.69095e-07
|
|
|
PGK2
|
[NCBI]
|
9.69095e-07
|
|
|
FOXP2
|
[NCBI]
|
9.69095e-07
|
|
|
MGMT
|
[NCBI]
|
9.69095e-07
|
|
|
adipocyte-derived leucine aminopeptidase
|
[NCBI]
|
9.69095e-07
|
|
|
TP73
|
[NCBI]
|
9.69095e-07
|
|
|
CHH
|
[NCBI]
|
9.50023e-07
|
|
|
FANCA
|
[NCBI]
|
9.45423e-07
|
|
|
ERBB2
|
[NCBI]
|
9.25376e-07
|
|
|
DCT
|
[NCBI]
|
9.25376e-07
|
|
|
PZP
|
[NCBI]
|
9.25376e-07
|
|
|
cortisol 11-beta-ketoreductase deficiency
|
[NCBI]
|
8.97655e-07
|
|
|
APRT
|
[NCBI]
|
8.76385e-07
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
8.748e-07
|
|
|
APS1
|
[NCBI]
|
8.69837e-07
|
|
|
UCP3
|
[NCBI]
|
8.53605e-07
|
|
|
ATRX
|
[NCBI]
|
8.44959e-07
|
|
|
RS1
|
[NCBI]
|
8.40616e-07
|
|
|
RUNX2
|
[NCBI]
|
8.40616e-07
|
|
|
wolman disease
|
[NCBI]
|
8.40616e-07
|
|
|
SPG3A
|
[NCBI]
|
8.23388e-07
|
|
|
glycogen storage disease vii
|
[NCBI]
|
8.23388e-07
|
|
|
PGL1
|
[NCBI]
|
8.23388e-07
|
|
|
PARK2
|
[NCBI]
|
8.23388e-07
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
8.23388e-07
|
|
|
BMPR1A
|
[NCBI]
|
8.01359e-07
|
|
|
PANK2
|
[NCBI]
|
8.01359e-07
|
|
|
FLG
|
[NCBI]
|
8.01359e-07
|
|
|
SLC26A2
|
[NCBI]
|
8.01359e-07
|
|
|
PCSK1
|
[NCBI]
|
8.01359e-07
|
|
|
NCOR2
|
[NCBI]
|
8.01359e-07
|
|
|
LAMA2
|
[NCBI]
|
8.01359e-07
|
|
|
PIK3CG
|
[NCBI]
|
8.01359e-07
|
|
|
PLIN
|
[NCBI]
|
8.01359e-07
|
|
|
PNPLA2
|
[NCBI]
|
8.01359e-07
|
|
|
MC3R
|
[NCBI]
|
8.01359e-07
|
|
|
NPHS1
|
[NCBI]
|
8.01359e-07
|
|
|
PLA2G2A
|
[NCBI]
|
8.01359e-07
|
|
|
CNR1
|
[NCBI]
|
8.01359e-07
|
|
|
BEST1
|
[NCBI]
|
8.01359e-07
|
|
|
SCN9A
|
[NCBI]
|
8.01359e-07
|
|
|
RUNX1
|
[NCBI]
|
7.6718e-07
|
|
|
ZNF145
|
[NCBI]
|
7.6718e-07
|
|
|
VWM
|
[NCBI]
|
7.66901e-07
|
|
|
PCLD
|
[NCBI]
|
7.66901e-07
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
7.66901e-07
|
|
|
HIDS
|
[NCBI]
|
7.66901e-07
|
|
|
KAL2
|
[NCBI]
|
7.66901e-07
|
|
|
AIED
|
[NCBI]
|
7.66901e-07
|
|
|
bethlem myopathy
|
[NCBI]
|
7.66901e-07
|
|
|
TBP
|
[NCBI]
|
7.64736e-07
|
|
|
AKR1B1
|
[NCBI]
|
7.63462e-07
|
|
|
RP
|
[NCBI]
|
7.07947e-07
|
|
|
SOX9
|
[NCBI]
|
6.92154e-07
|
|
|
LBP
|
[NCBI]
|
6.68711e-07
|
|
|
TNFRSF1A
|
[NCBI]
|
6.68711e-07
|
|
|
HAE
|
[NCBI]
|
6.6156e-07
|
|
|
SMAD3
|
[NCBI]
|
6.55538e-07
|
|
|
orotic aciduria i
|
[NCBI]
|
6.55538e-07
|
|
|
MEF2A
|
[NCBI]
|
6.55538e-07
|
|
|
MIF
|
[NCBI]
|
6.55538e-07
|
|
|
RNASEL
|
[NCBI]
|
6.55538e-07
|
|
|
CSH1
|
[NCBI]
|
6.55538e-07
|
|
|
TAZ
|
[NCBI]
|
6.55538e-07
|
|
|
GCG
|
[NCBI]
|
6.55538e-07
|
|
|
CALM1
|
[NCBI]
|
6.55538e-07
|
|
|
PAX1
|
[NCBI]
|
6.55538e-07
|
|
|
GABRG2
|
[NCBI]
|
6.55538e-07
|
|
|
MAN2B1
|
[NCBI]
|
6.55538e-07
|
|
|
CCR2
|
[NCBI]
|
6.55538e-07
|
|
|
APOBEC3G
|
[NCBI]
|
6.55538e-07
|
|
|
CRYBA1
|
[NCBI]
|
6.55538e-07
|
|
|
EDN1
|
[NCBI]
|
6.54108e-07
|
|
|
gastric cancer
|
[NCBI]
|
6.38995e-07
|
|
|
SGBS1
|
[NCBI]
|
6.38995e-07
|
|
|
HEXB
|
[NCBI]
|
6.20004e-07
|
|
|
BRAF
|
[NCBI]
|
6.20004e-07
|
|
|
LIPC
|
[NCBI]
|
6.07581e-07
|
|
|
PMP22
|
[NCBI]
|
5.96104e-07
|
|
|
CDA
|
[NCBI]
|
5.71662e-07
|
|
|
PARP1
|
[NCBI]
|
5.61912e-07
|
|
|
PFKM
|
[NCBI]
|
5.29192e-07
|
|
|
IL6ST
|
[NCBI]
|
5.29192e-07
|
|
|
CBP
|
[NCBI]
|
5.29192e-07
|
|
|
BHMT
|
[NCBI]
|
5.29192e-07
|
|
|
PTS
|
[NCBI]
|
5.29192e-07
|
|
|
NEFL
|
[NCBI]
|
5.29192e-07
|
|
|
ALDOA
|
[NCBI]
|
5.29192e-07
|
|
|
EPB42
|
[NCBI]
|
5.29192e-07
|
|
|
SQSTM1
|
[NCBI]
|
5.29192e-07
|
|
|
ANGPT2
|
[NCBI]
|
5.29192e-07
|
|
|
NCOA1
|
[NCBI]
|
5.29192e-07
|
|
|
ACTA1
|
[NCBI]
|
5.29192e-07
|
|
|
RAF1
|
[NCBI]
|
5.29192e-07
|
|
|
USH1C
|
[NCBI]
|
5.29192e-07
|
|
|
PJS
|
[NCBI]
|
5.27301e-07
|
|
|
fabry disease
|
[NCBI]
|
5.25708e-07
|
|
|
SCA10
|
[NCBI]
|
5.22387e-07
|
|
|
epidermolysis bullosa letalis
|
[NCBI]
|
5.22387e-07
|
|
|
PARK8
|
[NCBI]
|
5.22387e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
5.22387e-07
|
|
|
ORW2
|
[NCBI]
|
5.22387e-07
|
|
|
PMC
|
[NCBI]
|
5.22387e-07
|
|
|
KTCN1
|
[NCBI]
|
5.22387e-07
|
|
|
MPZ
|
[NCBI]
|
5.09716e-07
|
|
|
JPS
|
[NCBI]
|
5.06204e-07
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
4.98772e-07
|
|
|
myeloproliferative syndrome, transient
|
[NCBI]
|
4.98772e-07
|
|
|
AS
|
[NCBI]
|
4.91591e-07
|
|
|
NR5A1
|
[NCBI]
|
4.87297e-07
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
4.87297e-07
|
|
|
PDHA1
|
[NCBI]
|
4.84863e-07
|
|
|
SCP2
|
[NCBI]
|
4.84863e-07
|
|
|
ABCG2
|
[NCBI]
|
4.7751e-07
|
|
|
LGMD2C
|
[NCBI]
|
4.7482e-07
|
|
|
APOD
|
[NCBI]
|
4.32923e-07
|
|
|
CCL2
|
[NCBI]
|
4.32923e-07
|
|
|
AMACR
|
[NCBI]
|
4.26716e-07
|
|
|
GNMT
|
[NCBI]
|
4.22162e-07
|
|
|
STK11
|
[NCBI]
|
4.22162e-07
|
|
|
SNRPN
|
[NCBI]
|
4.22162e-07
|
|
|
CUTL1
|
[NCBI]
|
4.22162e-07
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
4.20268e-07
|
|
|
ERCC3
|
[NCBI]
|
4.20268e-07
|
|
|
G6PT1
|
[NCBI]
|
4.20268e-07
|
|
|
SPR
|
[NCBI]
|
4.20268e-07
|
|
|
FLT4
|
[NCBI]
|
4.20268e-07
|
|
|
ACACA
|
[NCBI]
|
4.20268e-07
|
|
|
FUT2
|
[NCBI]
|
4.20268e-07
|
|
|
MUTYH
|
[NCBI]
|
4.20268e-07
|
|
|
IL9
|
[NCBI]
|
4.20268e-07
|
|
|
FOXL2
|
[NCBI]
|
4.20268e-07
|
|
|
HADHA
|
[NCBI]
|
4.20268e-07
|
|
|
GUCY2D
|
[NCBI]
|
4.20268e-07
|
|
|
ECM1
|
[NCBI]
|
4.20268e-07
|
|
|
EV
|
[NCBI]
|
3.93048e-07
|
|
|
ABL
|
[NCBI]
|
3.73594e-07
|
|
|
EDMD
|
[NCBI]
|
3.73594e-07
|
|
|
NR0B2
|
[NCBI]
|
3.7086e-07
|
|
|
VCP
|
[NCBI]
|
3.7086e-07
|
|
|
PPT1
|
[NCBI]
|
3.62918e-07
|
|
|
DSG1
|
[NCBI]
|
3.62918e-07
|
|
|
EDNRB
|
[NCBI]
|
3.62918e-07
|
|
|
ALS1
|
[NCBI]
|
3.45661e-07
|
|
|
DKC
|
[NCBI]
|
3.3221e-07
|
|
|
STL1
|
[NCBI]
|
3.3221e-07
|
|
|
LSA
|
[NCBI]
|
3.3221e-07
|
|
|
HHC1
|
[NCBI]
|
3.3221e-07
|
|
|
DDC
|
[NCBI]
|
3.31812e-07
|
|
|
CGL2
|
[NCBI]
|
3.30677e-07
|
|
|
MNGIE
|
[NCBI]
|
3.30677e-07
|
|
|
CCAL2
|
[NCBI]
|
3.30677e-07
|
|
|
CDPX1
|
[NCBI]
|
3.30677e-07
|
|
|
UCMD
|
[NCBI]
|
3.30677e-07
|
|
|
NHS
|
[NCBI]
|
3.30677e-07
|
|
|
ETM1
|
[NCBI]
|
3.30677e-07
|
|
|
pfeiffer syndrome
|
[NCBI]
|
3.30677e-07
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
3.30677e-07
|
|
|
SCA17
|
[NCBI]
|
3.30677e-07
|
|
|
MPO
|
[NCBI]
|
3.28809e-07
|
|
|
CA2
|
[NCBI]
|
3.27022e-07
|
|
|
FTH1
|
[NCBI]
|
3.27022e-07
|
|
|
MME
|
[NCBI]
|
3.27022e-07
|
|
|
DBT
|
[NCBI]
|
3.27022e-07
|
|
|
HSD11B1
|
[NCBI]
|
3.27022e-07
|
|
|
RAG2
|
[NCBI]
|
3.27022e-07
|
|
|
HAP1
|
[NCBI]
|
3.27022e-07
|
|
|
DHCR7
|
[NCBI]
|
3.27022e-07
|
|
|
PHB
|
[NCBI]
|
3.27022e-07
|
|
|
ERCC6
|
[NCBI]
|
3.27022e-07
|
|
|
GAD2
|
[NCBI]
|
3.27022e-07
|
|
|
BMP1
|
[NCBI]
|
3.27022e-07
|
|
|
LQT1
|
[NCBI]
|
3.24179e-07
|
|
|
FANCC
|
[NCBI]
|
3.07303e-07
|
|
|
GRIA2
|
[NCBI]
|
3.07303e-07
|
|
|
SHOX
|
[NCBI]
|
3.07303e-07
|
|
|
CHEK2
|
[NCBI]
|
3.07303e-07
|
|
|
PEMT
|
[NCBI]
|
3.07303e-07
|
|
|
RECQL2
|
[NCBI]
|
3.07303e-07
|
|
|
IDE
|
[NCBI]
|
2.72288e-07
|
|
|
WHS
|
[NCBI]
|
2.69959e-07
|
|
|
SST
|
[NCBI]
|
2.68644e-07
|
|
|
PTGS2
|
[NCBI]
|
2.63056e-07
|
|
|
SCIDX1
|
[NCBI]
|
2.62684e-07
|
|
|
glycogen storage disease i
|
[NCBI]
|
2.55504e-07
|
|
|
ASPA
|
[NCBI]
|
2.55504e-07
|
|
|
JAK1
|
[NCBI]
|
2.55504e-07
|
|
|
FN1
|
[NCBI]
|
2.55504e-07
|
|
|
GK
|
[NCBI]
|
2.55504e-07
|
|
|
RAG1
|
[NCBI]
|
2.55504e-07
|
|
|
ATP7A
|
[NCBI]
|
2.55504e-07
|
|
|
BGN
|
[NCBI]
|
2.55504e-07
|
|
|
RELN
|
[NCBI]
|
2.54804e-07
|
|
|
LOX
|
[NCBI]
|
2.51384e-07
|
|
|
PAX3
|
[NCBI]
|
2.50221e-07
|
|
|
ANG
|
[NCBI]
|
2.50221e-07
|
|
|
ABCD1
|
[NCBI]
|
2.50221e-07
|
|
|
NRL
|
[NCBI]
|
2.47959e-07
|
|
|
PTGS1
|
[NCBI]
|
2.47959e-07
|
|
|
HIP1
|
[NCBI]
|
2.47959e-07
|
|
|
CUBN
|
[NCBI]
|
2.47959e-07
|
|
|
ABCC3
|
[NCBI]
|
2.47959e-07
|
|
|
CLN3
|
[NCBI]
|
2.47959e-07
|
|
|
ITGB1
|
[NCBI]
|
2.47959e-07
|
|
|
EPHB2
|
[NCBI]
|
2.47959e-07
|
|
|
GJB6
|
[NCBI]
|
2.47959e-07
|
|
|
PI3
|
[NCBI]
|
2.47959e-07
|
|
|
SSTR2
|
[NCBI]
|
2.47959e-07
|
|
|
GPR54
|
[NCBI]
|
2.47959e-07
|
|
|
TSD
|
[NCBI]
|
2.46242e-07
|
|
|
BPES
|
[NCBI]
|
2.35682e-07
|
|
|
ATRX
|
[NCBI]
|
2.12653e-07
|
|
|
testicular tumors
|
[NCBI]
|
2.12653e-07
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
2.12653e-07
|
|
|
apert syndrome
|
[NCBI]
|
2.12653e-07
|
|
|
ABCA1
|
[NCBI]
|
2.08603e-07
|
|
|
TNFRSF6
|
[NCBI]
|
2.08603e-07
|
|
|
FGF10
|
[NCBI]
|
2.07721e-07
|
|
|
NGB
|
[NCBI]
|
2.07721e-07
|
|
|
RPS6KA3
|
[NCBI]
|
2.07721e-07
|
|
|
NTRK2
|
[NCBI]
|
2.07721e-07
|
|
|
PDGFB
|
[NCBI]
|
2.07721e-07
|
|
|
BCL6
|
[NCBI]
|
2.07721e-07
|
|
|
thrombocythemia, essential
|
[NCBI]
|
1.86737e-07
|
|
|
mucopolysaccharidosis type vi
|
[NCBI]
|
1.86737e-07
|
|
|
mucolipidosis iv
|
[NCBI]
|
1.86737e-07
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
1.86737e-07
|
|
|
CNC1
|
[NCBI]
|
1.86737e-07
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
1.86737e-07
|
|
|
PPH1
|
[NCBI]
|
1.86737e-07
|
|
|
GHSR
|
[NCBI]
|
1.81789e-07
|
|
|
ERCC1
|
[NCBI]
|
1.81789e-07
|
|
|
HOXD13
|
[NCBI]
|
1.81789e-07
|
|
|
IFNAR1
|
[NCBI]
|
1.81789e-07
|
|
|
MYB
|
[NCBI]
|
1.81789e-07
|
|
|
MC2R
|
[NCBI]
|
1.81789e-07
|
|
|
KRT1
|
[NCBI]
|
1.81789e-07
|
|
|
MPL
|
[NCBI]
|
1.81789e-07
|
|
|
PLOD1
|
[NCBI]
|
1.81789e-07
|
|
|
DLK1
|
[NCBI]
|
1.81789e-07
|
|
|
CYCS
|
[NCBI]
|
1.81789e-07
|
|
|
ADAMTS13
|
[NCBI]
|
1.81789e-07
|
|
|
LRE1
|
[NCBI]
|
1.81789e-07
|
|
|
RTT
|
[NCBI]
|
1.76879e-07
|
|
|
SCD
|
[NCBI]
|
1.72566e-07
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
1.72498e-07
|
|
|
SCA6
|
[NCBI]
|
1.72498e-07
|
|
|
TLR5
|
[NCBI]
|
1.67571e-07
|
|
|
PPARA
|
[NCBI]
|
1.6731e-07
|
|
|
GDXY
|
[NCBI]
|
1.64172e-07
|
|
|
IGKC
|
[NCBI]
|
1.64172e-07
|
|
|
NPC1
|
[NCBI]
|
1.60449e-07
|
|
|
IP
|
[NCBI]
|
1.47231e-07
|
|
|
FOS
|
[NCBI]
|
1.27388e-07
|
|
|
VAMP2
|
[NCBI]
|
1.27388e-07
|
|
|
HSPA1A
|
[NCBI]
|
1.27388e-07
|
|
|
NR3C2
|
[NCBI]
|
1.27388e-07
|
|
|
RPE65
|
[NCBI]
|
1.27388e-07
|
|
|
GLB1
|
[NCBI]
|
1.25093e-07
|
|
|
ERCC5
|
[NCBI]
|
1.25093e-07
|
|
|
PEPD
|
[NCBI]
|
1.25093e-07
|
|
|
FABP3
|
[NCBI]
|
1.25093e-07
|
|
|
IKBKG
|
[NCBI]
|
1.25093e-07
|
|
|
ACCN2
|
[NCBI]
|
1.25093e-07
|
|
|
PRKDC
|
[NCBI]
|
1.25093e-07
|
|
|
CD36
|
[NCBI]
|
1.22787e-07
|
|
|
usher syndrome, type i
|
[NCBI]
|
1.17797e-07
|
|
|
PPSH
|
[NCBI]
|
1.17797e-07
|
|
|
SPDA1
|
[NCBI]
|
1.17797e-07
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
1.17797e-07
|
|
|
GJB2
|
[NCBI]
|
1.13645e-07
|
|
|
GUSB
|
[NCBI]
|
1.02288e-07
|
|
|
UGB
|
[NCBI]
|
9.83153e-08
|
|
|
TS
|
[NCBI]
|
9.4283e-08
|
|
|
CYBB
|
[NCBI]
|
9.07377e-08
|
|
|
POU1F1
|
[NCBI]
|
9.07377e-08
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
8.62206e-08
|
|
|
DRD
|
[NCBI]
|
8.62206e-08
|
|
|
MADD
|
[NCBI]
|
8.62206e-08
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
8.62206e-08
|
|
|
MAPK8
|
[NCBI]
|
8.37765e-08
|
|
|
HSR
|
[NCBI]
|
8.37765e-08
|
|
|
TGFBI
|
[NCBI]
|
8.37765e-08
|
|
|
LDHA
|
[NCBI]
|
8.37765e-08
|
|
|
LHB
|
[NCBI]
|
8.37765e-08
|
|
|
TK1
|
[NCBI]
|
8.37765e-08
|
|
|
EDA
|
[NCBI]
|
8.37765e-08
|
|
|
DSG3
|
[NCBI]
|
7.34594e-08
|
|
|
TNFRSF14
|
[NCBI]
|
6.13851e-08
|
|
|
RECQL3
|
[NCBI]
|
6.13851e-08
|
|
|
BLM
|
[NCBI]
|
5.90098e-08
|
|
|
SNCA
|
[NCBI]
|
5.79255e-08
|
|
|
PTEN
|
[NCBI]
|
5.37215e-08
|
|
|
ED1
|
[NCBI]
|
5.17864e-08
|
|
|
MIP
|
[NCBI]
|
5.00894e-08
|
|
|
GZMB
|
[NCBI]
|
5.00894e-08
|
|
|
EGR2
|
[NCBI]
|
5.00894e-08
|
|
|
FKRP
|
[NCBI]
|
5.00894e-08
|
|
|
HK1
|
[NCBI]
|
5.00894e-08
|
|
|
TGM1
|
[NCBI]
|
5.00894e-08
|
|
|
LRP5
|
[NCBI]
|
5.00894e-08
|
|
|
SLC12A3
|
[NCBI]
|
5.00894e-08
|
|
|
HBFQTL1
|
[NCBI]
|
4.94697e-08
|
|
|
DFNB1
|
[NCBI]
|
4.94697e-08
|
|
|
OKS
|
[NCBI]
|
4.94697e-08
|
|
|
ERCC2
|
[NCBI]
|
3.73382e-08
|
|
|
IRF3
|
[NCBI]
|
3.73382e-08
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
3.73382e-08
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
3.73382e-08
|
|
|
IL18
|
[NCBI]
|
3.73382e-08
|
|
|
MEFV
|
[NCBI]
|
3.73382e-08
|
|
|
GCH1
|
[NCBI]
|
3.73382e-08
|
|
|
SMAD4
|
[NCBI]
|
3.73382e-08
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.91632e-08
|
|
|
factor v deficiency
|
[NCBI]
|
2.85634e-08
|
|
|
HBA1
|
[NCBI]
|
2.73445e-08
|
|
|
GJB1
|
[NCBI]
|
2.60916e-08
|
|
|
LDHB
|
[NCBI]
|
2.55633e-08
|
|
|
LYZ
|
[NCBI]
|
2.55633e-08
|
|
|
PAX2
|
[NCBI]
|
2.55633e-08
|
|
|
SCDO1
|
[NCBI]
|
2.53489e-08
|
|
|
glycogen storage disease v
|
[NCBI]
|
2.53489e-08
|
|
|
glycogen storage disease ib
|
[NCBI]
|
2.53489e-08
|
|
|
KRAS
|
[NCBI]
|
2.39036e-08
|
|
|
PD
|
[NCBI]
|
2.19908e-08
|
|
|
HEXA
|
[NCBI]
|
1.95662e-08
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.95662e-08
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.94352e-08
|
|
|
ITGB2
|
[NCBI]
|
1.904e-08
|
|
|
CD40LG
|
[NCBI]
|
1.89287e-08
|
|
|
CAV3
|
[NCBI]
|
1.89287e-08
|
|
|
GRIN1
|
[NCBI]
|
1.89287e-08
|
|
|
KCNJ11
|
[NCBI]
|
1.89287e-08
|
|
|
MSH6
|
[NCBI]
|
1.89287e-08
|
|
|
TWIST1
|
[NCBI]
|
1.89287e-08
|
|
|
RHO
|
[NCBI]
|
1.85522e-08
|
|
|
HPRT1
|
[NCBI]
|
1.76151e-08
|
|
|
ATM
|
[NCBI]
|
1.76151e-08
|
|
|
GRA
|
[NCBI]
|
1.74671e-08
|
|
|
MECP2
|
[NCBI]
|
1.66374e-08
|
|
|
CCD
|
[NCBI]
|
1.54401e-08
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
9.71413e-09
|
|
|
LCA1
|
[NCBI]
|
9.71413e-09
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
9.71413e-09
|
|
|
PPARGC1A
|
[NCBI]
|
9.5189e-09
|
|
|
LRP8
|
[NCBI]
|
9.5189e-09
|
|
|
CD44
|
[NCBI]
|
9.5189e-09
|
|
|
COL4A3
|
[NCBI]
|
9.5189e-09
|
|
|
ATF6
|
[NCBI]
|
9.5189e-09
|
|
|
RPS6
|
[NCBI]
|
9.5189e-09
|
|
|
SLC22A5
|
[NCBI]
|
9.5189e-09
|
|
|
CRYAB
|
[NCBI]
|
9.5189e-09
|
|
|
NOS1
|
[NCBI]
|
9.5189e-09
|
|
|
KIT
|
[NCBI]
|
8.97191e-09
|
|
|
XPC
|
[NCBI]
|
6.52044e-09
|
|
|
ETV6
|
[NCBI]
|
6.52044e-09
|
|
|
PROS1
|
[NCBI]
|
6.52044e-09
|
|
|
TNFSF8
|
[NCBI]
|
6.52044e-09
|
|
|
AREG
|
[NCBI]
|
6.52044e-09
|
|
|
TP73L
|
[NCBI]
|
6.52044e-09
|
|
|
WS1
|
[NCBI]
|
2.50977e-09
|
|
|
HHF2
|
[NCBI]
|
1.63317e-09
|
|
|
CHRNE
|
[NCBI]
|
1.3502e-09
|
|
|
CES1
|
[NCBI]
|
1.3502e-09
|
|
|
GJA8
|
[NCBI]
|
1.3502e-09
|
|
|
PRKAR1A
|
[NCBI]
|
1.3502e-09
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
1.3502e-09
|
|
|
TIMP3
|
[NCBI]
|
1.3502e-09
|
|
|
CD8A
|
[NCBI]
|
1.3502e-09
|
|
|
DYT1
|
[NCBI]
|
1.3502e-09
|
|
|
IFNGR1
|
[NCBI]
|
1.3502e-09
|
|
|
CEL
|
[NCBI]
|
1.02757e-09
|
|
|
charge syndrome
|
[NCBI]
|
8.163e-10
|
|
|
ODDD
|
[NCBI]
|
8.163e-10
|
|
|
OCRL
|
[NCBI]
|
8.163e-10
|
|
|
thiourea tasting
|
[NCBI]
|
8.163e-10
|
|
|
PBD
|
[NCBI]
|
8.163e-10
|
|
|
MRXHF1
|
[NCBI]
|
8.163e-10
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
8.163e-10
|
|
|
gaucher disease, type iii
|
[NCBI]
|
8.163e-10
|
|
|
IPF1
|
[NCBI]
|
5.13723e-10
|
|
|
PITX2
|
[NCBI]
|
5.13723e-10
|
|
|
SMPD1
|
[NCBI]
|
5.13723e-10
|
|
|
TNFRSF10A
|
[NCBI]
|
5.13723e-10
|
|
|
NOG
|
[NCBI]
|
5.13723e-10
|
|
|
PRSS1
|
[NCBI]
|
5.13723e-10
|
|
|
CD2AP
|
[NCBI]
|
5.13723e-10
|
|
|
ARX
|
[NCBI]
|
5.13723e-10
|
|
|
KRT14
|
[NCBI]
|
5.13723e-10
|
|
|
DCC
|
[NCBI]
|
9.43768e-11
|
|